<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>a08-8252_1ex2d1.htm
<DESCRIPTION>AGREEMENT AND PLAN OF MERGER
<TEXT>

<html>

<head>





</head>

<body lang="EN-US">

<div>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 2.1</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="border:none;border-top:double windowtext 1.5pt;padding:1.0pt 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AGREEMENT AND PLAN OF MERGER</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BY AND AMONG</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">IMMUCOR, INC.,</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">MATRIX ACQUISITION COMPANY, INC.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AND</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIOARRAY SOLUTIONS, LTD.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="border:none;border-top:double windowtext 1.5pt;padding:1.0pt 0in 0in 0in;">

<p align="center" style="border:none;margin:0in 0in .0001pt;padding:0in;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Dated March&nbsp;11, 2008</font></b></p>

<div style="border:none;border-bottom:double windowtext 1.5pt;padding:0in 0in 1.0pt 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">TABLE OF CONTENTS</font></b></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.34%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="71%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:71.28%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.38%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Page</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE I. THE MERGER</font></p>
  </td>
  <td width="15%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Merger</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effective Time; Closing</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effect of the Merger</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.4</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate of Incorporation and Bylaws</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.5</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Directors and Officers</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.6</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conversion of Capital Stock</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.7</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Treatment of Matrix Options</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.8</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dissenting Shares</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.9</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Adjustments to Aggregate Merger Consideration</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.10</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional Post-Closing Consideration Adjustments</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE II. EXCHANGE PROCEDURES; ESCROW</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exchange of Certificates</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Escrow</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE III. REPRESENTATIONS AND WARRANTIES WITH RESPECT TO MATRIX</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Organization and Qualification</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Capitalization and Ownership</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authority</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.4</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Consents Required</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.5</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Absence of Violations or Conflicts</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.6</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Financial Statements</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.7</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Absence of Certain Changes or Events</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.8</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Claims Against Matrix</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.9</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Absence of Undisclosed Liabilities</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.10</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Legal Proceedings</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.11</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Environmental Matters</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.12</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Governmental Authorization and Compliance with Laws</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.13</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intellectual Property</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.14</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employee Plans</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.15</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Taxes</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.16</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title to Properties; Adequacy</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.17</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contracts</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.18</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Inventory</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.19</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accounts Receivable</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.20</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Defective Products; Product Liability; Product Recalls</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.21</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Major Customers</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.22</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Major Suppliers</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.23</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Labor Relations</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.24</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Insider Interests</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="100" style="border:none;"></td>
  <td width="22" style="border:none;"></td>
  <td width="511" style="border:none;"></td>
  <td width="115" style="border:none;"></td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.25</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Insurance</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.26</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Corporate Records</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.27</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bank Accounts</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.28</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accounting Controls</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.29</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Board Recommendation</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.30</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Combinations Involving Matrix</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.31</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Brokers, Finders and Investment Bankers</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;3.32</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Information Statement; Warranties True and Correct</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE IV. REPRESENTATIONS AND WARRANTIES OF IMMUCOR</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Organization and Qualification</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authority</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Consents Required</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.4</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Absence of Violations or Conflicts</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.5</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Litigation</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.6</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Brokers, Finders and Investment Bankers</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;4.7</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Financial Ability</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE V. ADDITIONAL COVENANTS AND AGREEMENTS</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preparation of Information Statement; Majority Stockholders Consent</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conduct of Business Pending the Closing</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Reasonable Best Efforts; Further Assurances; Cooperation</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">35</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.4</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expenses</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.5</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Solicitation of Transactions</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.6</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Public Announcements</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.7</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filing under the HSR Act</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.8</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain Employee and Employee Benefit Matters</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.9</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Termination of Matrix Shareholder Agreements</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.10</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Taxes</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.11</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New Subsidiary License and Operating Agreement</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.12</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Trade Secrets Protocol</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;5.13</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Actions to Avoid and Notices of Breaches of Representations and
  Warranties</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE VI. CONDITIONS PRECEDENT TO THE CLOSING</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;6.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions of the Parties&#146; Obligations to Effect the Closing</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;6.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions to Obligations of Immucor and Merger Sub</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;6.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions to Obligations of Matrix</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE VII. ITEMS TO BE DELIVERED AT THE CLOSING</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">45</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;7.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To be Delivered by Matrix</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">45</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;7.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To be Delivered by Immucor and Merger Sub</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">46</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">&nbsp;</font></i></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE VIII. TERMINATION AND ABANDONMENT</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">47</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Termination and Abandonment</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">47</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Specific Performance; Remedies Cumulative</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">47</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='ii',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rights and Obligations upon Termination</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.4</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effect of Termination</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.5</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment upon Termination under Certain Circumstances</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE IX. GENERAL PROVISIONS</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notices</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Table of Contents; Headings; Rules&nbsp;of Construction</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amendment</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.4</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Severability</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.5</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Waiver</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.6</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Third Party Beneficiaries; Assignment</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.7</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Time of the Essence; Computation of Time</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.8</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Counterparts</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.9</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Governing Law; Consent to Jurisdiction; Waiver of Jury Trial</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.10</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Entire Agreement</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;9.11</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnification by Immucor</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 20.15pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE X. SHAREHOLDERS AGENT COMMITTEE</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Appointment and Acceptance</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authorization</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Procedural Matters</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">55</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.4</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Third Party Beneficiaries and Reliance</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">56</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.5</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Successors</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">56</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.6</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Survival of Authorization</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">56</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.7</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Standards and Liability</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">57</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.8</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnification</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">57</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.9</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Implied Agency or Partnership</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">57</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;10.10</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expenses</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">57</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE XI. CERTAIN POST-CLOSING CONSIDERATION ADJUSTMENTS</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">57</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;11.1</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Survival; Agreed Disclaimer of Effect of Knowledge</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">57</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;11.2</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Damages</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">58</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;11.3</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain Limitations</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">61</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;11.4</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distributions from the Escrow Fund</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">62</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;11.5</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Procedures</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">63</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;11.6</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain Rules</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66</font></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.26%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;11.7</font></p>
  </td>
  <td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.36%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exclusive Remedies</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="84%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:84.62%;">
  <p style="margin:0in 1.0in .0001pt 0in;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE XII. DEFINITIONS</font></p>
  </td>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='iii',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DEFINED
TERMS</font></b></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#145;54 Code</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2006 Balance Sheet</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">409A Plan</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">AAA</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">65</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Acquisition Proposal</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Affiliate</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Aggregate Merger Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Antitrust Division</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assumed Option Aggregate Transaction
  Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assumed Option Per Share Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authorization</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authorizations</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Breach</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Business Day</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CERCLA</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate of Designation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate of Merger</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Claim</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Claimant</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">63</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing Bonus Plan</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing Date</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">COBRA</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Code</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Commercially Available Software</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Common Stock Per Share Merger Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Common Stock Share Valuation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Computer Software</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Convertible Preferred Stock</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Copyrights</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Damages</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered General Damages</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">58</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered IP Damages</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">60</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered License Fees</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">61</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Loss</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Delaware Law</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Designated Matrix Employees</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Disclosure Letter</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dispute Notice</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dissenting Shares</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dissenting Stockholder</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distributor</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iv</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='iv',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DOL</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effective Time</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employee Bonus Plan</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" color="black" face="Times New Roman" style="color:black;font-size:10.0pt;">Employee Plans</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employment Agreements</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">End-User Customer</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Environmental Law</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ERISA</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" color="black" face="Times New Roman" style="color:black;font-size:10.0pt;">ERISA Affiliate</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Escrow Agent</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Escrow Agreement</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Escrow Amount Per Share</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Estimated Price Adjustments</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exchange Act</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exchange Agent</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exchange Fund</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Excluded Shares</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expenses Fund</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FIRPTA Certificate</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FTC</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">GAAP</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Governmental Entity</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Governmental Order</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">71</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Hazardous Materials</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">71</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">herein</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">hereof</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">hereto</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">HIPAA</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">HSR Act</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">HSR Waiting Period</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">71</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immucor</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immucor Affiliate</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immucor Material Adverse Effect</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">71</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immucor Protected Party</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">58</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Include</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">including</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indebtedness</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">71</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Independent Accountants</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Individual Escrow Amount</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Information Statement</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intellectual Property</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment Amount</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IRS</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Knowledge</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laws</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lazard</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">v</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='v',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Leases</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Liabilities</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Licensed Matrix Intellectual Property</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Liens</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Majority Stockholders Consent</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Capital Stock</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Certificates</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Common Stock</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Contracts</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Delivered Agreements</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Financial Statements</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Intellectual Property</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Licenses</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Material Adverse Effect</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Option</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Shareholders</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Shareholders Agreements</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Memorandum</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merger</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merger Sub</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Multi-Employer Plan</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New Subsidiary</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New Subsidiary License</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Non-Competition Agreements</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notice of Defense</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">64</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">OGT Patents</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Option Cash Payment</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Owned Matrix Intellectual Property</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" color="black" face="Times New Roman" style="color:black;font-size:10.0pt;">Participants</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Participating Option Holders</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parties</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Party</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Patents</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PBGC</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pending Claim</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pension/Profit-Sharing Plan</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Per Share Merger Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Person</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preferred Class Merger Votes</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preferred Stock Waivers</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Price Adjustments</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prime Rate</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prior Transactions</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Properties</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchaser Delivered Agreements</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">vi</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='vi',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">RCRA</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Reasonable License</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">61</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Required Merger Stockholder Votes</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rules</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">65</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SEC</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series A Per Share Merger Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series A Stock</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series B Per Share Merger Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series B Stock</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series C Certificate of Designation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series C Per Share Merger Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series C Share Valuation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series C Stock</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series D Certificate of Designation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series D Per Share Merger Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series D Share Valuation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series D Stock</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series E Certificate of Designation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series E Per Share Merger Consideration</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series E Share Valuation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Series E Stock</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Share Valuation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shareholders Agent Committee</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Specified Taxes</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Straddle Period</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Subsidiary</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Surviving Corporation</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tax</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tax Authority</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tax Return</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Taxes</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Third Party Claim</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">63</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Third Party Intellectual Property Licenses</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Fund Shares</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Option Cash Payments</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Trade Secrets</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">77</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Trademarks</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">77</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Transaction Document</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">USCIS</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">77</font></p>
  </td>
 </tr>
 <tr>
  <td width="90%" valign="top" style="padding:0in 0in 0in 0in;width:90.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">USPTO</font></p>
  </td>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.86%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">77</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBITS</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.08%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.5%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form&nbsp;of Matrix Legal
  Opinion</font></p>
  </td>
 </tr>
 <tr>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.08%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.5%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form&nbsp;of New Subsidiary
  License</font></p>
  </td>
 </tr>
 <tr>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.08%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.5%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Terms of Matrix Ownership
  of Membership Interests in New Subsidiary</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">vii</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='vii',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D.</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.08%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.5%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employee Bonus Plan and
  Closing Bonus Plan</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">viii</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='viii',FILE='C:\JMS\eudelhofen\08-8252-1\task2785794\8252-1-kc-01.htm',USER='eudelho',CD='Mar 17 14:34 2008' -->



<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;page-break-after:avoid;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AGREEMENT AND PLAN OF MERGER</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;page-break-after:avoid;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THIS AGREEMENT AND PLAN OF
MERGER (this &#147;<b><u style="font-weight:bold;">Agreement</u></b>&#148;)
is made March&nbsp;11,&nbsp;2008, by and among IMMUCOR, INC., a Georgia
corporation (&#147;<b><u style="font-weight:bold;">Immucor</u></b>&#148;),
MATRIX ACQUISITION COMPANY, INC., a Delaware corporation and a wholly owned
subsidiary of Immucor (&#147;<b><u style="font-weight:bold;">Merger Sub</u></b>&#148;),
and BIOARRAY SOLUTIONS, LTD, a Delaware corporation (&#147;<b><u style="font-weight:bold;">Matrix</u></b>&#148;).&#160; The foregoing parties to this Agreement are
each a &#147;<b><u style="font-weight:bold;">Party</u></b>&#148; and
collectively the &#147;<b><u style="font-weight:bold;">Parties</u></b>.&#148;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BACKGROUND STATEMENT</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The respective Boards of Directors of Immucor
and Matrix have approved this Agreement and the transactions contemplated
hereby, including the Merger, and deemed it advisable and in the best interests
of their respective corporations and stockholders that the Parties consummate
the Merger and the other transactions provided for herein.&#160; Contemporaneously with the execution and
delivery of this Agreement, Immucor entered into (A)&nbsp;employment agreements
with Michael Seul, Ph.D., Chiu Chau, and James E. Russo (the &#147;<b><u style="font-weight:bold;">Employment Agreements</u></b>&#148;) and (B)&nbsp;non-competition
and non-disclosure Agreements with Michael Seul, Ph.D., Chiu Chau, R. James
Danehy, James E. Russo, Ghazala Hashmi, Ph.D. and Yongjian (Jack) Zheng, Ph.D.
(the &#147;<b><u style="font-weight:bold;">Non-Competition Agreements</u></b>&#148;).&#160; Such agreements will become effective upon
consummation of the transactions contemplated hereby.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;page-break-after:avoid;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">STATEMENT OF AGREEMENT</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;page-break-after:avoid;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, in consideration of the
mutual representations, warranties, covenants and agreements contained herein,
and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, and intending to be legally bound hereby, the Parties
agree as follows:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h1 style="font-size:10.0pt;font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;text-indent:0in;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:none;">ARTICLE I.</font></b><font face="Times New Roman" style="font-weight:normal;text-transform:none;"><br>
</font><font face="Times New Roman" style="text-transform:none;">THE MERGER</font></h1>

<h1 style="font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;text-indent:0in;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></h1>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.1</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
Merger.</b>&#160; At the Effective Time and
subject to and upon the terms and conditions of this Agreement and the applicable
provisions of the Delaware General Corporation Law (&#147;<b><u style="font-weight:bold;">DGCL</u></b>&#148;), Merger Sub shall be merged with
and into Matrix (the &#147;<b><u style="font-weight:bold;">Merger</u></b>&#148;),
the separate corporate existence of Merger Sub shall cease and Matrix shall
continue as the surviving<b>  </b>corporation.&#160; Matrix, as the surviving corporation after
the Merger, is hereinafter sometimes referred to as the &#147;<b><u style="font-weight:bold;">Surviving Corporation</u></b>.&#148;</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.2</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Effective
Time; Closing.</b>&#160; Subject to the
provisions of this Agreement, the Parties shall cause the Merger to be
consummated by filing a Certificate of Merger with the Secretary of State of
the State of Delaware (the &#147;<b><u style="font-weight:bold;">Certificate of
Merger</u></b>&#148;) (the time of such filing being the &#147;<b><u style="font-weight:bold;">Effective Time</u></b>&#148;) as soon as practicable
on or after the Closing Date.&#160; The
closing of the Merger (the &#147;<b><u style="font-weight:bold;">Closing</u></b>&#148;)
shall take place (a)&nbsp;at the offices of Sutherland Asbill&nbsp;&amp;
Brennan </p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='1',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">LLP, 999 Peachtree Street NE, Atlanta, Georgia 30309, 10:00&nbsp;a.m.,
local time on the third (3rd) Business Day after the conditions set forth in <u>Article&nbsp;VI</u>
are satisfied or waived by the Party or Parties entitled to waive them, or (b)&nbsp;at
such other place and time as the Parties may agree (the &#147;<b><u style="font-weight:bold;">Closing Date</u></b>&#148;).</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.3</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Effect
of the Merger.</b>&#160; At the Effective
Time, the effect of the Merger shall be as provided in this Agreement and the
applicable provisions of the DGCL.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.4</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Certificate
of Incorporation and Bylaws.</b>&#160; The
Certificate of Incorporation of Merger Sub as in effect immediately prior to
the Effective Time shall be the Certificate of Incorporation of the Surviving
Corporation, until thereafter amended in accordance with and as provided in
such Certificate of Incorporation and applicable law, except that at the
Effective Time, the name of the Surviving Corporation will remain BioArray
Solutions, Ltd.&#160; The Bylaws of Merger Sub
as in effect immediately prior to the Effective Time shall be the Bylaws of the
Surviving Corporation, until thereafter amended in accordance with and as
provided in such Bylaws, the Certificate of Incorporation and applicable law.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.5</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Directors
and Officers.</b>&#160; The members of the
Board of Directors of the Merger Sub immediately prior to the Effective Time
shall be the Board of Directors of the Surviving Corporation until their
respective successors are duly elected or appointed and qualified.&#160; The officers of the Merger Sub immediately
prior to the Effective Time shall be the officers of the Surviving Corporation
until their respective successors are duly appointed.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.6</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Conversion
of Capital Stock.</b>&#160; At the Effective
Time, by virtue of the Merger and without any action on the part of Immucor,
Merger Sub, Matrix or the holder of any shares of capital stock of Merger Sub
or of shares of capital stock of Matrix:</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Conversion of Merger Sub Capital
Stock</i></b>.<i>&nbsp; </i>The
capital stock of Merger Sub issued and outstanding immediately prior to the
Effective Time shall be converted into and become a like number of fully paid
and non-assessable shares of capital stock of the Surviving Corporation.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Cancellation of Treasury Stock</i></b>.<i>&nbsp; </i>Each share of Matrix Capital Stock
held in treasury by Matrix immediately prior to the Effective Time
(collectively, the &#147;<b><u style="font-weight:bold;">Excluded Shares</u></b>&#148;)&nbsp;shall
be canceled automatically and shall cease to exist, and no consideration shall
be paid in exchange for those Excluded Shares.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Consideration; Conversion of Matrix
Capital Stock</i></b>.<i>&nbsp; </i>The
&#147;<b><u style="font-weight:bold;">Aggregate Merger Consideration</u></b>&#148;
shall consist of an amount equal to $120,000,000, subject to adjustment as
provided in <u>Section&nbsp;1.9</u>.&#160; The
Aggregate Merger Consideration also is subject to adjustment after the Closing
Date as provided in <u>Section&nbsp;1.10</u> and <u>Article&nbsp;XI</u>.&#160; However, solely for purposes of determining
the Aggregate Merger Consideration in connection with consummation of the
Merger at the Effective Time (including with respect to determining the Common
Stock Share Valuation under <u>Section&nbsp;1.6(c)(vii)</u>), and without
limiting or otherwise impairing the effect of <u>Article&nbsp;XI</u> for any
other purpose, the adjustments contemplated under <u>Article&nbsp;XI</u> shall
not be taken into account.</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each
Matrix Shareholder that is not a Dissenting Stockholder shall receive the
portion of the Aggregate Merger Consideration allocated to such Matrix
Shareholder in accordance with <u>Sections 1.6(c)(ii)-(vii)</u>.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each
share of Series&nbsp;E Stock issued and outstanding immediately prior to the
Effective Time, other than Dissenting Shares, shall be converted into the right
to receive an amount of cash, without interest (the &#147;<b><u style="font-weight:bold;">Series&nbsp;E Per Share Merger Consideration</u></b>&#148;),
equal to $0.50, plus the amount of any accrued and unpaid dividends thereon as
of the Effective Time (the &#147;<b><u style="font-weight:bold;">Series&nbsp;E
Share Valuation</u></b>&#148;).</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each share of Series&nbsp;D Stock issued and
outstanding immediately prior to the Effective Time, other than Dissenting
Shares, shall be converted into the right to receive an amount of cash, without
interest (the &#147;<b><u style="font-weight:bold;">Series&nbsp;D Per Share
Merger Consideration</u></b>&#148;), equal to $0.50, plus the amount of any
accrued and unpaid dividends thereon as of the Effective Time (the &#147;<b><u style="font-weight:bold;">Series&nbsp;D Share Valuation</u></b>&#148;).</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each
share of Series&nbsp;C Stock issued and outstanding immediately prior to the
Effective Time, other than Dissenting Shares, shall be converted into the right
to receive an amount of cash, without interest (the &#147;<b><u style="font-weight:bold;">Series&nbsp;C Per Share Merger Consideration</u></b>&#148;),
equal to $0.50, plus the amount of any accrued and unpaid dividends thereon as
of the Effective Time (the &#147;<b><u style="font-weight:bold;">Series&nbsp;C
Share Valuation</u></b>&#148;).</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each
share of Series&nbsp;B Stock issued and outstanding immediately prior to the
Effective Time, other than Dissenting Shares, shall be converted into the right
to receive the consideration per share provided for in <u>Section&nbsp;1.6(c)(vii)&nbsp;</u>(the
&#147;<b><u style="font-weight:bold;">Series&nbsp;B Per Share Merger
Consideration</u></b>&#148;).</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each
share of Series&nbsp;A Stock issued and outstanding immediately prior to the
Effective Time, other than Dissenting Shares, shall be converted into the right
to receive the consideration per share provided for in <u>Section&nbsp;1.6(c)(vii)&nbsp;</u>(the
&#147;<b><u style="font-weight:bold;">Series&nbsp;A Per Share Merger
Consideration</u></b>&#148;).</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each share of Matrix Common Stock, Series&nbsp;A
Stock and Series&nbsp;B Stock issued and outstanding immediately prior to the
Effective Time, other than Dissenting Shares, shall be converted into the right
to receive an amount of cash, without interest (the &#147;<b><u style="font-weight:bold;">Common Stock Per Share Merger Consideration</u></b>&#148;),
equal to the result obtained by dividing (A)&nbsp;an amount equal to the
Aggregate Merger Consideration minus the aggregate of all amounts to be paid
pursuant to <u>Sections 1.6(c)(ii)</u>, <u>(iii)&nbsp;</u>and <u>(iv)</u>; by (B)&nbsp;the
total number of shares of Matrix Common Stock, Series&nbsp;A Stock and Series&nbsp;B
Stock issued and outstanding immediately prior to the Effective Time, other
than Excluded Shares (the &#147;<b><u style="font-weight:bold;">Common Stock
Share Valuation</u></b>&#148;).</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(viii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any election by a holder of Series&nbsp;E
Stock, Series&nbsp;D Stock, Series&nbsp;C Stock, Series&nbsp;B or Series&nbsp;A
Stock (collectively, the &#147;<b><u style="font-weight:bold;">Convertible
Preferred Stock</u></b>&#148;) to convert such holder&#146;s Convertible Preferred
Stock into Matrix Common Stock must be communicated by such holder to Matrix,
if at all, prior to the Closing Date.</h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ix)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All
issued and outstanding shares of Matrix Capital Stock that have been converted
into the right to receive the Per Share Merger Consideration as provided in
this <u>Section&nbsp;1.6(c)&nbsp;</u>shall be canceled automatically and shall
cease to exist, and the holders of certificates which immediately prior to the
Effective Time represented those shares (&#147;<b><u style="font-weight:bold;">Matrix
Certificates</u></b>&#148;) shall cease to have any rights with respect to
those shares, other than the right to receive the Per Share Merger
Consideration upon surrender of Matrix Certificates in accordance with <u>Section&nbsp;2.1(b)</u>.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.7</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Treatment
of Matrix Options.</b>&#160; Matrix shall take
all necessary actions to cause each Matrix Option outstanding, whether or not
then exercisable or vested, either to be exercised or terminated and cancelled
prior to the Effective Time and without any Liability as of or after the
Effective Time to Matrix, Immucor or any of their Affiliates (other than as
provided in this <u>Section&nbsp;1.7</u>), including obtaining all necessary
consents or approvals from holders of Matrix Options.&#160; Each holder of a Matrix Option, whether
vested or unvested, unexercised prior to the Effective Time shall be entitled
to receive in exchange for such Matrix Option, as promptly as practicable
following the Effective Time, a cash payment (less applicable withholding taxes
and without interest) from the Surviving Corporation, in the case of employee
stock options, and from the Exchange Agent, in the case of other stock options
and warrants<b>  </b>(the &#147;<b><u style="font-weight:bold;">Option Cash Payment</u></b>&#148; and the sum of all
such payments, the &#147;<b><u style="font-weight:bold;">Total Option Cash
Payments</u></b>&#148;), equal to the product of (a)&nbsp;the excess, if any,
of the Assumed Option Per Share Merger Consideration over the exercise price
per share of such Matrix Option multiplied by (b)&nbsp;the number of shares of
Matrix Common Stock issuable upon exercise of such Matrix Option.&#160; No payment will be due with respect of any
Matrix Option with an exercise price equal to or greater than the Per Share Merger
Consideration as so determined.&#160; From and
after the Effective Time, no holder of a Matrix Option shall have any rights in
respect thereof other than to receive the Option Cash Payment, if any, due with
respect thereto.&#160; Matrix will use
reasonable best efforts to cause each holder of a Matrix Option to execute and
deliver to Immucor prior to the Closing a waiver and release form relating to
the termination and cancellation of each Matrix Option, together with an
agreement to be bound by <u>Section&nbsp;2.2</u>, <u>Article&nbsp;XI</u> and
the provisions relating to the Shareholders Agent Committee, in a form
reasonably satisfactory to Immucor.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.8</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Dissenting
Shares.</b>&#160; Notwithstanding anything in
this Agreement to the contrary, any issued and outstanding share of Matrix Capital
Stock held by a Person (a &#147;<font style="text-decoration:underline;"><b><u style="font-weight:bold;">Dissenting Stockholder</u></b></font>&#148;) who has not voted in favor
of or consented to the adoption of this Agreement and has complied with all the
provisions of the DGCL concerning the right of holders of Matrix Capital Stock
to require appraisal of their shares of Matrix Capital Stock (&#147;<font style="text-decoration:underline;"><b><u style="font-weight:bold;">Dissenting Shares</u></b></font>&#148;)
shall not be converted into the right to receive the Per Share Merger
Consideration as described in <font style="text-decoration:underline;"><u>Section&nbsp;1.6(c)</u></font>,
but shall become the right to receive such consideration as may be determined
to be due to such Dissenting Stockholder pursuant to the procedures set forth
in Section&nbsp;262 of the DGCL.&#160; If such
Dissenting Stockholder withdraws its demand for appraisal or fails to perfect
or otherwise loses its right of appraisal, in any case pursuant to the DGCL,
its shares of Matrix Capital Stock shall be deemed to be converted as of the
Effective Time into the right to receive the Per Share Merger Consideration for
</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">each such share of Matrix Capital Stock in accordance with the
provisions of this Agreement (it being understood that if such Dissenting
Stockholder withdraws its demand for appraisal or fails to perfect or otherwise
loses its right of appraisal, in any case pursuant to the DGCL, its shares of
Matrix Capital Stock shall be deemed to be converted as of the Effective Time
into the right to receive the Merger Consideration for each such share of
Matrix Capital Stock, without interest).&#160;
At the Effective Time, any holder of Dissenting Shares shall cease to
have any rights with respect thereto, except the rights set forth in Section&nbsp;262
of the DGCL and as provided in the previous sentence.&#160; Any payments required to be made with respect
to the Dissenting Shares shall be made by the Surviving Corporation (and not by
Immucor).&#160; Matrix shall give Immucor
prompt notice of any demands for appraisal of Matrix Capital Stock received by
Matrix, withdrawals of such demands and any other instruments served pursuant
to Section&nbsp;262 of the DGCL and shall give Immucor the opportunity to
participate in all negotiations and proceedings with respect thereto.&#160; Matrix shall not, without the prior written
consent of Immucor, make any payment with respect to, or settle or offer to
settle, any such demands.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.9</font></b><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Adjustments to Aggregate Merger Consideration</font>.</b></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
amount of the Aggregate Merger Consideration shall be subject to the following
adjustments (the &#147;<b><u style="font-weight:bold;">Price Adjustments</u></b>&#148;).&#160; The Aggregate Merger Consideration shall be:</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Decreased
by an amount equal to any Indebtedness of Matrix or any Subsidiary outstanding
as of the Effective Time, including accrued but unpaid interest and the amount
of any breakage, prepayment penalties or fees payable in connection with the
pay-off of such Indebtedness as of the Effective Time.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Decreased
by an amount equal to the amount due or to become due to Lazard Freres&nbsp;&amp;
Co. LLC (&#147;<b><u style="font-weight:bold;">Lazard</u></b>&#148;) from
Matrix or any Subsidiary arising in any way out of the Merger and the
engagement by Matrix of Lazard in connection with the potential sale of Matrix,
including fees and expense reimbursements.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>[Intentionally Omitted]</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Decreased
by an amount equal to the excess of (A)&nbsp;the sum of amounts paid or payable
to Dissenting Stockholders <u>plus</u> the amount of any expenses and fees
(including reasonable attorneys fees and expenses) incurred or paid by Matrix
or the Surviving Corporation after the date of this Agreement or by Immucor in
connection with any proceedings or negotiations with Dissenting Stockholders
over (B)&nbsp;the amounts, calculated for each class of Matrix Capital Stock to
which Dissenting Shares belong, equal to the applicable Per Share Merger
Consideration (with Aggregate Merger Consideration being determined for this
purpose without regard to the Price Adjustment provided for in this <u>Section&nbsp;1.9(a)(iv)</u>)
multiplied by the total number of Dissenting Shares belonging to the class of
Matrix Capital Stock to which such Per Share Merger Consideration applies.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Decreased
by an amount equal to the sum of the following with respect to any current or
former member of the Matrix Board of Directors, officer, employee, leased
employee or independent contractor arising as a result of the execution and
delivery of this Agreement or the consummation of the transactions contemplated
hereby (either alone or in combination with another event): (A)&nbsp;any
payment made or to be made in connection with the Closing pursuant to any
non-competition agreements, or </h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='5',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">any severance, retention, closing bonus or other payment becoming due
(including any amounts paid pursuant to <u>Section&nbsp;5.2(b)(viii)(A)&nbsp;</u>and
the total amounts payable under the Employee Bonus Plan and the Closing Bonus
Plan in accordance with their terms, but excluding with respect to Designated
Matrix Employees to the extent stated in the proviso in the fifth sentence of <u>Section&nbsp;5.8</u>);
(B)&nbsp;the added cost to Matrix of the amount of any compensation or benefit
the time of payment of which is accelerated or the vesting of which is accelerated
(other than Matrix Options); (C)&nbsp;any cost or other liability, including
the value of any lost tax deduction, that arises with respect to the payment of
any amount that could, individually or in combination with any other such
payment, constitute an &#147;excess parachute payment,&#148; as defined in Section&nbsp;280G(b)(1)&nbsp;of
the Code; and (D)&nbsp;the amount of any Indebtedness forgiven.</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Decreased
by an amount equal to the sum of (A)&nbsp;all cash dividends, if any, paid
after the date of this Agreement and (B)&nbsp;all cash redemptions or
other&nbsp;purchases of any Matrix Capital Stock after the date of this
Agreement.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Decreased by an amount equal to the Total
Option Cash Payments to be made in cancellation of Matrix Options, as
contemplated by <u>Section&nbsp;1.7</u>.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(viii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Decreased by the amounts required pursuant to <u>Section&nbsp;6.2(b)(ii)&nbsp;</u>and
the first sentence of <u>Section&nbsp;6.2(b)(v)</u>.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Not
less than five Business Days prior to Closing, Matrix will deliver to Immucor a
reasonably detailed estimate of the Price Adjustments (the &#147;<b><u style="font-weight:bold;">Estimated Price Adjustments</u></b>&#148;).&#160; Matrix will provide to Immucor all additional
information reasonably requested by Immucor to allow it to review the
calculation and amount of the Price Adjustments, including verification from
third parties as to amounts owed.&#160;
Subject to Immucor&#146;s review and reasonable approval of the Estimated
Price Adjustments, the Aggregate Merger Consideration to be payable at the
Effective Time will be increased or decreased, as applicable, based on the
Estimated Price Adjustments.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Immucor
shall be entitled to verify the Estimated Price Adjustments after the
Closing.&#160; If it elects to do so, as
promptly as practicable and in any event within 60 days after the Effective
Time, Immucor shall deliver to the Shareholders Agent Committee Immucor&#146;s
calculation of the Price Adjustments (exclusive of any unresolved adjustments
in respect of any Dissenting Shares), which shall reflect in reasonable detail
the differences between Immucor&#146;s calculation and the Estimated Price
Adjustments.&#160; If there are any Dissenting
Shares, Immucor shall supplement its calculation of the Price Adjustments
within 20 days after the final resolution of all obligations in respect of
Dissenting Shares.&#160; If Immucor does not
deliver its calculations within the timeframes set forth in this <u>Section&nbsp;1.9(c)</u>,
the Estimated Price Adjustments shall be the final Price Adjustments and shall
become final, binding and conclusive for all purposes of this <u>Section&nbsp;1.9</u>.&#160; Immucor will provide to the Shareholders
Agent Committee all additional information reasonably requested by the
Shareholders Agent Committee to allow it to review Immucor&#146;s calculation of the
Price Adjustments.&#160; Immucor&#146;s calculation
of the Price Adjustments shall be final and binding on the parties hereto,
subject to the process of objection provided below in this <u>Section&nbsp;1.9</u>.</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='6',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If
the Shareholders Agent Committee disagrees with Immucor&#146;s calculation of the
Price Adjustments, then the Shareholders Agent Committee may, within 20 days
after delivery of Immucor&#146;s calculation of the Price Adjustments, deliver a
notice (the &#147;<b><u style="font-weight:bold;">Dispute Notice</u></b>&#148;)
to Immucor, setting forth the Shareholders Agent Committee&#146;s calculation of the
Price Adjustments and specifying, in reasonable detail, those items or amounts
affecting the calculation as to which it disagrees and the reasons for such
disagreement.&#160; If, prior to the
conclusion of such 20-day period, the Shareholders Agent Committee notifies
Immucor in writing that it will not provide a Dispute Notice, or if a Dispute
Notice is not delivered within such 20-day period, Immucor&#146;s calculation of the
Price Adjustments shall become final, conclusive and binding on the parties
hereto for all purposes of this <u>Section&nbsp;1.9</u>.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If
the Shareholders Agent Committee delivers a Dispute Notice as provided above,
Immucor and the Shareholders Agent Committee shall use commercially reasonable
efforts to reach agreement on the disputed items or amounts.&#160; If they do not resolve all disputed items or
amounts set forth in the Dispute Notice within 15 days after delivery of such
Dispute Notice, the remaining disputed items and amounts will be submitted to
BDO Seidman, LLP or such other nationally&#160;
recognized independent accounting firm in the U.S. as mutually agreed to
by Immucor and the Shareholders Agent Committee (the &#147;<b><u style="font-weight:bold;">Independent Accountants</u></b>&#148;)&nbsp;for
resolution of such disputed items and amounts.&#160;
Immucor and the Shareholders Agent Committee will have the opportunity
to present their positions with respect to such disputed items and amounts to
the Independent Accountants, and such disputed items and amounts shall be
resolved by the Independent Accountants in accordance with the requirements of
this <u>Section&nbsp;1.9</u>; provided that the Independent Accountants may not
resolve a disputed amount outside the range defined by the values of such
amount requested by each of the Shareholders Agent Committee and Immucor.&#160; The Independent Accountants shall prepare a
written report setting forth the resolution of such disputed items and amounts
and calculating the revised amount of the Price Adjustments, which shall be
delivered to each of Immucor and the Shareholders Agent Committee promptly, but
in no event later than 30 days after such disputed items and amounts are
submitted to the Independent Accountants.&#160;
Such revised amount shall not reflect any difference from the amount of
Immucor&#146;s calculation of the Price Adjustments other than differences required
to reflect the resolution of such disputed items and amounts by the Independent
Accountants.&#160; The revised amount of the
Price Adjustments set forth on the Independent Accountants&#146; written report
shall be final, conclusive and binding upon the parties hereto.&#160; The procedures set forth in this Agreement
for resolution of disputes concerning the Price Adjustments shall be final and
binding on all of the parties, and shall not be subject to appeal of any
kind.&#160; The fees and disbursements of the
Independent Accountants shall be borne by the party whose determination of the
Price Adjustments is farthest in difference from the revised amount of the
Price Adjustments set forth in the Independent Accountants&#146; written report,
with the expenses of the Shareholders Agent Committee incurred during the
process of any dispute hereunder funded from the amounts in the Expenses
Fund.&#160; Each of Immucor and the
Shareholders Agent Committee shall execute a reasonably acceptable engagement
letter, if requested to do so by the Independent Accountants, and shall provide
reasonable access to their respective employees who are responsible for
financial matters, and Immucor shall provide reasonable access to the books and
records of Immucor and its subsidiaries, including the Surviving Corporation.</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='7',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon
the final determination of the Price Adjustments in accordance with this <u>Section&nbsp;1.9</u>:</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If
the Aggregate Merger Consideration as calculated at the Effective Time is
greater than the Aggregate Merger Consideration when calculated with the final
Price Adjustments, then Immucor and the Shareholders Agent Committee will
execute and deliver to the Escrow Agent, within five Business Days after such
final determination, instructions for the payment of the difference to Immucor
out of the Escrow Fund.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If
the Aggregate Merger Consideration as calculated at the Effective Time is less
than the Aggregate Merger Consideration when calculated with the final Price
Adjustments, then Immucor shall cause the Surviving Corporation to deliver to
the Shareholders Agent Committee, within five Business Days after such final
determination, for distribution by them to the Matrix Shareholders and holders
of Matrix Options as an increase to the Aggregate Merger Consideration, cash
(by wire transfer of immediately available funds) in an amount equal to the
difference.&#160; Payment by the Surviving
Corporation to the Shareholders Agent Committee pursuant hereto shall fully
discharge all obligations of Immucor, the Surviving Corporation, Matrix and
their respective Affiliates to make payments to the Matrix Shareholders and
holders of Matrix Options as a result of Price Adjustments.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;1.10</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Additional
Post-Closing Consideration Adjustments.</b>&#160;
The Aggregate Merger Consideration shall be reduced by (a)&nbsp;the
amount, if any, of Covered Damages payable to an Immucor Protected Party
pursuant to <u>Article&nbsp;XI</u> and (b)&nbsp;upon final resolution of a
Pending Claim, the aggregate of the amounts, if any, of the Covered Damages
payable to an Immucor Protected Party pursuant to such resolution.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h1 style="font-size:10.0pt;font-weight:bold;margin:0in 0in .0001pt;page-break-after:avoid;text-align:center;text-indent:0in;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:none;">ARTICLE II.</font></b><font face="Times New Roman" style="font-weight:normal;text-transform:none;"><br>
</font><font face="Times New Roman" style="text-transform:none;">EXCHANGE PROCEDURES; ESCROW</font></h1>

<h1 style="font-weight:bold;margin:0in 0in .0001pt;page-break-after:avoid;text-align:center;text-indent:0in;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></h1>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.1</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Exchange
of Certificates.</b></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Exchange Agent</i></b>.<i>&nbsp; </i>Subject to the provisions of <u>Sections
1.9</u>, <u>2.1(b)(ii)</u>, <u>2.1(e)</u>, <u>2.2</u>, <u>6.2(b)(v)&nbsp;</u>and
<u>6.2(h)</u>, at the Effective Time, Immucor shall deposit with its transfer
agent, or with such other bank or trust company designated by Immucor prior to
the Effective Time and reasonably acceptable to Matrix (the &#147;<b><u style="font-weight:bold;">Exchange Agent</u></b>&#148;), for exchange in
accordance with <u>Article&nbsp;I</u>, immediately available funds in amounts
necessary to make the payments pursuant to <u>Section&nbsp;1.6(c)&nbsp;</u>(such
funds being hereinafter referred to as the &#147;<b><u style="font-weight:bold;">Exchange Fund</u></b>&#148;).&#160; No
later than five (5)&nbsp;Business Days before the Closing, Matrix shall submit
to Immucor a schedule (the &#147;<b><u style="font-weight:bold;">Final Payment Schedule</u></b>&#148;)
listing:</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
full name of each legal and beneficial holder of Matrix Capital Stock and
Matrix Options;</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In
separate columns for each class of Matrix Capital Stock next to the name of
each legal and beneficial holder of Matrix Capital Stock, (A)&nbsp;the
certificate number of each Matrix Certificate issued to such holder, (B)&nbsp;the
number of shares of the </h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='8',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">class in question represented by each such Matrix Certificate, (C)&nbsp;the
aggregate number of shares of the class in question owned by such holder, and (D)&nbsp;the
payments required to be made to such holder in accordance with the provisions
of this Agreement as a result of the Merger with respect to shares of Matrix
Capital Stock issued and outstanding as of the Closing, whether or not the
holder is or will be a Dissenting Stockholder and without taking into account
any withholdings or set offs; and</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In separate columns for each legal and
beneficial holder of a Matrix Option, (A)&nbsp;for each Matrix Option held by
such holder, the number of shares of Matrix Common Stock subject to such Matrix
Option, (B)&nbsp;the exercise price per share of each Matrix Option and (C)&nbsp;the
total amount of the payments to be made to such holder in accordance with the
provisions of this Agreement as a result of the Merger with respect to such
Matrix Options assuming they are not exercised.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of each Matrix Certificate (front and reverse side) shall be
attached to the Final Payment Schedule in the order presented on the Final
Payment Schedule. The Final Payment Schedule shall be subject to the review of
Immucor, shall be adjusted as necessary to comply with the requirements of this
Agreement and, upon final approval by Immucor and Matrix, shall be reflected in
a jointly executed certificate. Immucor shall bear all charges and fees of the
Exchange Agent.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Exchange Procedures</i></b>.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Letter of Transmittal</u></i>.&#160; The parties shall cause to be mailed to each
holder of record of a Matrix Certificate or a Matrix Option, (A)&nbsp;a letter
of transmittal, specifying that delivery shall be effected, and risk of loss
and title to the Matrix Certificates shall pass, only upon proper delivery of
Matrix Certificates to the Exchange Agent; (B)&nbsp;a certificate in customary
form stating that such Matrix Shareholder is not a &#147;foreign person&#148; within the
meaning of Section&nbsp;1445 of the Code (the &#147;<b><u style="font-weight:bold;">FIRPTA Certificate</u></b>&#148;) and (C)&nbsp;instructions for
surrendering Matrix Certificates.&#160; The
letter of transmittal will include a release of all claims a holder of Matrix
Capital Stock may have against Matrix, Immucor, their officers, directors and
Affiliates, other than claims related to (i)&nbsp;rights arising under this
Agreement with respect to the Merger, (ii)&nbsp;in the case of employees,
rights to accrued but unpaid compensation, and (iii)&nbsp;rights under agreements
entered into pursuant to this Agreement or contemplated by this Agreement to
survive the Effective Time.&#160; The letter
of transmittal will contain an agreement and acknowledgement that, by executing
the letter of transmittal, a Matrix Shareholder consents to, approves and
agrees to be bound by the terms and conditions of (i)&nbsp;this Agreement,
including <u>Article&nbsp;XI</u>, and (ii)&nbsp;the Escrow Agreement.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Surrender of Matrix Certificates</u></i>.&#160; Upon surrender of a Matrix Certificate for
cancellation to the Exchange Agent, together with a duly executed letter of
transmittal and any other documents required by the Exchange Agent, the holder
of that Matrix Certificate shall be entitled to receive in exchange therefor
the Per Share Merger Consideration payable in respect of that Matrix
Certificate (less any withholding of Taxes as provided in <u>Section&nbsp;2.1(f)&nbsp;</u>and
any withholdings pursuant to the last sentence of this <u>Section&nbsp;2.1(b)(ii)</u>)
promptly thereafter, and in any event within five Business Days </h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='9',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">thereafter.&#160; Any
Matrix Certificates so surrendered shall be canceled immediately.&#160; No interest shall accrue or be paid on any
amount payable upon surrender of Matrix Certificates.&#160; Such payment shall be made at the Effective Time
by wire transfer with respect to those Matrix Certificates surrendered for
cancellation to the Exchange Agent not later than five (5)&nbsp;Business Days
prior to the Effective Time, together with a duly completed and executed letter
of transmittal and any other documents required by the Exchange Agent and
together with wire transfer instructions.&#160;
Each of the Exchange Agent and the Surviving Corporation shall be
entitled to deduct and withhold from any consideration payable or otherwise
deliverable pursuant to this Agreement to any holder or former holder of Matrix
Capital Stock the amount of any Indebtedness owed by such holder or former
holder to Matrix, in which case such Indebtedness shall be deemed satisfied and
paid in full. Immucor shall cause Matrix to mark any note in its possession for
such Indebtedness &#147;paid in full&#148; and to return the marked note to the maker.</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Unregistered
Transferees</u></i>.&#160; If any Per
Share Merger Consideration is to be issued or paid to a Person other than the
Person in whose name the surrendered Matrix Certificate is registered, then the
Per Share Merger Consideration may be issued or paid to such a transferee so
long as (A)&nbsp;the surrendered Matrix Certificate is accompanied by all
documents required to evidence and effect that transfer and (B)&nbsp;the Person
requesting such exchange (1)&nbsp;pays any applicable transfer Taxes or (2)&nbsp;establishes
to the reasonable satisfaction of Immucor and the Exchange Agent that any such
Taxes have already been paid or are not applicable.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">No Other Rights</u></i>.&#160; Until surrendered in accordance with this <u>Section&nbsp;2.1(b)</u>,
each Matrix Certificate shall be deemed, from and after the Effective Time, to
represent only the right to receive the applicable Per Share Merger
Consideration.&#160; The Per Share Merger
Consideration issued or paid upon the surrender of any Matrix Certificate shall
be deemed to have been issued or paid in full satisfaction of all rights
pertaining to that Matrix Certificate and the shares of Matrix Capital Stock
formerly represented by it.</h4>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Distributions with Respect to
Unexchanged Shares</i></b>.<i>&nbsp; </i>No
dividends or other distributions shall be payable with respect to any
unsurrendered Matrix Certificate.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">No Further Transfers</i></b>.<i>&nbsp; </i>At the Effective Time, the transfer
books of Matrix shall be closed and there shall be no further registration of
transfers of the shares of Matrix Capital Stock that were outstanding
immediately prior to the Effective Time.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Required Withholding</i></b>.<i>&nbsp; </i>Each of the Exchange Agent and the
Surviving Corporation shall be entitled to deduct and withhold from any
consideration payable or otherwise deliverable pursuant to this Agreement to
any holder or former holder of Matrix Capital Stock such amounts as may be
required to be deducted or withheld therefrom under the Code or under any
provision of state, local or foreign Tax law.&#160;
To the extent such amounts are so deducted or withheld, the amount of
such consideration shall be treated for all purposes under this Agreement as
having been paid to the Person to whom such consideration would otherwise have
been paid.</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='10',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Investment of Exchange Fund</i></b>.<i>&nbsp; </i>The Exchange Agent shall invest the
Exchange Fund as directed by Immucor.&#160;
Any interest and other income resulting from such investment shall
become a part of the Exchange Fund, and any amounts in excess of the amounts
payable under <u>Section&nbsp;1.6(c)&nbsp;</u>shall be paid promptly to
Immucor.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Termination of Exchange Fund</i></b>.<i>&nbsp; </i>Any portion of the Exchange Fund
that remains unclaimed by the holders of Matrix Certificates 90 days after the
Effective Time shall be delivered by the Exchange Agent to Immucor upon
demand.&#160; Any holder of Matrix
Certificates who has not complied with <u>Article&nbsp;II</u> shall look
thereafter only to Immucor for payment of the Per Share Merger Consideration.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">No Liability</i></b>.<i>&nbsp; </i>None of Immucor, the Surviving
Corporation or the Exchange Agent shall be liable to any holder of Matrix
Certificates for any Per Share Merger Consideration properly delivered to a
public official under any applicable abandoned property, escheat or similar
Laws.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Lost, Stolen or Destroyed
Certificates</i></b>.<i>&nbsp; </i>If
any Matrix Certificate is lost, stolen or destroyed, upon the making of an
affidavit of that fact by the Person claiming such Matrix Certificate to be
lost, stolen or destroyed and the posting by such Person of a bond in the form
and amount reasonably required by Immucor or the Exchange Agent as indemnity
against any claim that may be made against Immucor or the Exchange Agent on
account of the alleged loss, theft or destruction, the Exchange Agent shall
issue the Per Share Merger Consideration in exchange for such lost, stolen or
destroyed Matrix Certificate.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;2.2</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Escrow.</b></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There
shall be withheld from the cash that would otherwise be included in the Per
Share Merger Consideration payable to each holder of Matrix Capital Stock (the &#147;<b><u style="font-weight:bold;">Matrix Shareholders</u></b>&#148;) pursuant to <u>Section&nbsp;1.6(c)&nbsp;</u>and
the amounts payable to each holder of Matrix Options as contemplated by <u>Section&nbsp;1.7</u>
who agrees to be bound by this <u>Section&nbsp;2.2</u> as further contemplated
by <u>Section&nbsp;1.7</u> (&#147;<b><u style="font-weight:bold;">Participating
Option Holders</u></b>&#148;), cash in an amount resulting in
$15.0&nbsp;million (such cash being withheld, together with any additional
amounts to be withheld pursuant to <u>Sections 6.2(b)&nbsp;</u>and <u>6.2(h)</u>,
the &#147;<b><u style="font-weight:bold;">Escrow Fund</u></b>&#148;).&#160; To determine the amount of cash to be
withheld from each Matrix Shareholder and each Participating Option Holder (the
&#147;<b><u style="font-weight:bold;">Escrow Amount Per Share</u></b>&#148;),
the amount of the Escrow Fund will be divided by the sum of the number of
shares of Matrix Capital Stock issued and outstanding immediately prior to the
Effective Time, other than Excluded Shares and Dissenting Shares, plus the
number of shares of Matrix Capital Stock represented by the Matrix Options held
by the Participating Option Holders (such sum, the &#147;<b><u style="font-weight:bold;">Total Fund Shares</u></b>&#148;).&#160; The amount to be withheld from the Per Share
Merger Consideration payable to each Matrix Shareholder (the &#147;<b><u style="font-weight:bold;">Individual Escrow Amount</u></b>&#148;) will be
determined by multiplying the number of shares of Matrix Capital Stock owned by
such Matrix Shareholder immediately prior to the Effective Time by the Escrow
Amount Per Share and the amount to be withheld from the cash payable to each
Participating Option Holder as contemplated by <u>Section&nbsp;1.7</u> will be
determined by multiplying the number of shares of Matrix Capital Stock
represented by the Matrix Options, if any, of that Participating Option Holder
converted to cash as contemplated by <u>Section&nbsp;1.7</u> by the Escrow
Amount Per Share.</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='11',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-03.htm',USER='c900127',CD='Mar 15 04:10 2008' -->



<br clear="all" style="page-break-before:always;">
<div>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160; Immucor shall deliver an
amount equal to the Escrow Fund to an institution reasonably acceptable to
Immucor and the Shareholders Agent Committee as escrow agent (the &#147;<b><u style="font-weight:bold;">Escrow Agent</u></b>&#148;) instead of the Exchange
Agent.&#160; The Escrow Agent shall hold the
Escrow Fund as the exclusive source of funds for the payment after Closing of
any amount owed to Immucor pursuant to <u>Section&nbsp;1.9</u> or <u>Article&nbsp;XI</u>.&#160; Any interest earned on the Escrow Fund shall
be retained in the Escrow Fund.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160; By their approval and
adoption of this Agreement and by their acceptance of the Per Share Merger
Consideration, the Matrix Shareholders will be conclusively deemed to have
consented to, approved and agreed to be bound by: (i)&nbsp;the obligations
under <u>Section&nbsp;1.9</u> and <u>Article&nbsp;XI</u> in respect of post
Effective Time adjustments to the Aggregate Merger Consideration; (ii)&nbsp;the
Escrow Agreement; and (iii)&nbsp;the appointment of the Shareholders Agent
Committee and the terms of <u>Article&nbsp;X</u>.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160; There shall also be
withheld from the Aggregate Merger Consideration and from amounts payable to
holders of Matrix Options as contemplated by <u>Section&nbsp;1.7</u> the amount
of $250,000 (the &#147;<b><u style="font-weight:bold;">Expenses Fund</u></b>&#148;),
allocated to each Matrix Shareholder and each Participating Option Holder pro
rata based on the number of Total Fund Shares of each.&#160; The Expenses Fund shall be paid over to the
Shareholders Agent Committee instead of the Exchange Agent as an advance on
expenses that it may incur in performing its duties as such and may be held and
applied by it in the manner it considers appropriate.&#160; Upon paying the Expenses Fund over to the
Shareholders Agent Committee as herein provided, neither Immucor nor any of its
Affiliates shall have any further obligations or any Liability with respect
thereto.&#160; Upon the termination of the
Escrow Agreement and the release of all funds thereunder, the balance, if any,
in the Expenses Fund shall be released to the Matrix Shareholders and the
Participating Option Holders pro rata based on the number of Total Fund Shares
held by each immediately prior to the Effective Time.&#160; The interest accrued on the Escrow Fund shall
be reported to the Matrix Shareholders and Participating Option Holders for Tax
purposes on the same pro rata basis.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE III.<br>
REPRESENTATIONS AND WARRANTIES WITH RESPECT TO MATRIX</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix represents and warrants to Immucor and Merger Sub as follows:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h2 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Organization and Qualification.</font></b></h2>

<h2 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h2>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><i style="font-weight:bold;">Matrix</i></b>.&#160; Matrix is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware
and has the corporate power and authority to own all of its properties and
assets and to carry on its Business.&#160; The
copies of Matrix&#146;s certificate of incorporation and bylaws, each as amended to
date, which have been delivered or made available to Immucor, are complete and
correct, and such certificate of incorporation and bylaws, as so amended, are
in full force and effect.&#160; Matrix is duly
qualified and is in good standing to do business in all jurisdictions in which
it is required to be qualified, except where the lack of such qualification
would not have a Matrix Material Adverse Effect.</font></h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>

<div align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='12',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><i style="font-weight:bold;">New Subsidiary</i></b>.&#160; New Subsidiary is a limited liability company
duly organized, validly existing and in good standing under the laws of the
State of Delaware and has the limited liability company power and authority to
own all of its properties and assets and to carry on its business.&#160; The copies of the New Subsidiary&#146;s
certificate of organization and operating agreement, together with all
amendments thereto to the date hereof (if any), which have been delivered or
made available to Immucor, are complete and correct, and such certificate of
organization and operating agreement, as so amended, are in full force and
effect.</font></h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h2 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Capitalization and Ownership.</font></b></h2>

<h2 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h2>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><i style="font-weight:bold;">Matrix</i></b>.&#160; The authorized capital stock of Matrix is
200,000,000 shares of $0.01 par value common stock (the &#147;<b><u style="font-weight:bold;">Matrix Common Stock</u></b>&#148;) and 150,000,000
shares of $0.01 par value preferred stock of which (i)&nbsp;12,000,000 shares
are designated Series&nbsp;A Convertible Preferred Stock (the &#147;<b><u style="font-weight:bold;">Series&nbsp;A Stock</u></b>&#148;), (ii)&nbsp;</font>4,400,000
shares are designated Series&nbsp;B Convertible Preferred Stock (the &#147;<b><u style="font-weight:bold;">Series&nbsp;B Stock</u></b>&#148;), (iii)&nbsp;22,940,000
shares are designated Series&nbsp;C Convertible Preferred Stock (&#147;<b><u style="font-weight:bold;">Series&nbsp;C Stock</u></b>&#148;), (iv)&nbsp;24,500,000 shares are
designated Series&nbsp;D Convertible Preferred Stock (the &#147;<b><u style="font-weight:bold;">Series&nbsp;D Stock</u></b>&#148;) and (v)&nbsp;52,000,000
shares are designated Series&nbsp;E Convertible Preferred Stock (the &#147;<b><u style="font-weight:bold;">Series&nbsp;E Stock</u></b>&#148; and together with
the Matrix Common Stock, Series&nbsp;A Stock, Series&nbsp;B Stock, Series&nbsp;C
Stock and Series&nbsp;D Stock, collectively, the &#147;<b><u style="font-weight:bold;">Matrix Capital Stock</u></b>&#148;).&#160;
As of the date of this Agreement, subject to update or correction in the
Final Payment Schedule, there are (1)&nbsp;32,109,250 shares of Matrix Common Stock, (2)&nbsp;4,055,558 shares of Series&nbsp;A
Stock, (3)&nbsp;4,400,000 shares
of Series&nbsp;B Stock, (4)&nbsp;22,740,000
shares of Series&nbsp;C Stock, (5)&nbsp;25,050,774
shares of Series&nbsp;D Stock and (6)&nbsp;51,162,509 shares of Series&nbsp;E Stock issued and outstanding
and 38,750 shares of Matrix Common Stock held as treasury
stock.&#160; A sufficient number of shares of
Matrix Common Stock are properly reserved for issuance upon exercise of Matrix
Options.&#160; Other than Matrix Common Stock,
no other shares of Matrix Capital Stock are issuable upon exercise of Matrix
Options.&#160; All of the issued and
outstanding shares of Matrix Capital Stock are duly authorized, validly issued,
fully paid and nonassessable, and were not issued in violation of any preemptive
rights or rights of first refusal.&#160; The
issued and outstanding shares of Matrix Capital Stock as represented in the
second sentence of this <u>Section&nbsp;3.2(a)&nbsp;</u>constitute all of the
issued and outstanding capital stock, and there is no other issued and
outstanding equity, of Matrix.&#160; Except for
the Matrix Options, there are no subscriptions, options, convertible
securities, calls, rights, warrants or other agreements, claims or commitments
of any nature whatsoever obligating Matrix to issue, transfer, register with
any securities commission or other authority, deliver or sell or cause to be
issued, transferred, so registered, delivered or sold, additional shares of
Matrix or other securities of Matrix or obligating Matrix to grant, extend or
enter into any such agreement or commitment.&#160;
Except as set forth in <u>Section&nbsp;3.2(a)&nbsp;of the Disclosure
Letter</u>, there are no stockholders&#146; agreements, voting trusts, proxies or
other similar agreements with respect to the Matrix Capital Stock.&#160; Subject to update or correction in the Final
Payment Schedule, the stockholders of Matrix as of the date of this Agreement
and the numbers and classes of shares held by each are set forth in <u>Section&nbsp;3.2(a)&nbsp;of
the Disclosure Letter</u> and each stockholder is the sole beneficial owner of
such Matrix Capital Stock. Subject to update or correction in the Final Payment
Schedule, <u>Section&nbsp;3.2(a)&nbsp;of the Disclosure Letter</u> also sets
forth all holders of Matrix Options, the number and kind of Matrix Options each
holds as of the date of this Agreement and the exercise price.&#160; All shares of Matrix Capital Stock issuable
upon exercise of Matrix Options are duly authorized and, upon issuance, will be
validly issued, fully paid and nonassessable, and<b>, </b>except as set forth in <u>Section&nbsp;3.2(a)&nbsp;of </u></font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='13',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:0in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">the Disclosure
Letter</font></u>, are not subject to any preemptive rights.&#160; Subject to update or correction in the Final
Payment Schedule, the numbers of shares of Matrix Capital Stock set forth in
the list of Matrix Options included in&#160; <u>Section&nbsp;3.2(a)&nbsp;of
the Disclosure Letter</u> include all shares issuable pursuant to any
anti-dilution rights (contractual or otherwise), and <u>Section&nbsp;3.2(a)&nbsp;of
the Disclosure Letter</u> sets forth all holders entitled to anti-dilution
rights as a consequence of the exercise of any Matrix Options and the number of
shares to be issued pursuant to such anti-dilution rights.&#160; All issued and outstanding shares of Matrix
Capital Stock, and all shares of Matrix Capital Stock issuable upon exercise of
Matrix Options (including those subject to anti-dilution rights and all shares
of Matrix Capital Stock to be issued pursuant thereto), have been and will be
issued in full compliance with all applicable securities and other Laws.&#160; <u>Section&nbsp;3.2(a)&nbsp;of the Disclosure
Letter</u> contains a complete list of all Matrix Options, and either a copy of
such Matrix Option has been delivered to Immucor or, if no such copy has been
delivered, the Matrix Option was issued on the form option agreement attached
to <u>Section&nbsp;3.2(a)&nbsp;of the Disclosure Letter</u>, without any changes
or deviations from the form other than the names of grantees, vesting and
termination dates and number of shares.&#160;
There are no accrued but unpaid dividends on any Matrix Capital Stock.</p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><i style="font-weight:bold;">Subsidiaries</i></b>.<b>&#160; </b>Matrix
does not have any Subsidiaries or any investment or equity interest in any
other Person, except for its ownership interest in New Subsidiary.&#160; New Subsidiary has one class of membership
interests.&#160; All issued and outstanding
membership interests in New Subsidiary are duly authorized, validly issued,
fully paid and nonassessable, and were not issued in violation of any
preemptive rights or rights of first refusal.&#160;
The issued and outstanding membership interests in New Subsidiary
represent all of the issued and outstanding equity of New Subsidiary.&#160; There are no subscriptions, options,
convertible securities, calls, rights, warrants or other agreements, claims or
commitments of any nature whatsoever obligating New Subsidiary to issue,
transfer, register with any securities commission or other authority, deliver
or sell or cause to be issued, transferred, so registered, delivered or sold,
additional membership interests of New Subsidiary or other securities of New
Subsidiary or obligating New Subsidiary to grant, extend or enter into any such
agreement or commitment.&#160; Except for the
operating agreement of New Subsidiary, there are no equity holders&#146; agreements,
voting trusts, proxies or other similar agreements with respect to the
membership interests in New Subsidiary.&#160;
As of the date of Closing: (i)&nbsp;Matrix will own 19% of the
outstanding common membership interests in New Subsidiary, (ii)&nbsp;the other
members of New Subsidiary will be existing Matrix Shareholders and holders of
Matrix Options in proportion to respective ownership interests in Matrix, and (iii)&nbsp;each
such other member will be the sole beneficial owner of such New Subsidiary
membership interests.&#160; All issued and
outstanding membership interests of New Subsidiary have been and will be issued
in full compliance with all applicable securities and other Laws.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h2 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Authority.</font></b></h2>

<h2 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h2>

<p style="margin:0in 0in .0001pt 16.55pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160; With respect to this
Agreement and any other agreements, instruments and documents executed and
delivered by Matrix pursuant to this Agreement (this Agreement and such other
agreements, instruments and documents delivered by Matrix are collectively
referred to as the &#147;<b><u style="font-weight:bold;">Matrix Delivered
Agreements</u></b>&#148;) (i)&nbsp;Matrix has the corporate power and
authority to enter into the Matrix Delivered Agreements executed and delivered
by it and, subject to obtaining the necessary approvals of the Matrix
Shareholders, to consummate the</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='14',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 16.55pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">transactions contemplated by, and otherwise to comply with and perform
its obligations under, them; (ii)&nbsp;the execution and delivery by Matrix of
the Matrix Delivered Agreements and the consummation by Matrix of the
transactions contemplated on its part thereby have been duly authorized by its
Board of Directors; (iii)&nbsp;other than the approval of the requisite classes
and number of stockholders of Matrix, no other action on the part of Matrix is
necessary to authorize the execution and delivery of the Matrix Delivered
Agreements by Matrix or the consummation by Matrix of the transactions
contemplated thereby; and (iv)&nbsp;subject to obtaining the Authorizations of
Governmental Entities contemplated by <u>Section&nbsp;3.4</u>, the Matrix
Delivered Agreements will, when executed and delivered, constitute valid and
binding obligations of Matrix enforceable against Matrix in accordance with
their terms except to the extent that such enforceability may be limited by
bankruptcy, insolvency, reorganization, moratorium or other Laws and court
decisions relating to or affecting the enforcement of creditors&#146; rights
generally (including statutory or other Laws regarding fraudulent transfers),
and subject to general principles of equity.</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160; The approvals of the Matrix
Shareholders required in connection with the execution and delivery of the
Matrix Delivered Agreements by Matrix and the consummation by Matrix of the
transactions contemplated by, or other compliance with or performance under,
the Matrix Delivered Agreements consist only of (i)&nbsp;the adoption of this
Agreement by affirmative votes of the holders of (a)&nbsp;a majority of the
outstanding shares of Matrix Capital Stock voting together on an as-if
converted to Common Stock basis as a single class, (b)&nbsp;a majority of the
outstanding shares of Series&nbsp;C Stock voting as a separate class, (c)&nbsp;a
majority of the outstanding shares of Series&nbsp;D Stock voting as a separate
class, and (d)&nbsp;a majority of the outstanding shares of Series&nbsp;E Stock
voting as a separate class (the votes referred to in clauses &#147;(b)&#148;, &#147;(c)&#148; and &#147;(d)&#148;
of clause &#147;(i)&#148; of this sentence being referred to together as the &#147;<b><u style="font-weight:bold;">Preferred Class&nbsp;Merger Votes</u></b>&#148;),
and (ii)&nbsp;the waiver by not less than a majority of the outstanding shares
of each of the Series&nbsp;C Stock, the Series&nbsp;D Stock and the Series&nbsp;E
Stock of the rights (a)&nbsp;to both (x)&nbsp;receive any consideration for
their shares other than, as applicable, the Series&nbsp;C Per Share Merger Consideration,
the Series&nbsp;D Per Share Merger Consideration, or the Series&nbsp;E Per
Share Merger Consideration, and (y)&nbsp;elect to convert such shares into
capital stock of the Surviving Corporation, and (b)&nbsp;to have such shares
remain outstanding and be convertible into stock of Immucor (the waivers
referred to in clauses &#147;(a)&#148; and &#147;(b)&#148; of clause &#147;(ii)&#148; of this sentence being
referred to together as the &#147;<b><u style="font-weight:bold;">Preferred Stock Waivers</u></b>&#148;).&#160; As used herein, the term &#147;<b><u style="font-weight:bold;">Required Merger Stockholder Votes</u></b>&#148;
shall mean, collectively, the approvals referred to in clause (i)&nbsp;of this<u>
Section&nbsp;3.3(b)&nbsp;</u>and the waivers referred to in clause (ii)&nbsp;of
this <u>Section&nbsp;3.3(b)</u>.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160; Pursuant
to (i)&nbsp;Section&nbsp;12(a)(ii)&nbsp;of the Matrix certificate of
incorporation, and (ii)&nbsp;the approval of this Agreement and the
transactions contemplated hereunder by a majority of the Continuing Directors
(as that term is defined in the Certificate of Incorporation), the approval of
a majority of the shares of Matrix Capital Stock is sufficient, in conjunction
with the Preferred Class&nbsp;Merger Votes, to constitute approval of this
Agreement by the Matrix Shareholders.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160; The shares of Matrix
Capital Stock that are subject to the Majority Stockholders Consent will be,
when executed and delivered to Matrix (and will continue through the Closing to
be) sufficient to obtain the Required Merger Stockholder Votes. The</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='15',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">holders of a majority of
the outstanding Series&nbsp;C Stock, Series&nbsp;D Stock, and Series&nbsp;E
Stock, in each case voting together as a single class, will have, upon the
execution of the Majority Stockholders Consent, validly elected, pursuant to
paragraph 10 of each applicable Certificate of Designation, to waive the rights
referred to in clause (ii)&nbsp;of <u>Section&nbsp;3.3(b)&nbsp;</u>above.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160; The Escrow Agreement, when
executed and delivered by the Shareholders Agent Committee on behalf of the
Matrix Shareholders and holders of Matrix Options, subject to obtaining the
Matrix Shareholders&#146; approval of the Merger, will constitute a valid and
binding obligation of the Matrix Shareholders and holders of Matrix Options,
enforceable against them in accordance with its terms except to the extent that
such enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium or other Laws and court decisions relating to or affecting the
enforcement of creditors&#146; rights generally (including statutory or other Laws
regarding fraudulent transfers), and subject to general principles of equity.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No
Consents Required.</font></b> &#160;Except as set forth in <u>Section&nbsp;3.4 of
the Disclosure Letter</u> and except for (i)&nbsp;the pre-merger notification
requirements of the HSR Act and the rules&nbsp;and regulations thereunder, (ii)&nbsp;the
filing of the Certificate of Merger, and (iii)&nbsp;the Required Merger
Stockholder Votes, no Authorization of or with any Governmental Entity or any
other Authorization of or with any other Person, is required in connection with
the execution and delivery of the Matrix Delivered Agreements by Matrix and the
consummation by Matrix of the transactions contemplated by, or other compliance
with or performance under, the Matrix Delivered Agreements.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Absence
of Violations or Conflicts.</font></b>&#160; Except as set forth in <u>Section&nbsp;3.5 of
the Disclosure Letter</u>, the execution and delivery of the Matrix Delivered
Agreements and the consummation by Matrix of the transactions contemplated by,
or other compliance with or performance under, them do not and will not with
the passing of time or giving of notice or both (a)&nbsp;constitute a violation
of, be in conflict with, constitute a default or require any payment under,
permit a termination of, or result in the creation or imposition of any Lien
upon any assets of Matrix under (i)&nbsp;any material contract, agreement,
commitment, undertaking or understanding (including rights of refusal or
similar rights or other transfer restrictions), (ii)&nbsp;any Governmental
Order to which Matrix is subject, (iii)&nbsp;any Laws to which Matrix is
subject or (iv)&nbsp;the certificate of incorporation or bylaws or other
governing documents of Matrix; or (b)&nbsp;create, or cause the acceleration of
the maturity of, any debt, obligation or liability of Matrix.&#160; Matrix has taken all action necessary in
order to exempt this Agreement, the Merger and the other transactions contemplated
hereby from (x)&nbsp;the requirements of any &#147;moratorium&#148;, &#147;control share&#148;, &#147;fair
price&#148; or other anti-takeover laws and regulations of the State of Delaware,
including Section&nbsp;203 of the Delaware General Corporation Law, and of any
other state and (y)&nbsp;any applicable provisions of Matrix&#146;s certificate of
incorporation and bylaws.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman"><font style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Financial
Statements.</font>&#160; </font></b>Matrix has previously
provided to Immucor true and complete copies of the audited balance sheets of
Matrix as of December&nbsp;31, 2004, December&nbsp;31, 2005, and December&nbsp;31,
2006, and the related statements of operations, stockholders&#146; equity and cash
flows for the years then ended, including the notes thereto, together with the
unqualified audit report thereon of Matrix&#146;s independent certified public
accountants, and a true and complete copy of the unaudited consolidated balance
sheet and related statement of</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='16',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">operations of Matrix for the
period ended December&nbsp;31, 2007 (together with any other financial
statements required to be delivered pursuant to <u>Section&nbsp;5.7</u>,
collectively, the &#147;<b><u style="font-weight:bold;">Matrix Financial
Statements</u></b>&#148;).&#160; The Matrix
Financial Statements have been prepared from, and are in accordance with, the
books and records of Matrix and present fairly, in all material respects, the
financial position and results of operations of Matrix as of the dates and for
the periods indicated in conformity with United States generally accepted
accounting principles (&#147;<b><u style="font-weight:bold;">GAAP</u></b>&#148;)
applied on a consistent basis throughout the periods covered by such
statements, except as otherwise stated in the Matrix Financial Statements or in
the notes thereto and, in the case of the interim Matrix Financial Statements,
subject to normal year-end adjustments, which are not in the aggregate
material, and the absence of footnotes.&#160;
Hereinafter, the Matrix balance sheet as of December&nbsp;31, 2006
referenced above shall be referred to as the &#147;<b><u style="font-weight:bold;">2006 Balance Sheet</u></b>.&#148;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Absence
of Certain Changes or Events.</font></b>&#160; Except as set forth in <u>Section&nbsp;3.7 of
the Disclosure Letter</u> or as permitted by this Agreement after the date
hereof, between January&nbsp;1, 2007, and the date of this Agreement, the date
of mailing of the Information Statement and any amendment or supplement thereto
(each, a &#147;<b><u style="font-weight:bold;">Mailing Date</u></b>&#148;)<b>  </b>and the Closing Date, there has not been: (i)&nbsp;any
change, development, event or condition that has resulted in, or could be
reasonably expected to result in, a Matrix Material Adverse Effect; (ii)&nbsp;any
material damage, destruction, loss or casualty to property or assets of Matrix
whether or not covered by insurance; (iii)&nbsp;any strike, work stoppage&nbsp;or
slowdown or other labor trouble involving Matrix; (iv)&nbsp;any declaration,
setting aside or payment of any dividend or distribution (whether in cash,
capital shares or property) with respect to the capital stock of Matrix, other
than the distribution of the equity securities of New Subsidiary; (v)&nbsp;except
for issuance of Matrix Common Stock upon exercise of Matrix Options outstanding
on the date of this Agreement, any issuance or sale by, or any redemption or
other acquisition by Matrix of any of the shares of Matrix Capital Stock; (vi)&nbsp;any
split, combination, reclassification or other similar change in the outstanding
shares of Matrix Capital Stock; (vii)&nbsp;any transaction entered into by
Matrix other than in the ordinary course of business; or (viii)&nbsp;any
agreement by Matrix to do any of the foregoing.&#160;
All trade payables, accruals and other Liabilities of Matrix are current
and not past due.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No
Claims Against Matrix.</font></b>&#160;
No stockholder or former stockholder or other equity holder of Matrix or
its predecessors in interest has any claim against Matrix, except as disclosed
in <u>Section&nbsp;3.8 of the Disclosure Letter</u> and except as otherwise
specifically provided in this Agreement.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Absence
of Undisclosed Liabilities.</font></b>&#160; Matrix does not have any Liabilities except (i)&nbsp;as
and to the extent expressly reflected or specifically reserved against in the
Matrix Financial Statements as of December&nbsp;31, 2006 (which reserves are
adequate), (ii)&nbsp;as set forth in <u>Section&nbsp;3.9 of the Disclosure
Letter</u>, and (iii)&nbsp;for trade payables and similar ordinary and
necessary liabilities (which do not include liabilities arising which are
related to Indebtedness or negligent or unlawful actions of Matrix or Matrix&#146;s
officers, directors, shareholders, agents or employees) arising in the ordinary
course of business since December&nbsp;31, 2006.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Legal
Proceedings.</font></b>&#160;
Except as disclosed in <u>Section&nbsp;3.10 of the Disclosure Letter</u>,
(i)&nbsp;there is no Claim pending or, to the Knowledge of Matrix, threatened
against Matrix or any of its properties or assets (or any of its officers or
directors in connection with the Business of Matrix) before any arbitrator or
Governmental Entity, nor has Matrix received notice of any</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>

<div align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='17',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">investigation by any Governmental Entity or other Person against Matrix
(or any of its officers or directors in connection with the Business of
Matrix); and (ii)&nbsp;neither Matrix nor any of its officers or directors in
connection with the Business of Matrix is a party to or bound by any
Governmental Order of any Governmental Entity, arbitrator or any other Person
against Matrix.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.11&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Environmental
Matters.</font></b>&#160; Except
as disclosed in <u>Section&nbsp;3.11 of the Disclosure Letter</u>, (i)&nbsp;the
properties and operations of Matrix are in material compliance with all
applicable Environmental Laws, (ii)&nbsp;Matrix is not<b>  </b>subject to any pending or, to its
Knowledge, threatened, Claim or remediation activity under any Environmental
Law, (iii)&nbsp;Matrix has not<b>  </b>released,
discharged, buried or dumped any Hazardous Materials on, beneath or adjacent to
any of its currently or formerly owned or operated properties in violation of
any applicable Environmental Laws, and (iv)&nbsp;to the Knowledge of Matrix,
there is no condition, including the presence or release of any Hazardous
Material in violation of Environmental Law, which may present a substantial,
adverse effect to human health or the environment, at any property or building
currently or formerly owned or operated by Matrix.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.12&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Governmental
Authorization and Compliance with Laws.</font></b>&#160; Matrix is, and since January&nbsp;1, 2002,
has been, in material compliance with all Laws of all Governmental Entities
applicable to Matrix or its<b>  </b>Business,
properties or assets.&#160; Matrix holds and
has held all Matrix Licenses.&#160; All of the
Matrix Licenses are valid and in full force and effect, and the terms of such
Matrix Licenses are not subject to any restrictions or conditions that limit or
would limit the operations of the Business of Matrix, other than restrictions
or conditions generally applicable to licenses of that type.&#160; There are no proceedings pending or, to the
Knowledge of Matrix, complaints or petitions by others, or threatened proceedings,
before any Governmental Entity relating to the Matrix Licenses.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.13&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Intellectual
Property.</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160; <u>Section&nbsp;3.13(a)&nbsp;of
the Disclosure Letter</u> contains a true, correct and complete list of the
following categories of Owned Matrix Intellectual Property and all other
material Owned Matrix Intellectual Property: (i)&nbsp;Patents, including the
application serial number or registration Patent number, and the status of the
application or Patent, including deadlines for any renewals or other required
filings required to be made in the next two (2)&nbsp;years; (ii)&nbsp;all
registered Trademarks and material unregistered Trademarks; (iii)&nbsp;domain
names and uniform resource locators; (iv)&nbsp;all registered Copyrights; and (v)&nbsp;Computer
Software, in each case listing, as applicable, the name of the
applicant/registrant and current owner, except such list shall not be required
to include the name of the applicant/registrant of any Commercially Available
Software.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160; <u>Section&nbsp;3.13(b)&nbsp;of
the Disclosure Letter</u> separately contains a true, correct and complete list
of all agreements (the &#147;<b><u style="font-weight:bold;">Third Party
Intellectual Property Licenses</u></b>&#148;), other than for Commercially
Available Software, (i)&nbsp;under which Matrix uses or has the right to use
any Licensed Matrix Intellectual Property (other than licenses for Commercially
Available Software), and (ii)&nbsp;under which Matrix has licensed to others
the right to use any of the Matrix Intellectual Property.&#160; Matrix has provided or made available to
Immucor true and complete copies of all agreements listed in <u>Section&nbsp;3.13(b)&nbsp;of
the Disclosure Letter</u>.</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='18',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160; The Intellectual Property
owned by Matrix (the &#147;<b><u style="font-weight:bold;">Owned Matrix
Intellectual Property</u></b>&#148;) together with the Intellectual Property
licensed by Matrix from others (the &#147;<b><u style="font-weight:bold;">Licensed
Matrix Intellectual Property</u></b>&#148;) is all of the Matrix Intellectual
Property and is sufficient to carry on the Business of Matrix and the
consummation of the transactions contemplated hereby will not alter or impair
the Matrix Intellectual Property in any manner.&#160;
Except as set forth in <u>Section&nbsp;3.13(c)&nbsp;of the Disclosure
Letter</u>, since January&nbsp;1, 2007, Matrix has not sold, transferred,
assigned, conveyed, licensed or released rights to any Intellectual Property.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(d)&#160;&#160;&#160; </font>Matrix
owns<b>  </b>all of the Owned Matrix
Intellectual Property and, except as otherwise reflected in <u>Section&nbsp;3.13(d)&nbsp;of
the Disclosure Letter</u>, has all right, title and interest in and to such
Owned Matrix Intellectual Property free and clear of Liens.&#160; Other than Third Party Intellectual Property
Licenses, there are no agreements that restrict or limit the use by Matrix of
the Matrix Intellectual Property.&#160; With
respect to Matrix&#146;s rights to use any Licensed Matrix Intellectual Property,
such rights are used pursuant to an agreement or license which is one of the
Third Party Intellectual Property Licenses; each such agreement or license is
enforceable against Matrix and, to the Knowledge of Matrix, the other party
thereto; Matrix has not received or given any notice of termination with respect
to any such agreement or license; Matrix is not (and will not be as a result of
the transactions contemplated hereby) in default under or in breach of any such
license or agreement, which default or breach would constitute or may
constitute grounds on which any material license or agreement can be
terminated, suspended, varied or revoked as a result of such default or breach
by Matrix without the consent of Matrix; there has not occurred any event
which, with the lapse of time or the giving of notice or both, would constitute
such a default;<b>  </b>and, to the
Knowledge of Matrix, none of such third party licensors is in default under or
in breach of any such license or agreement.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(e)&#160;&#160;&#160; </font>Matrix
has taken reasonable steps to protect and maintain the Matrix Intellectual
Property used by it, and where Matrix has registered any Owned Matrix
Intellectual Property, such registrations are valid and subsisting in all
material respects.&#160; None of the Owned
Matrix Intellectual Property is the subject of any pending or threatened
opposition, interference, cancellation proceeding or other proceeding before
any registration authority in any jurisdiction, and all registrations and
applications for the Owned Matrix Intellectual Property are in full force and
effect in all material respects and have not been abandoned or withdrawn.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160; </font>All
Trade Secrets are owned by Matrix free and clear of all Liens, except as
otherwise disclosed in <u>Section&nbsp;3.13(f)&nbsp;of the Disclosure Letter</u>.&#160;&#160;&#160;&#160; Matrix has taken all reasonable and
appropriate steps to protect and preserve the confidentiality of all of the
material Trade Secrets used by it that comprise any part of the Matrix
Intellectual Property, and there are no unauthorized uses, disclosures or
infringements of any such Trade Secrets by any Person.&#160; All use and disclosure by Matrix of Trade
Secrets owned by another Person have been pursuant to the terms of a written
agreement with such Person which is one of the Third Party Intellectual
Property Licenses.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(g)&#160;&#160;&#160; </font><u>Section&nbsp;3.13(g)&nbsp;of
the Disclosure Letter</u> lists all Persons who have created any material
portion of the Owned Matrix Intellectual Property, other than employees</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='19',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">of Matrix whose work
product was created by them entirely within the scope of their employment and
constitutes &#147;work made for hire&#148; (as that term is defined under Section&nbsp;101
of the U.S. Copyright Act, 17 U.S.C. &#167;&nbsp;101) with Matrix being the person
for whom the work was prepared.&#160; Matrix
has secured and has a policy to secure valid written assignments from all
Persons who contribute or have contributed to the creation or development of
any of the Owned Matrix Intellectual Property, of the rights to such
contributions that Matrix does not already own by operation of law.&#160; No employee, independent contractor, agent,
representative or consultant of Matrix is entitled to or has claimed any
payment in respect of any Matrix Intellectual Property.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(h)&#160;&#160;&#160; </font>The
use of the Matrix Intellectual Property and the conduct of the Business of
Matrix, including the manufacture, use, provision and sale of Matrix&#146;s products
and services therein, does not infringe upon, misappropriate, violate or
conflict in any way with any Intellectual Property or other right held by any
Person.&#160; Except as set forth in <u>Section&nbsp;3.13(h)&nbsp;of
the Disclosure Letter</u>, there is no pending or, to the Knowledge of Matrix,
threatened assertion or claim, and there has been no such assertion or claim in
the last six (6)&nbsp;years, asserting that Matrix&#146;s use or exploitation of any
Matrix Intellectual Property or the conduct of the Business of Matrix infringes
upon, misappropriates, violates or conflicts in any way with the rights of any
Person.&#160; Matrix is not<b>  </b>a party to any action or proceeding that
involves a claim of infringement or misappropriation of (i)&nbsp;any
Intellectual Property of any Person or (ii)&nbsp;any Matrix Intellectual
Property.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160; The Owned Matrix
Intellectual Property and the Licensed Matrix Intellectual Property, and Matrix&#146;s
rights with respect thereto, including its respective rights to use any of the
Matrix Intellectual Property, are valid and enforceable.&#160; Except as set forth in <u>Section&nbsp;3.13(i)&nbsp;of
the Disclosure Letter</u>, there is no pending or, to the Knowledge of Matrix,
threatened assertion or claim, and there has been no such assertion or claim in
the last six (6)&nbsp;years, challenging the validity or enforceability of, or
contesting Matrix&#146;s rights with respect to, any of the Matrix Intellectual
Property or any agreement relating to the Matrix Intellectual Property.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(j)&#160;&#160;&#160;&#160; </font>There
is no basis on which any third party (other than a licensor under a Third Party
Intellectual Property License) could claim rights in, or challenge the
enforceability of, the Matrix Intellectual Property on any equitable basis,
including laches, equitable estoppel or implied license.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(k)&#160;&#160;&#160; </font>To
the Knowledge of Matrix, except as set forth in <u>Section&nbsp;3.13(k)&nbsp;of
the Disclosure Letter</u>, there are no unauthorized uses, disclosures,
infringements, or misappropriations by any Person of any Owned Matrix
Intellectual Property or any breaches by any Person of any licenses or other
agreements involving Owned Matrix Intellectual Property.&#160; Matrix has not<b>  </b>given any notice of infringement to any third party with
respect to any Matrix Intellectual Property.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">(l)&#160;&#160;&#160;&#160; </font>All
reagents, together with their current licensing status and the amount of the
research or commercial royalties or licensing fees payable for the use of such
reagents used (i)&nbsp;in the products currently sold or distributed by Matrix
are set forth in <u>Section&nbsp;3.13(l)(i)&nbsp;of the Disclosure Letter</u>
and (ii)&nbsp;in the products currently in development or</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='20',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">contemplated by Matrix to
be sold or distributed in the future, are set forth in <u>Section&nbsp;3.13(l)(ii)&nbsp;of
the Disclosure Letter</u>.&#160; All such
reagents are made by Persons who are not Affiliates of Matrix.&#160; Some or all of such reagents<b>  </b>are protected by Patents or other
Intellectual Property of such un-Affiliated Persons and may require payment of
royalties or licensing fees, or other additional costs (all of which are
disclosed in <u>Sections 3.13(l)(i)&nbsp;and (ii)&nbsp;of the Disclosure Letter</u>)
beyond those needed to purchase such reagents for research use if the reagents
are used in commercialized products, or if regulatory approval for sale of products
is obtained.&#160; All royalties and licensing
fees paid by Matrix for the use of reagents were properly classified under the
applicable agreement or arrangement as being paid for research or commercial
use, as applicable.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.14&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Employee
Plans.</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman">&nbsp;</font></b></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160; <b><i style="font-weight:bold;">Schedule of Plans</i></b>.&#160; <u>Section&nbsp;3.14(a)&nbsp;of the
Disclosure Letter</u> lists each of the following that Matrix<b>  </b>or any ERISA Affiliate maintains, is
required to contribute to or otherwise participates in or as to which Matrix<b>  </b>or any ERISA Affiliate has any liability
or obligation, whether accrued, contingent or otherwise:</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any &#147;employee
pension benefit plan&#148; (as defined in the Employee Retirement Income Security
Act of 1974, as amended (&#147;<b><u style="font-weight:bold;">ERISA</u></b>&#148;))
(&#147;<b><u style="font-weight:bold;">Pension/Profit-Sharing Plan</u></b>&#148;),
including any pension, profit-sharing, retirement, thrift or stock bonus plan;</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any &#147;employee
welfare benefit plan&#148; (as defined in ERISA);</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any &#147;multi-employer
plan&#148; (&#147;<b><u style="font-weight:bold;">Multi-Employer Plan</u></b>&#148;),&#160; &#147;multiple employer plan,&#148; &#147;multiple employer
welfare arrangement&#148; or &#147;voluntary employees&#146; beneficiary account&#148; (all as
defined in ERISA and/or the Code);</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any other
compensation, stock option, restricted stock, fringe benefit, equity or
retirement plan, program, policy, understanding or arrangement of any kind
whatsoever, whether formal or informal, not included in the foregoing and
providing for benefits for, or the welfare of, any or all of the Participants,
including any health, life insurance, retiree medical, bonus, employment,
consulting, employee leasing, incentive, retention or severance arrangement,
and all outstanding stock options, restricted shares, phantom stock awards,
stock appreciation rights, performance share unit awards or cash or other
similar incentive awards thereunder;</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(all of the foregoing in items (i), (ii), (iii)&nbsp;and (iv)&nbsp;being
referred to as &#147;<b><u style="font-weight:bold;">Employee Plans</u></b>&#148;).</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160; <b><i style="font-weight:bold;">Absence of Certain Types of Plans</i></b>.&#160; Except as set forth in <u>Section&nbsp;3.14(b)&nbsp;of
the Disclosure Letter</u>, neither Matrix<b>  </b>nor
any ERISA Affiliate has at any time incurred any liability under any Employee
Plan described in Section&nbsp;<u>3.14(a)(iii)</u>, including any liability,
joint or otherwise, under ERISA Title IV for a complete or partial withdrawal
from any Multi-Employer Plan.&#160; Except as
set forth in <u>Section&nbsp;3.14(b)&nbsp;of the Disclosure Letter</u>, no
Employee Plan provides retiree health, retiree life insurance, or other
post-retirement welfare benefits to any person, and neither Matrix not any
ERISA Affiliate is</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='21',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">contractually or
otherwise obligated (whether or not in writing) to provide any person with
health benefits, life insurance, or other post-retirement welfare benefits upon
retirement or other termination of employment, other than as required by the
provisions of ERISA Sections 601 through 608 and Code Section&nbsp;4980B and
applicable state law.&#160; None of the
Employee Plans that provide medical, health or life benefits are self-insured.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160; <b><i style="font-weight:bold;">Employee Plans Documentation.</i></b>&#160; Matrix has delivered to Immucor (and <u>Section&nbsp;3.14(c)&nbsp;of
the Disclosure Letter</u> lists each item delivered) copies of the following: (i)&nbsp;each
written Employee Plan, as amended; (ii)&nbsp;all Internal Revenue Service (&#147;<b><u style="font-weight:bold;">IRS</u></b>&#148;) determination and opinion letters
issued with respect to any Pension/Profit-Sharing Plan, as applicable; (iii)&nbsp;the
three (3)&nbsp;most recent actuarial valuations (if any) for any
Pension/Profit-Sharing Plan, as applicable; (iv)&nbsp;the three (3)&nbsp;most
recent annual reports on the Form&nbsp;5500 series, including all schedules
thereto; (v)&nbsp;each trust or custodial agreement, insurance contract or other
document setting forth any other funding arrangement, if any, with respect to
each Employee Plan; (vi)&nbsp;each administrative or other similar agreement
with respect to the Employee Plans; (vii)&nbsp;the most recent ERISA summary
plan description (including any summaries of material modifications) or other
summary of plan provisions distributed to participants or beneficiaries for
each Employee Plan; (viii)&nbsp;all materials submitted to or received from the
IRS, the U.S. Department of Labor (&#147;<b><u style="font-weight:bold;">DOL</u></b>&#148;),<b>  </b>the Pension Benefit Guaranty Corporation (&#147;<b><u style="font-weight:bold;">PBGC</u></b>&#148;) or other Governmental Entity
concerning any pending matter with respect to any Employee Plan; (ix)&nbsp;each
Registration Statement, amendment thereto and prospectus relating thereto filed
with the SEC or furnished to participants in connection with any Employee Plan;
(x)&nbsp;written descriptions of all non-written agreements relating to the
Employee Plans; (xi) a current sample of each notice or agreement required to
be provided to any party pursuant to Code Section&nbsp;4980B or ERISA Section&nbsp;601
et seq. (&#147;<b><u style="font-weight:bold;">COBRA</u></b>&#148;)<b>  </b>and Code Section&nbsp;9801 or ERISA Section&nbsp;701
et seq. (&#147;<b><u style="font-weight:bold;">HIPAA</u></b>&#148;); and
(xii) any nondiscrimination tests performed in the last three plan years.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160; <b><i style="font-weight:bold;">Compliance</i></b>.&#160; The Employee Plans have been established,
maintained, administered and their assets have been invested in accordance with
their terms and with all provisions of the Code, ERISA and other applicable
Laws.&#160; Each of Matrix<b>  </b>and all ERISA Affiliates have complied in
all material respects with all of their obligations under each of the Employee
Plans and with all provisions of the Code, ERISA and any and all other
applicable Laws.&#160; Except as set forth in <u>Section&nbsp;3.14(d)&nbsp;of
the Disclosure Letter</u>, all Pension/Profit-Sharing Plans and related trusts
that are intended to satisfy payment of Code Sections 401(k)&nbsp;and 501,
respectively, (i)&nbsp;have received a favorable determination letter from the
IRS to the effect that they are qualified under Code Sections 401(a)&nbsp;and
501, both as to the original plan and all restatements or material amendments
and (ii)&nbsp;have never been subject to any assertion by any Governmental
Entity that they are not so qualified.&#160;
No Employee Plan is subject to an audit by the IRS, DOL or any other
Governmental Entity at this time nor is it, and, to the Knowledge of Matrix,
there is no event or reason it would become, the subject of any voluntary
compliance program, amnesty program, closing agreement or other similar
programs, and no completed audit, compliance filing, closing agreement or
similar action or agreement has resulted in the imposition of any Tax or
penalty that has not been satisfied.</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='22',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160; <b><i style="font-weight:bold;">Accruals; Funding</i></b>.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Pension/Profit-Sharing
Plans</u>.&#160; Except as set forth in <u>Section&nbsp;3.14(e)&nbsp;of
the Disclosure Letter</u>: (1)&nbsp;none of the Employee Plans is a
Pension/Profit-Sharing Plan subject to ERISA Title IV (including those for
retired, terminated or other Participants) or the minimum funding requirements
of ERISA Section&nbsp;302 or Code Section&nbsp;412 and (2)&nbsp;none of Matrix<b>  </b>or any ERISA Affiliate has terminated any
Pension/Profit-Sharing Plan subject to Title IV as to which there is any
remaining liability, or incurred any outstanding liability under ERISA Section&nbsp;4062
to the PBGC or to a trustee appointed under ERISA Section&nbsp;4042.</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Contributions</u>.&#160; Except as set forth in <u>Section&nbsp;3.14(e)&nbsp;of
the Disclosure Letter</u>:&#160; (1)&nbsp;Matrix<b>  </b>and each ERISA Affiliate have made full
and timely payment of all amounts required to be contributed under the terms of
each Employee Plan and applicable Law, or required to be paid as expenses under
such Employee Plan, including administrative expenses, PBGC premiums and
amounts required to be contributed under Code Section&nbsp;412; (2)&nbsp;all
contributions have been made in accordance with the actuarial recommendations;
and (3)&nbsp;no excise taxes may be assessed as a result of any nondeductible
or other contributions made or not made to an Employee Plan.</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160; <b><i style="font-weight:bold;">Reporting and Disclosure</i></b>.&#160; Summary plan descriptions and all other
returns, reports, registration statements, prospectuses, documents, statements
and communications that are required to have been filed, published or
disseminated under the Code, ERISA or other Law and the rules&nbsp;and
regulations promulgated by the Treasury Department, the DOL or by the SEC or
any other Governmental Entity with respect to the Employee Plans have been so
filed, published or disseminated.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;&#160;&#160; <b><i style="font-weight:bold;">Claims</i></b>.&#160; Other than claims for benefits arising in the
ordinary course of the administration and operation of the Employee Plans, no
Claims, investigations, arbitrations or governmental investigations are pending
or, to the Knowledge of Matrix, threatened with respect to any Employee Plan,
Matrix, any ERISA Affiliate, any trust or arrangement created under or as part
of any Employee Plan, any trustee, fiduciary, custodian, administrator or other
Person holding or controlling assets of any Employee Plan, and no basis to
anticipate any such claim or claims exists.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)&#160;&#160;&#160; <b><i style="font-weight:bold;">Prohibited Transactions;
Terminations; Other Reportable Events</i></b>.&#160; Except as set forth in <u>Section&nbsp;3.14(h)&nbsp;of
the Disclosure Letter</u>, neither Matrix, any ERISA Affiliate, any Employee
Plan, any trust or arrangement created under any of them, nor, to the Knowledge
of Matrix, any trustee, fiduciary, custodian, administrator or any other person
or entity holding or controlling assets of any of the Employee Plans has
engaged in any &#147;prohibited transaction&#148; (as such term is defined in ERISA or
the Code) that could subject any of Matrix, any ERISA Affiliate or any Employee
Plan to any Tax, penalty or other cost or liability of any kind.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160; <b><i style="font-weight:bold;">Creation of Obligations By Reason of
the Merger</i></b>.&#160; Except as set
forth in <u>Section&nbsp;1.7</u> of this Agreement and <u>Section&nbsp;3.14(i)&nbsp;of
the Disclosure Letter</u>, the execution and delivery of the Matrix Delivered
Agreements and the consummation of the transactions contemplated by the Matrix
Delivered Agreements will not constitute an event under any Employee Plan that
will or may result in any payment (whether severance pay or otherwise),</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='23',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">acceleration, forgiveness
of indebtedness, vesting, distribution, increase in benefits or obligation to
fund benefits with respect to any Participant, including any obligation to make
a payment that would be nondeductible under Code section 280G or any other Code
provision.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)&#160;&#160;&#160;&#160; <b><i style="font-weight:bold;">Employee Recharacterization.&#160; </i></b>Neither Matrix nor any ERISA Affiliate
has or could have any liability arising from the recharacterization of any
Person engaged by Matrix<b>  </b>or any
ERISA Affiliate as an independent contractor, leased employee, consultant or
similar service provider as an employee of Matrix<b>  </b>or any ERISA Affiliate.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)&#160;&#160;&#160; <b><i style="font-weight:bold;">Code Section&nbsp;409A.&#160; </i></b>Any Employee Plan that
constitutes a nonqualified deferred compensation plan (within the meaning of
Code Section&nbsp;409A) is listed on <u>Section&nbsp;3.14(k)&nbsp;of the
Disclosure Letter</u> (each a &#147;<b><u style="font-weight:bold;">409A Plan</u></b>&#148;).&#160; Each 409A Plan has been amended or may be
amended under IRS Notice 2007-86 to comply with and has been operated in
accordance with the requirements of Code Section&nbsp;409A so as to avoid the
imposition of taxation under Code Section&nbsp;409A(a)(1).</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.15&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Taxes.</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160; <b><i style="font-weight:bold;">Filing of Returns; Payment of Taxes;
Liens.&#160; </i></b>Except as set
forth in <u>Section&nbsp;3.15(a)&nbsp;of the Disclosure Letter</u>: (i)&nbsp;all
returns of every nature of Taxes required to be filed by Matrix have been
timely and otherwise properly filed, and no extensions of time in which to file
any such returns are in effect; (ii)&nbsp;Matrix has paid and satisfied on or
before their respective due dates all Taxes for periods covered by such
returns; and without limiting the foregoing, Matrix has made estimated Tax
payments sufficient to pay all Taxes for the period ended December&nbsp;31,
2007 and has made all estimated payments for periods thereafter in accordance
with applicable Law and in an amount sufficient to pay the Taxes for such
period (and not just the minimum amounts necessary to comply with estimated
payment requirements of applicable Law); (iii)&nbsp;all Taxes and other amounts
that Matrix is or was required by applicable Law to withhold or collect have
been duly withheld and collected and have been paid over to the proper
Governmental Entities in accordance with applicable Law; (iv)&nbsp;there are no
Liens for Taxes on any of Matrix&#146;s assets other than any Lien imposed by
applicable Law for property Taxes for the current Tax period that are not yet
due and payable; and (v)&nbsp;no claim has been made in writing against Matrix
relating to any of its assets by any Governmental Entity in any jurisdiction in
which Matrix did not file sales, use, value-added or similar Tax returns or
other required filings or did not pay any such Taxes, that Matrix is or may be
subject to any such Tax by that jurisdiction..</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160; <b><i style="font-weight:bold;">Filing of Returns; Payment of Taxes;
Liens.&#160; </i></b><u>Section&nbsp;3.15(b)&nbsp;of
the Disclosure Letter</u> discloses the most recent audit or examination of
Matrix with respect to each of income Taxes, municipal license Taxes, real
property Taxes, sales and use Taxes and personal property Taxes.&#160; Except as set forth in <u>Section&nbsp;3.15(b)&nbsp;of
the Disclosure Letter</u>: (i)&nbsp;no audit of the returns of Matrix&#146;s Taxes
is currently being conducted (nor has any audit been conducted), and Matrix has
not received from any Governmental Entity with jurisdiction or other authority
as to Taxes (a &#147;<b><u style="font-weight:bold;">Tax Authority</u></b>&#148;)
either a notice that it intends to conduct any other audit of returns of Taxes
or any request for information with respect to Taxes; (ii)&nbsp;without
limiting Subsection (a)&nbsp;above, all Taxes asserted (and other matters
required) as a result of such examinations have been paid or finally settled; (iii)&nbsp;there
are no outstanding</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='24',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">agreements or waivers
extending the statutory period of limitation applicable to any return of Taxes
for any period with respect to Matrix; and (iv)&nbsp;there are no outstanding
requests by Matrix for rulings from, or closing agreements with, any Tax
Authority.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160; <b><i style="font-weight:bold;">No Special Tax Status.&#160; </i></b>Matrix has no special Tax
status granted by any Governmental Entity or under any applicable Law.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160; <b><i style="font-weight:bold;">Absence of Code &#167; 338 and Subchapter
S Elections.&#160; </i></b>Matrix has
not filed an election, and has not been deemed to have made an election, under
Code &#167;&nbsp;338 and has not elected to be taxed as a &#147;small business
corporation&#148; under Code Subchapter S.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160; <b><i style="font-weight:bold;">Industrial Development Bonds.&#160; </i></b>Except as set forth in <u>Section&nbsp;3.15(e)&nbsp;of
the Disclosure Letter</u>: (i)&nbsp;no assets owned, leased or used by Matrix
or by any &#147;Related Person&#148; (as that term is defined in Section&nbsp;103(b)(6)(C)&nbsp;of
the Internal Revenue Code of 1954, as amended but not as superseded by the Code
(the &#147;<b><u style="font-weight:bold;">&#145;54 Code</u></b>&#148;) and Code
&#167;&nbsp;144(a)(3)) have been financed by currently outstanding industrial
development bonds within the meaning of &#145;54 Code &#167;&nbsp;103(b)&nbsp;or private
activity bonds within the meaning of Code &#167;&nbsp;141(a); (ii)&nbsp;neither
Matrix nor any Related Person leases space in or occupies any building which
has been so financed; and (iii)&nbsp;neither Matrix nor any Related Person
acquires goods or services made available at a facility financed by industrial
development bonds or private activity bonds of which Matrix is a &#147;principal
user&#148; within the meaning of Code &#167;&nbsp;141(a)&nbsp;or &#145;54 Code &#167;&nbsp;103(b).</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160; <b><i style="font-weight:bold;">Excess Parachute Payments.&#160; </i></b>Matrix has not made any
payment which constitutes an &#147;excess parachute payment&#148; within the meaning of
Code Section&nbsp;280G, and, except as set forth in <u>Section&nbsp;3.15(f)&nbsp;of
the Disclosure Letter</u>, no payment by Matrix required to be made will, if
made, constitute an &#147;excess parachute payment&#148; within the meaning of Code Section&nbsp;280G.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;&#160;&#160; <b><i style="font-weight:bold;">NOL&#146;s.&#160; </i></b></font>As of December&nbsp;31, 2007, the consolidated net operating
loss of Matrix was not less than $45,300,000.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.16&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Title to
Properties; Adequacy.</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160; <u>Section&nbsp;3.16(a)&nbsp;of
the Disclosure Letter</u> lists all of the leases (the &#147;<b><u style="font-weight:bold;">Leases</u></b>&#148;) for real or personal property
to which Matrix<b>  </b>is a party and
describes the leased assets.&#160; Matrix does
not own any real property.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160; Matrix<b>  </b>has good and marketable title to or valid
leasehold interests in all properties and assets that are material to the
conduct of the Business of Matrix, including those reflected in the 2006
Balance Sheet (or acquired after the date of the 2006 Balance Sheet by Matrix),
or not reflected on the 2006 Balance Sheet but used by Matrix, except for
assets and properties sold, consumed or otherwise disposed of in the ordinary
course of business since January&nbsp;1, 2007 (which, to the extent material,
are disclosed in <u>Section&nbsp;3.16(b)&nbsp;of the Disclosure Letter</u>)
(collectively, the &#147;<b><u style="font-weight:bold;">Properties</u></b>&#148;),
free and clear of any title defects or Liens, except Liens for current ad
valorem Taxes and assessments not in default.</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='25',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-05.htm',USER='c900127',CD='Mar 15 03:39 2008' -->



<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>No Person other
than Matrix<b>  </b>is currently entitled
to possession of any of the Properties, whether owned or leased by Matrix.&#160; The buildings, structures and improvements
owned or leased by Matrix<b>  </b>conform
in all material respects to all applicable Laws, including zoning regulations,
none of which would upon consummation of the transactions contemplated hereby
materially adversely interfere with the use of such Properties, buildings,
structures or improvements for the purposes for which they are now utilized.&#160; Except as set forth in <u>Section&nbsp;3.16(c)&nbsp;of
the Disclosure Letter</u>, (i)&nbsp;each of the Properties is adequate in all
material respects for the operations for which it is being used by Matrix, (ii)&nbsp;each
of the Properties is in reasonably good repair and operating condition, normal
wear and tear excepted, and (iii)&nbsp;the Properties constitute all of the
properties that Matrix uses in connection with the operation of its Business.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.17</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Contracts.</b>&#160; <u>Section&nbsp;3.17 of the Disclosure Letter</u>
sets forth an accurate and complete list of each written and each oral
agreement, contract, obligation, promise, or undertaking (including any and all
amendments thereto) to which Matrix<b>  </b>is
a party or by which Matrix<b>  </b>is
bound which (a)&nbsp;relates to any Indebtedness; (b)&nbsp;is with any customer
or supplier or which involves expenditures in excess of $50,000; (c)&nbsp;is a
collective bargaining agreement; (d)&nbsp;obligates Matrix or any of its
Affiliates not to compete with any business or in any territory or which
otherwise restrains or prevents Matrix or any of its Affiliates from carrying
on any lawful business; (e)&nbsp;relates to employment, compensation,
severance, consulting or indemnification between Matrix<b>  </b>and any of its present or former officers,
directors, employees or consultants who are entitled to compensation thereunder
(other than indemnification of officers and directors under corporate charter
or bylaw provisions); (f)&nbsp;involves the grant by or to Matrix<b>  </b>of exclusive rights; (g)&nbsp;is an
exchange-traded or over-the-counter swap, forward, future, option, cap, floor
or collar financial contract or any other similar arrangement whether entered
into for Matrix&#146;s account or for the account of one or more of its customers; (h)&nbsp;imposes
confidentiality requirements on Matrix or any of its Affiliates; or (i)&nbsp;is
otherwise material to the assets, Business, operations, financial condition or
prospects of Matrix<b>  </b>(collectively,
the &#147;<b><u style="font-weight:bold;">Matrix Contracts</u></b>&#148;).&#160; All of the Matrix Contracts and Leases are
enforceable by Matrix<b>  </b>in
accordance with their terms except to the extent that such enforceability may
be limited by bankruptcy, insolvency, reorganization, moratorium or other Laws
and court decisions relating to or affecting the enforcement of creditors&#146;
rights generally, and is subject to general principles of equity.&#160; Matrix has not<b>  </b>received or given any notice of termination with respect to
any of the Matrix Contracts or Leases.&#160;
Except as set forth in <u>Section&nbsp;3.17 of the Disclosure Letter</u>,
Matrix is not<b>  </b>in breach or default
in any material respect under (and no event has occurred which with notice or
the passage of time or both would constitute a breach or default under) any
Matrix Contract or Lease nor, to the Knowledge of Matrix, is any other party to
any of the Matrix Contracts or Leases in default in any material respect
thereunder (and no event has occurred which with notice or the passage of time
or both would constitute a breach or default thereunder).&#160; Matrix has provided or made available to
Immucor true and complete copies of all of the Matrix Contracts and Leases.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.18</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Inventory.</b>&#160; Except as set forth in <u>Section&nbsp;3.18
of the Disclosure Letter</u>, the inventories as reflected in the Matrix
Financial Statements and in the books and records of Matrix: (a)&nbsp;are
determined and valued (with appropriate reserves) in accordance with GAAP
applied on a consistent basis; and (b)&nbsp;consist of items that are salable
in the ordinary course of business (subject to the inventory reserves shown in
the Matrix Financial Statements), are</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='26',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">currently being sold (or
reasonably expected to be sold during the twelve&nbsp;(12) months following the
Closing) and are not excessive in the Business&#146; current circumstances.&#160; Except as set forth in the Matrix Financial
Statements or <u>Section&nbsp;3.18 of the Disclosure Letter</u>, to the
knowledge of Matrix, no inventory sold by Matrix<b>  </b>is subject to returns or recalls.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.19</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Accounts
Receivable.</b>&#160; Matrix&#146;s accounts
receivable: (a)&nbsp;are valid and existing and collectable in the ordinary
course of business (subject to the bad debt reserves shown in the Matrix
Financial Statements); (b)&nbsp;represent monies due for goods sold and
delivered or services rendered in the ordinary course of business; and (c)&nbsp;to
the knowledge of Matrix, are subject to no refunds or other adjustments (except
discounts for prompt payment given in the ordinary course of business that are
described in <u>Section&nbsp;3.19 of the Disclosure Letter</u>) or to any
defenses, rights of set-off, assignments, restrictions, security interests,
encumbrances or conditions enforceable by third parties on or affecting any of
them.&#160; The bad debt reserves in the
Matrix Financial Statements are adequate, determined in accordance with GAAP
and calculated consistent with past practice.&#160;
Except as set forth in <u>Section&nbsp;3.19 of the Disclosure Letter</u>,
none of the accounts receivable of Matrix represents obligations for goods sold
on consignment, on approval or on a sale-or-return basis or subject to any
other repurchase or return arrangement.</p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.20</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Defective
Products; Product Liability; Product Recalls.</b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman">&nbsp;</font></b></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>Except as set
forth in <u>Section&nbsp;3.20(a)&nbsp;of the Disclosure Letter</u>: (i)&nbsp;Matrix
has maintained accurate sales records and order backlog with respect to all
products and services; and (ii)&nbsp;each of Matrix&#146;s products and services
comply in all material respects with applicable Law and with each warranty,
guaranty or claim made by Matrix or implied by applicable Law.&#160; Since January&nbsp;1, 2006, no product
manufactured, sold, leased, licensed or delivered by Matrix has been subject to
any product warranty beyond the applicable standard product warranties which
are set forth in <u>Section&nbsp;3.20(a)&nbsp;of the Disclosure Letter</u>.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>Matrix has<b>  </b>complied in all material respects with all
applicable Laws with respect to its products and services, including those of
the United States Food and Drug Administration, the Consumer Product Safety
Commission and the United States Environmental Protection Agency.&#160; <u>Section&nbsp;3.20(b)&nbsp;of the
Disclosure Letter</u> sets forth all correspondence with any Governmental
Entity alleging any non-compliance with applicable Law with respect to the
products and services of Matrix.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>Except as set
forth in <u>Section&nbsp;3.20(c)&nbsp;of the Disclosure Letter</u>, all of
Matrix&#146;s products are and have been merchantable, free from defects in
material, workmanship and design, perform in all material respects in the
manner, and have the functionality, described in the Memorandum or in the
Matrix promotional materials and technical documentation about such products,
and are suitable for the purpose for which they were sold.&#160; Except as disclosed in <u>Section&nbsp;3.20(c)&nbsp;of
the Disclosure Letter</u>, Matrix&#146;s<b>  </b>products
have not been subject to any product recall (including any safety related
recall) or service bulletin and there is no fact or facts existing which may
reasonably be expected to result in any such recall or service bulletin.&#160; Except as disclosed in <u>Section&nbsp;3.20(c)&nbsp;of
the Disclosure Letter</u>, there is no legal action, Claim, arbitration, or
other legal or administrative proceeding or investigation before any
Governmental Entity pending or, to the Knowledge of Matrix,</h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='27',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">threatened, involving any
product liability, product recall or otherwise involving any product of Matrix.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.21</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font style="font-weight:bold;">Major
Customers</font>.</b>&#160; <u>Section&nbsp;3.21 of the Disclosure Letter</u>
sets forth (a)&nbsp;the name of all Distributors and End-User Customers of
Matrix during the two-year period ended December&nbsp;31, 2007, and (b)&nbsp;the
name of all Distributors and End-User Customers listed pursuant to (a)&nbsp;above
as to which Matrix<b>  </b>has received a
termination notice or, to the Knowledge of Matrix, as to which Matrix<b>  </b>has a reasonable basis to believe that
such customer will terminate its relationship with Matrix<b>  </b>or materially reduce its future purchases
from Matrix.&#160; Except as set forth in <u>Section&nbsp;3.21
of the Disclosure Letter</u>, a valid and enforceable purchase order has been
issued and is currently outstanding under each Matrix Contract with an End-User
Customer or a Distributor and all amounts payable to Matrix under such purchase
order are consistent with the amounts specified in the relevant Matrix
Contract.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.22</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Major
Suppliers.</b>&#160; <u>Section&nbsp;3.22 of
the Disclosure Letter</u> sets forth (a)&nbsp;the name of each supplier of
Matrix which was among the ten (10)&nbsp;suppliers which generated the greatest
amount of expense during the two-year period ended December&nbsp;31, 2007 and (b)&nbsp;the
name of each supplier listed pursuant to (a)&nbsp;above and as to which Matrix
has received a termination notice or, to the Knowledge of Matrix, as to which
Matrix has a reasonable basis to believe that such supplier will terminate its
relationship with Matrix or materially reduce its future sales to Matrix.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.23</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Labor
Relations.</b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>Except as set
forth in <u>Section&nbsp;3.23(a)&nbsp;of the Disclosure Letter</u>, Matrix is
and since January&nbsp;1, 2003, has been, in compliance in all material
respects with all applicable Laws respecting employment and employment
practices, terms and conditions of employment, wages and hours, and is not
engaged in any unfair labor or unlawful employment practice.&#160; There is no unlawful employment practice or
discrimination charge pending involving Matrix before any Governmental Entity,
nor is there any pending or, to the Knowledge of Matrix, basis for or threatened,
unfair labor practice charge or complaint against Matrix before any
Governmental Entity.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>Except as set
forth in <u>Section&nbsp;3.23(b)&nbsp;of the Disclosure Letter</u>, Matrix is
not party to or is bound by any agreement, arrangement or understanding with
any employee or consultant that cannot be terminated on notice of (90) or fewer
days or that entitles any employee or consultant to receive any salary
continuation or severance payment or retain any specified position with Matrix.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>There is no
labor strike, dispute, slowdown or stoppage&nbsp;pending or, to the Knowledge
of Matrix, threatened against or involving or affecting Matrix, nor has Matrix
experienced any labor interruptions during the past three years.&#160; No grievance or arbitration proceeding is pending
and, to the Knowledge of Matrix, no written claim therefor exists involving
Matrix.&#160; There is no collective
bargaining agreement that is binding on Matrix.&#160;
No trade union, council of trade unions, employee bargaining agency or
affiliated bargaining agent (i)&nbsp;holds bargaining rights with respect to
any employees of Matrix; or (ii)&nbsp;has applied to be certified as the
bargaining agent of any employees of Matrix.</h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='28',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><u>Section&nbsp;3.23(d)&nbsp;of
the Disclosure Letter</u> contains a true and complete list of all employees of
Matrix working under USCIS authorization in E, F, H, J, L, M, O, P or TN visa
status, together with a listing of each such employee&#146;s visa status and visa
expiration date.&#160; Matrix has not had any
immigration violations, nor has it employed individuals not authorized to work
in the United States.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.24</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Insider
Interests.</b>&#160; Except as set forth in <u>Section&nbsp;3.24
of the Disclosure Letter</u>, no Affiliate, officer, director, stockholder,
employee, holder of Matrix Options, former member or former manager of Matrix,
nor any of their Affiliates,<b>  </b>(a)&nbsp;has
any agreement with Matrix<b>  </b>or any
interest in any property, real or personal, tangible or intangible, owned or
used by Matrix or previously owned or used by Matrix (other than cash); (b)&nbsp;has
any pending or, to the Knowledge of Matrix, threatened<b>  </b>Claim against Matrix, except for accrued
compensation, benefits (including stock options issued as of the date hereof)
and expenses incurred in the ordinary course of business with respect to
employees of Matrix; or (c)&nbsp;has any direct or indirect equity interest in
any supplier or customer of Matrix.&#160;
Except as set forth in <u>Section&nbsp;3.24 of the Disclosure Letter</u>,
Matrix has not extended or modified credit, arranged for the extension of
credit, or renewed an extension of credit, in the form of a personal loan to or
for any director or executive officer (or equivalent thereof) of Matrix.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.25</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Insurance.</b>&#160; Matrix maintains the amount and scope of all
insurance policies or contracts providing coverage as summarized and set forth
in <u>Section&nbsp;3.25 of the Disclosure Letter</u>.&#160; All such policies or contracts of insurance
are sufficient for compliance in all material respects with all Laws and of all
agreements to which Matrix<b>  </b>is a
party, and have been issued by insurers, which, to the Knowledge of Matrix, are
responsible and financially sound.&#160; All
insurance policies pursuant to which any such insurance is provided are in full
force and effect and no effective written notice of cancellation or termination
of any such insurance policies has been given to Matrix<b>  </b>by the carrier of any such policy.&#160; All premiums required to be paid in
connection therewith have been paid in full.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.26</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Corporate
Records.</b>&#160; The corporate record books
(including the share transfer records) of Matrix<b>  </b>are complete, accurate and up to date in all material
respects with all necessary signatures and set forth all meetings and actions
taken by the stockholders and directors (or members and managers, as
applicable) of Matrix and its predecessors and all transactions involving
shares or other equity units of Matrix<b>  </b>and
its predecessors (and contain all canceled certificates).&#160; Matrix has provided to Immucor prior to the
date hereof true, correct and complete copies of all such records.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.27</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Bank
Accounts.</b>&#160; <u>Section&nbsp;3.27 of
the Disclosure Letter</u> lists all bank, money market, savings and similar
accounts and safe deposit boxes of Matrix, specifying the account numbers, the
authorized signatories or persons having access to them, and Matrix will
separately furnish to Immucor at Closing the passwords used to access such
accounts, including through voice response and internet services.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.28</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Accounting
Controls.</b>&#160; Except as set forth in <u>Section&nbsp;3.28
of the Disclosure Letter</u>, to the Knowledge of Matrix, (i)&nbsp;all material
transactions of Matrix are executed in accordance with management&#146;s general or
specific authorization; (ii)&nbsp;all material transactions of Matrix are
recorded as necessary to permit the preparation of financial statements</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>

<div align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='29',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">in conformity with GAAP consistently applied or any other criteria
applicable to such statements; and (iii)&nbsp;access to the material property
and assets of Matrix<b>  </b>is permitted
only in accordance with management&#146;s general or specific authorization.&#160; <u>Section&nbsp;3.28 of the Disclosure Letter</u>
lists, and Matrix has delivered to Immucor copies of, all written descriptions
of, and all policies, manuals and other documents promulgating, disclosure
controls and procedures to the extent such materials are of general
applicability with respect to the disclosure controls and procedures of Matrix.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.29</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Board
Recommendation.</b>&#160; The Board of
Directors of Matrix, at a meeting duly called and held, has by the unanimous
vote of the directors (i)&nbsp;determined that this Agreement and the
transactions contemplated hereby, including the Merger, the execution and
delivery of the Matrix Delivered Agreements and other agreements and arrangements,
and the transactions contemplated thereby, taken together, are advisable and
fair to and in the best interests of the stockholders of Matrix and has
approved the same, and (ii)&nbsp;resolved to recommend that the stockholders of
Matrix approve this Agreement and the transactions contemplated herein,
including the Merger.&#160; Such resolutions
have not been rescinded or modified and are in full force and effect.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.30</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Combinations
Involving Matrix.</b>&#160; All mergers,
consolidations or other business combinations involving Matrix, all conversions
or other changes of Matrix&#146;s business form,<b>  </b>and
all liquidations, purchases or other transactions by which Matrix acquired or
disposed of a material portion of any of its<b>  </b>Business<b>  </b>or properties (collectively, the &#147;<b><u style="font-weight:bold;">Prior Transactions</u></b>&#148;) were conducted in
compliance with applicable charter documents, bylaws, any other applicable
agreements, instruments and documents and applicable Laws.&#160; Except as disclosed in <u>Section&nbsp;3.30
of the Disclosure Letter</u>, none of the parties to any of the Prior
Transactions have made any claims against any other party or parties thereto
for any breach of the definitive documents for such transaction.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.31</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Brokers,
Finders and Investment Bankers.</b>&#160; Except
as disclosed in <u>Section&nbsp;3.31 of the Disclosure Letter</u>, neither
Matrix<b>  </b>nor any of its<b>  </b>officers, directors or employees has
employed any broker, finder or investment banker or incurred any liability for
any investment banking fees, financial advisory fees, brokerage fees or finders&#146;
or similar fees in connection with the transactions contemplated by this
Agreement.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;3.32</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Information
Statement; Warranties True and Correct.</b>&#160;
None of the information supplied or to be supplied by Matrix in writing
for inclusion in the Information Statement as of each Mailing Date shall
contain any untrue statement of a material fact, or omit to state any material
fact necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading.&#160; No representation or warranty by Matrix in
any Matrix Delivered Agreement and no statement in any Section&nbsp;of the
Disclosure Letter contains or will contain any untrue statement of a material
fact, or omits or will omit, a material fact, necessary to make any statement
in any of them not misleading.&#160; The
foregoing representations and warranties are in addition to, and do not limit
in any way whatsoever, any other representation or warranty in this <u>Article&nbsp;III</u>.</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>

<div align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='30',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE IV.<br>
REPRESENTATIONS AND WARRANTIES OF IMMUCOR</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immucor and Merger Sub, jointly and severally, represent and warrant to
Matrix as follows:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.1</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Organization
and Qualification.</b>&#160; Immucor is a
corporation duly organized, validly existing and in good standing under the
laws of the State of Georgia and has the corporate power and authority to own
all of its properties and assets and to carry on its business as it is now
being conducted.&#160; Merger Sub is a
corporation duly organized, validly existing and in good standing under the
laws of the State of Delaware and has the corporate power and authority to own
all of its properties and assets and to carry on its business as it is now
being conducted.&#160; Each of Immucor and Merger
Sub is duly qualified to do business and is in good standing in all
jurisdictions in which it is required to be qualified and in which the failure
to be so qualified would not have an Immucor Material Adverse Effect.&#160; Immucor is the sole stockholder of Merger
Sub.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.2</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Authority.</b>&#160; Each of Immucor and Merger Sub has the
corporate power and authority to execute and deliver this Agreement and any
other agreements, instruments and documents executed and delivered by Immucor
and Merger Sub pursuant to this Agreement (this Agreement and such other
agreements, instruments and documents are collectively referred to as the &#147;<b><u style="font-weight:bold;">Purchaser Delivered Agreements</u></b>&#148;) and to
consummate the transactions contemplated by, and otherwise to comply with and
perform its obligations under, them.&#160; The
execution and delivery by Immucor and Merger Sub of the Purchaser Delivered
Agreements and the consummation by Immucor and Merger Sub of the transactions
contemplated on its part thereby have been duly authorized by each of them by
all necessary corporate action.&#160; The
Purchaser Delivered Agreements will, when executed and delivered by Immucor and
Merger Sub, constitute valid and binding obligations of Immucor and Merger Sub
enforceable against Immucor and Merger Sub, in accordance with their terms,
except to the extent that such enforceability may be limited by bankruptcy,
insolvency, reorganization, moratorium or other Laws and court decisions
relating to or affecting the enforcement of creditors&#146; rights generally
(including statutory or other Laws regarding fraudulent transfers), and is
subject to general principles of equity.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.3</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No
Consents Required.</b>&#160; Except for (i)&nbsp;the
pre-merger notification requirements of the HSR Act and the rules&nbsp;and
regulations thereunder, if required, and (ii)&nbsp;the filing of the Certificate
of Merger, no Authorization of or with any Governmental Entity is required in
connection with the execution and delivery of the Purchaser Delivered
Agreements by Immucor or the consummation by Immucor and Merger Sub of the
transactions contemplated by, or other compliance with or performance under,
the Purchaser Delivered Agreements.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.4</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Absence
of Violations or Conflicts.</b>&#160; Subject
to obtaining the Authorizations of Government Entities contemplated by <u>Section&nbsp;4.3</u>,
the execution and delivery of the Purchaser Delivered Agreements by Immucor and
Merger Sub and the consummation by Immucor and Merger Sub of the transactions
contemplated by, or other compliance with or performance under, them do not and
will not with the passage of time or the giving of notice or both (a)&nbsp;constitute
a violation of, be in conflict with, constitute a default or require any
payment under, permit a termination of, or result in the creation or imposition
of any Lien upon any assets of Immucor and Merger Sub under (i)&nbsp;any material
contract, agreement, commitment, undertaking or understanding (including rights
of refusal or similar rights or other transfer</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='31',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">restrictions) to which Immucor
or Merger Sub is a party, by which it is bound or to which any of its assets
are subject, (ii)&nbsp;any Governmental Order to which Immucor or Merger Sub is
subject, (iii)&nbsp;any Laws to which Immucor or Merger Sub is subject or (iv)&nbsp;the
certificate of incorporation or bylaws or other governing documents of Immucor
or Merger Sub; or (b)&nbsp;create, or cause the acceleration of the maturity
of, any debt, obligation or liability of Immucor or Merger Sub;&#160; except, in the case of (a)(i), (a)(ii)&nbsp;and
(b), where such violation, conflict, default, termination or imposition could
not reasonably be expected to have an Immucor Material Adverse Effect or
restrict the transactions contemplated in this Agreement.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.5</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Litigation.</b>&#160; As of the date of this Agreement, there is no
Claim pending or, to the Knowledge of Immucor, threatened against or affecting
Immucor at law or in equity, or before or by any arbitrator or Governmental
Entity which would adversely affect Immucor&#146;s performance of its obligations
under this Agreement or the consummation of the transactions contemplated
hereby or otherwise could be reasonably expected to have an Immucor Material
Adverse Effect (other than any Claims reflected in Immucor&#146;s SEC filings, as to
which Claims no representation or warranty is made).</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.6</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Brokers,
Finders and Investment Bankers.</b>&#160;
Except for TM Capital Corp., neither Immucor, Merger Sub nor any of
their officers, directors or employees has employed any broker, finder or
investment banker or incurred any liability for any investment banking fees,
financial advisory fees, brokerage fees or finders&#146; or similar fees in
connection with the transactions contemplated by this Agreement.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;4.7</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Financial
Ability.</b>&#160; Immucor has the financial
ability to consummate the transactions contemplated by this Agreement.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE V.<br>
ADDITIONAL COVENANTS AND AGREEMENTS</font></b></p>

<h1 style="font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;text-decoration:underline;text-indent:0in;text-transform:uppercase;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;"><font style="text-decoration:none;">&nbsp;</font></font></u></b></h1>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.1</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Preparation
of Information Statement; Majority Stockholders Consent.</b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>As soon as
practicable following the date of this Agreement, Matrix, in cooperation with
Immucor, shall prepare an information statement (the &#147;<b><u style="font-weight:bold;">Information Statement</u></b>&#148;)
as Matrix deems necessary or appropriate that complies in all material respects
with applicable provisions of Delaware corporate law and federal and state
securities laws, in each case as applicable to transactions of the type
contemplated by this Agreement.&#160; Matrix
shall use reasonable best efforts to cause the Information Statement to be
mailed to the Matrix Shareholders on a timely basis.&#160; Matrix will provide Immucor and its counsel
the reasonable opportunity to review and approve such information as set forth
in the Information Statement prior to the mailing thereof to the Matrix
Shareholders.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>If prior to the
Effective Time, any event occurs with respect to Matrix, or any change occurs
with respect to information included in the Information Statement, Matrix shall
promptly notify Immucor of such event, and Matrix and Immucor shall cooperate
in disseminating the information to the Matrix Shareholders in an appropriate
manner.</h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='32',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>As soon as
practicable following the date of this Agreement, Matrix shall solicit from
Persons holding the Preferred Class&nbsp;Merger Votes written consent of such
Matrix Shareholders in lieu of a meeting of the Matrix Shareholders for
purposes of obtaining the Required Merger Stockholder Votes (the &#147;<b><u style="font-weight:bold;">Majority Stockholders Consent</u></b>&#148;).&#160; Such Majority Stockholders Consent shall be
obtained by Matrix in accordance with Section&nbsp;228 of the DGCL.&#160; Promptly after receiving the Majority
Stockholder Consent from the holders described above, Matrix shall provide
notice thereof to the Matrix Shareholders entitled to receive notice thereof
pursuant to Section&nbsp;228 and Section&nbsp;262(d)(2)&nbsp;of the DGCL, such
notice to be in form and substance reasonably satisfactory to Immucor and to
specify that further information regarding the matters described therein shall
be provided in the Information Statement.&#160;
Matrix shall provide Immucor with a copy of all materials to be distributed
to the Matrix Shareholders describing the transactions contemplated hereby not
later than three days prior to distribution.&#160;
Matrix and Immucor each agree to execute and deliver such further
documents and instruments and to do such other acts and things as may be
required to complete all requisite corporate action in connection with the
transactions contemplated by this Agreement.&#160;
All materials distributed to the Matrix Shareholders with respect to
this Agreement or with respect to any description of appraisal rights available
to such stockholders shall be in form and substance reasonably acceptable to
Immucor and shall be in accordance with applicable Law.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.2</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Conduct
of Business Pending the Closing.</b>&#160;
Except as may be contemplated by this Agreement or required by
applicable Law, or as Immucor may otherwise consent to in writing (which
consent shall not be unreasonably withheld or delayed), during the period from
the date hereof to the Closing Date:</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Operation of Matrix in the Ordinary
Course of Business</i></b>.&#160; Other
than as set forth in <u>Section&nbsp;5.2 of the Disclosure Letter</u>, Matrix
shall<b>  </b>operate its Business in the
ordinary and usual course in substantially the same manner as heretofore
conducted.&#160; Matrix shall<b>  </b>(i)&nbsp;prepare and file all income Tax
and other material Tax Returns and amendments thereto required to be filed by
it during the period from the date of this Agreement until the Closing, and
shall allow Immucor, at its request, to review all such Tax Returns prior to
the filing thereof, which review shall not interfere with the timely filing
thereof; (ii)&nbsp;timely pay all Taxes due and payable with respect to such
Tax Returns; and (iii)&nbsp;comply in all material respects with all applicable
Laws relating to the withholding of Taxes.</h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Forbearances by Matrix</i></b>.&#160; Without limiting the generality of <u>Section&nbsp;5.2(a)</u>,
except as set forth in <u>Section&nbsp;5.2 of the Disclosure Letter</u>,
without the prior written consent of Immucor, which consent shall not be
unreasonably withheld or delayed, Matrix shall not:</h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>incur
any Indebtedness or any other Liability other than current Liabilities (other
than Indebtedness) incurred in the ordinary and usual course of business, or
fail to pay any Liability when due or take or fail to take any action, the
taking of which, or the failure to take of which, would permit any Liability to
be accelerated;</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>

<div align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='33',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>assume,
guarantee, endorse or otherwise become responsible for the obligations of any
other Person other than endorsements of negotiable instruments in the ordinary
course of business, or make any loans or advances to any Person;</p>

<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>declare,
set aside or pay any dividend in cash or property with respect to its capital
shares or declare or make any distribution in cash or property on, redeem, or
purchase or otherwise acquire any Matrix Capital Stock, or split, combine or
otherwise similarly change the outstanding shares of Matrix Capital Stock, or
authorize the creation or issuance of or issue or sell (other than issuance of
Matrix Common Stock upon exercise of Matrix Options outstanding on the date
hereof) any capital shares or any securities or obligations convertible into or
exchangeable for, or giving any Person any right to acquire from it, any of its
capital shares, or agree to take any such action;</p>

<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>mortgage,
pledge or otherwise encumber any property or asset;</p>

<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>except for
the New Subsidiary License, sell, lease, transfer or dispose of any of its
properties or assets, waive or release any rights or cancel, compromise,
release or assign any indebtedness owed to it or any claims held by it, except
for sales of products in the ordinary and usual course of business;</p>

<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>organize
any Subsidiary other than New Subsidiary or make any investments of a capital
nature either by purchase of shares or securities, contributions to capital,
property transfers or otherwise, or by the purchase of any property or assets
of any other Person;</p>

<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>fail
to perform its material obligations under Matrix Contracts or agreements with
respect to Matrix Intellectual Property (except those being contested in good
faith) or enter into (other than the New Subsidiary License), assume or amend
in any material respect any material license, contract or commitment other than
contracts to purchase or sell goods or provide services entered into in the
ordinary and usual course of business;</p>

<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(viii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>except
for (A)&nbsp;payment of up to $500,000 in performance-based, pre-Closing
bonuses to Matrix employees or (B)&nbsp;regularly scheduled increases in
accordance with, and the determination of and payment of annual bonuses
consistent with, normal prior practice (both as to timing and amount), increase
in any manner the compensation or benefits of any of its officers or employees
or other Persons, or pay or agree to pay any amount not required to be paid by
any existing plan or agreement to any such officers or employees, or commit
itself to or enter into any employment agreement or any benefit arrangement,
including an incentive compensation, deferred compensation, change of control
or similar arrangement, profit sharing, stock option, share purchase, savings,</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>

<div align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='34',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">consulting, retirement or pension plan, award or arrangement with or
for the benefit of any officer, employee or other Person;</font></p>

<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ix)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>permit
any insurance policy naming it as a beneficiary or a loss payable payee to be
canceled or terminated or any of the coverage thereunder to lapse, unless it
makes its reasonable best efforts to obtain simultaneously with such
termination or cancellation replacement policies providing substantially the
same coverage on commercially reasonable terms and, if so available, such
policies are in full force and effect;</p>

<p align="left" style="margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(x)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>amend
its Certificate of Incorporation or Bylaws;</p>

<p align="left" style="margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xi)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>enter
into any union, collective bargaining or similar agreement;</p>

<p align="left" style="margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>fail to pay any trade accounts payable or
other amount due to suppliers or other creditors of Matrix as they become due
in accordance with their terms (except those being contested in good faith);</p>

<p align="left" style="margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xiii)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>acquire any other corporation, entity or
business (whether by purchase of stock, acquisition of assets, merger or
otherwise);</p>

<p align="left" style="margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xiv)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>fail to take actions (including continued
patent prosecution) necessary or appropriate to protect Matrix Intellectual
Property diligently and substantially in the manner Matrix has protected the
Matrix Intellectual Property prior to the date of this Agreement; or</p>

<p align="left" style="margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xv)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>enter
into an agreement to take any of the actions described in clauses (i)&nbsp;through
(xiv).</p>

<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immucor acknowledges that, notwithstanding the foregoing, Immucor shall
have no right to control in any manner the Business of Matrix<b>  </b>between the date of this Agreement and the
Closing Date.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Investigation</i></b>.&#160; After the date of this Agreement, Matrix
shall permit Immucor to make or cause to be made such investigation of the
Business and properties of Matrix<b>  </b>and
its<b>  </b>financial and legal condition
as Immucor deems necessary or advisable, provided that such investigations
shall not unreasonably interfere with normal operations of Matrix.&#160; Matrix shall permit Immucor and its
authorized representatives to have full access to the premises, books and
records of Matrix<b>  </b>with reasonable
prior notice and at reasonable hours, and shall furnish Immucor with such
financial and operating data and other information with respect to Matrix<b>  </b>as Immucor may from time to time
reasonably request.&#160; In addition, at the
reasonable request of Immucor, representatives of Matrix shall meet from time
to time with one or more representatives of Immucor to allow those Immucor
representatives to ask questions about such books, records data and other
information.</h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.3</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Reasonable
Best Efforts; Further Assurances; Cooperation.</b>&#160; Subject to the other provisions of this
Agreement, each of the Parties hereto shall in good faith perform their
obligations under this Agreement and shall use their reasonable best efforts to
do, or cause</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">35</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='35',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">to be done, all things
necessary, proper or advisable under applicable Law to obtain all
Authorizations and satisfy all conditions to the obligations of the Parties
under this Agreement and to cause the transactions contemplated by this
Agreement to be carried out promptly in accordance with the terms hereof and
shall cooperate fully with each other and their respective officers, directors,
employees, agents, counsel, accountants and other designees in connection with
any steps required to be taken as part of their respective obligations under
this Agreement, including cooperation with respect to the satisfaction of any
of the conditions to the Closing set forth in <u>Article&nbsp;VI</u>.&#160; Upon the execution of this Agreement and
thereafter, each Party shall take such actions and execute and deliver such
documents as may be reasonably requested by the other Parties hereto in order
to consummate the transactions contemplated by this Agreement.&#160; Without limiting the foregoing, Matrix and
its<b>  </b>accountants shall cooperate with
Immucor in the preparation of and filing, in accordance with applicable Law,
with the SEC and filing with
other Governmental Entities of required reports of Immucor with respect to such
financial statements and historical pro forma financial information of Matrix
as may be required pursuant to the requirements of the SEC for filing set forth
in Form&nbsp;8-K under the Exchange Act.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.4</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Expenses.</b>&#160; Except as otherwise provided in this
Agreement, whether or not the transactions contemplated hereby are consummated,
all costs and expenses (including any brokerage commissions or any finder&#146;s or
investment banker&#146;s fees and including attorneys&#146; and accountants&#146; fees)
incurred in connection with this Agreement and the transactions contemplated
hereby shall be paid (a)&nbsp;by the Matrix Shareholders or from the Aggregate
Merger Consideration, with respect to all such costs and expenses incurred by
Matrix, and (b)&nbsp;by Immucor, with respect to all such costs and expenses
incurred by Immucor (and Immucor&#146;s fees and expenses shall include HSR filing
fees).</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.5</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No
Solicitation of Transactions.</b>&#160; Prior
to the termination and abandonment of this Agreement, Matrix shall not, and
shall cause the Affiliates that it controls, and its and their officers,
directors and representatives, not to: (a)&nbsp;solicit, initiate or encourage
submission of proposals or offers from any Person other than Immucor relating
to any acquisition or purchase of all or a material part of the stock or assets
of, or any merger, consolidation, share exchange or business combination with,
or any recapitalization, restructuring or issuance or offering of debt or
equity securities of, Matrix (an &#147;<b><u style="font-weight:bold;">Acquisition
Proposal</u></b>&#148;); or (b)&nbsp;except as may be required by law but
only prior to receipt of the Majority Stockholders Consent, participate in any
discussions or negotiations regarding, or furnish to any Person other than
Immucor and its representatives, any information with respect to, or otherwise
cooperate in any way or assist, facilitate or encourage, or enter into any
agreement or understanding with respect to, any Acquisition Proposal by any
Person other than Immucor.&#160; Matrix will
immediately cease and cause to be terminated any existing activity, discussions
or negotiations with any Person other than Immucor and its representatives
conducted prior to the execution and delivery of this Agreement with respect to
any Acquisition Proposal.&#160; If,
notwithstanding the foregoing, Matrix should receive any Acquisition Proposal
or any inquiry regarding any such proposal from any Person, then Matrix shall
promptly inform Immucor.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.6</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Public
Announcements.</b>&#160; The timing and
content of all press releases or other announcements regarding any aspect of
this Agreement to the financial community, Governmental Entities, employees or
the general public by Immucor or Matrix prior to the Closing Date shall be
subject to the other Parties&#146; prior approval, except as may be required by</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='36',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">applicable Law or rule&nbsp;or
regulation of a self-regulated organization to which such disclosing Party may
be subject.&#160; Notwithstanding the
foregoing, Immucor and<b>  </b>Matrix
shall cooperate reasonably to prepare a joint press release to be issued with
respect to the transactions contemplated hereby following the execution of this
Agreement by all parties hereto.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.7</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Filing
under the HSR Act.</b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">General</i></b>.&#160; The Parties acknowledge that the transactions
contemplated by this Agreement will require filings with the Federal Trade
Commission (the &#147;<b><u style="font-weight:bold;">FTC</u></b>&#148;) and
the Antitrust Division of the United States Department of Justice&#160; (the &#147;<b><u style="font-weight:bold;">Antitrust
Division</u></b>&#148;) under the Hart-Scott-Rodino Antitrust Improvement Act
of 1976, as amended (the &#147;<b><u style="font-weight:bold;">HSR Act</u></b>&#148;).</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Filings</i></b>.&#160; The Parties will each promptly, but in no
event later than ten (10)&nbsp;Business Days after the date of this Agreement,
file or cause to be filed with the FTC and the Antitrust Division the
notifications and reports required to be filed pursuant to the HSR Act in
connection with the transactions contemplated by this Agreement and will
undertake in good faith to file promptly any supplemental information which may
be requested, which notifications and reports and filing of supplemental
information will comply in all material respects with the requirements of such
act.&#160; The Parties will each furnish to the
other such information as either may reasonably request to make such
filings.&#160; Immucor shall be responsible
for any filing fees with respect to such filings.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Communications</i></b>.&#160; The Parties will each promptly inform the
other of any material communication made to, or received by it from, the FTC or
the Antitrust Division.&#160; To the extent
feasible, Matrix will seek to permit counsel for Immucor to participate in any
discussions with the FTC or the Antitrust Division concerning the transactions
contemplated by this Agreement.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Objections</i></b>.&#160; In furtherance and not in limitation of the
agreements of the Parties contained in this <u>Section&nbsp;5.7</u>, each Party
shall use its reasonable best efforts to resolve such objections if any, as may
be asserted by a Governmental Entity or other Person with respect to the
transactions contemplated hereby under any applicable Law.&#160; In connection with the foregoing, if any
administrative or judicial action or proceeding, including any proceeding by a
private party, is instituted (or threatened to be instituted) challenging any
transaction contemplated by this Agreement as violative of any applicable Law,
subject to the right of Immucor to terminate this Agreement pursuant to <u>Section&nbsp;8.1(e)</u>,
each Party shall cooperate in all respects with the other and use its respective
reasonable best efforts to contest and resist any such action or proceeding and
to have vacated, lifted, reversed or overturned any decree, judgment,
injunction or other order, whether temporary, preliminary or permanent, that is
in effect and that prohibits, prevents or restricts consummation of the
transactions contemplated by this Agreement.&#160;
Notwithstanding the foregoing or any other provision of this Agreement,
nothing herein shall require Immucor to enter into any settlement agreement or
consent decree or to undertake or agree to the disposition of any assets or
businesses, the mandatory licensing of any intellectual property, or any
operating or other restrictions on the conduct of its business or Matrix&#146;s
Business in</h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='37',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">order to resolve any such
objection or resolve any such administrative or judicial actions or
proceedings.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.8</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Certain
Employee and Employee Benefit Matters.</b>&#160;
Matrix will cooperate with Immucor in allowing Immucor to interview and
otherwise evaluate Matrix&#146;s employees prior to the Effective Time.&#160; Except as prohibited by Law, Matrix will
provide Immucor prior to Closing with such information about the employees as
Immucor may reasonably request.&#160; Not less
than ten Business Days before Closing, Immucor will provide Matrix with a list
of those employees, if any, who Immucor does not wish to retain after the
Effective Time (&#147;<b><u style="font-weight:bold;">Designated Matrix
Employees</u></b>&#148;).&#160; Matrix will
take all actions necessary to terminate the employment of the Designated Matrix
Employees as of the Effective Time in accordance with all applicable Laws.&#160; All severance and other costs and liabilities
related to such terminations of employment will be the responsibility of Matrix
Shareholders and shall reduce the Aggregate Merger Consideration pursuant to <u>Section&nbsp;1.9(a)(v)</u>;
<b><i><u style="font-style:italic;font-weight:bold;">provided</u></i></b>,
<b><i><u style="font-style:italic;font-weight:bold;">however</u></i></b>,
that the Aggregate Merger Consideration will not be so reduced by an amount
equal to the aggregate amount, as certified by Immucor prior to the Effective
Time, the Designated Matrix Employees would have been entitled to receive as
severance pay under Immucor policies had they been employees of Immucor as of
the Effective Time, assuming the Designated Matrix Employees had with Immucor
the same period of service and compensation that they have with Matrix.&#160; At the direction of Immucor prior to Closing,
Matrix shall take all action required to terminate or amend the Matrix 401(k)&nbsp;plan
to make it consistent with the Immucor 401(k)&nbsp;plan before Closing.&#160; In addition, Matrix will take all actions
necessary to terminate all employment agreements, change of control agreements
and other agreements with officers, directors or employees pertaining to
employment (other than confidentiality, inventions, non-solicitation and
non-competition agreements in favor of Matrix, including employment agreements
but only to the extent employment agreements contain confidentiality,
inventions, non-solicitation and non-competition agreements in favor of Matrix)
as of the Effective Time.&#160; All
termination and other costs and liabilities that relate to the arrangements
contemplated by the foregoing sentence, including with respect to the
termination of those arrangements, will be the responsibility of Matrix
Shareholders and shall reduce the Aggregate Merger Consideration pursuant to <u>Section&nbsp;1.9(a)(v)</u>.&#160; Following the Closing, Immucor shall cause
the Surviving Corporation to pay all amounts due under the Employee Bonus Plan
and the Closing Bonus Plan.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.9</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Termination
of Matrix Shareholder Agreements.</b>&#160;
Matrix shall take all necessary actions required to terminate all
agreements of the Matrix Shareholders with respect to any rights whatsoever of
the Matrix Shareholders in the Matrix Capital Stock (collectively, &#147;<b><u style="font-weight:bold;">Matrix Shareholders Agreements</u></b>&#148;)
including any rights granted therein with respect to the exchange of Matrix
Capital Stock for securities issued in any recapitalization, merger,
consolidation, share exchange, business combination or similar transaction, and
all such Matrix Shareholders Agreements shall be terminated prior to or
effective as of the Effective Time.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.10</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Taxes.</b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">To be Filed by the Matrix
Shareholders</i></b>.&#160; The
Shareholders Agent Committee will be responsible, at its expense, for causing
the preparation of Matrix&#146;s Tax Returns for the taxable periods ending on the
day before the Closing Date, but Immucor will file such returns without any
changes thereto.&#160; As provided in <u>Section&nbsp;5.10(c)&nbsp;</u>below,
the</h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='38',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Matrix Shareholders will
bear all such taxes, and the Matrix Shareholders will also bear all the Taxes
they and Matrix incur as a result of the Merger.&#160; Matrix will not make any election or take any
action or position on any Tax Return filed after the date of this Agreement for
or relating to any period ending on the day before the Closing Date with
respect to any item of income, deduction or credit of Matrix that is
inconsistent with any previous position or prior reporting without the consent
of Immucor (which will not be unreasonably withheld or delayed) unless required
by applicable Law.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">To be Filed by Immucor</i></b>.&#160; Immucor will be responsible for filing Matrix&#146;s
Tax returns (i)&nbsp;for any taxable period beginning before and ending on or
after (and including) the Closing Date (a &#147;<b><u style="font-weight:bold;">Straddle
Period</u></b>&#148;) and (ii)&nbsp;for all Tax Returns of Matrix for taxable
periods beginning on or after the Closing Date.&#160;
As provided in <u>Section&nbsp;5.10(c)&nbsp;</u>below, the Matrix
Shareholders will bear all Taxes for the portion of any Straddle Period ending
on the day before the Closing Date as determined in accordance with <u>Section&nbsp;5.10(d)&nbsp;</u>below,
but Matrix will be responsible for Taxes for the other portions of Straddle
Periods and for returns contemplated by clause (ii)&nbsp;in the foregoing
sentence.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Matrix Shareholders&#146; Payments with
Respect to Taxes</i></b>. The aggregate amount of the Taxes on Tax
Returns attributable to periods ending on the day before the Closing Date and
the portion of any Straddle Periods ending on the day before the Closing Date
as determined in accordance with <u>Section&nbsp;5.10(d)&nbsp;</u>below (the &#147;<b><u style="font-weight:bold;">Specified Taxes</u></b>&#148;) is a Covered Loss to
be satisfied pursuant to <u>Section&nbsp;11.2(a)(ii)(A)&nbsp;</u>without being
subject to arbitration or other challenges by the Matrix Shareholders.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Allocation of Taxes for Straddle
Periods</i></b>.&#160; For purposes of <u>Sections
5.10(b)&nbsp;</u>and <u>(c)&nbsp;</u>above, whenever it is necessary to
determine the liability for Taxes of the Matrix Shareholders and Matrix for a
Straddle Period, the determination of the Taxes of Matrix for the portion of
the Straddle Period ending on and including the day before the Closing Date
(borne by the Matrix Shareholders) and the portion of the Straddle Period
ending on or after the Closing Date (borne by Matrix) will be determined by
assuming that the Straddle Period consisted of two taxable years or periods,
one of which ended at the close of business on the day before the Closing Date
and the other of which began at the opening of business on the Closing Date,
and items of income, gain, deduction, loss or credit of Matrix for the Straddle
Period will be allocated between such two taxable years or periods on a &#147;closing
of the books basis&#148; by assuming that the books of Matrix were closed at the
close of business on the day before the Closing Date; <u>provided</u>, <u>however</u>,
that exemptions, allowances or deductions that are calculated on an annual
basis, such as the deduction for depreciation, will be apportioned between such
two taxable years or periods on a daily basis.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><b><i style="font-weight:bold;">No IRC &#167; 338 Election</i></b>.&#160; The Matrix Shareholders and Immucor hereby
acknowledge and agree that no election pursuant to Code &#167;&nbsp;338 will be made
by Matrix or Immucor or the Matrix Shareholders in connection with the
transactions contemplated by this Agreement.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Review of Tax Returns</i></b>.&#160; Any Tax Return prepared by the Shareholders
Agent Committee for periods ending on the day before the Closing will be
submitted to Immucor at least fifteen (15) days before its due date for its
review.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="center" style="font-weight:normal;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></h3>

</div>
<!-- SEQ.=1,FOLIO='39',FILE='C:\jms\jsavariar\08-8252-1\task2782416\8252-1-kc-07.htm',USER='105228',CD='Mar 15 05:58 2008' -->



<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Refunds</i></b>.&#160; The net operating loss represented in <u>Section&nbsp;3.15(g)</u>&nbsp;is
an important consideration for Immucor.&#160;
Immucor will be entitled to any refund of Taxes with respect to a
taxable period ending or before the Closing Date.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Tax Audits</i></b>.&#160; Immucor will promptly notify the Shareholders
Agent Committee upon its receipt of any notice of pending or threatened Tax
audits, examinations or assessments with respect to taxable periods ending on
the day before or before the Closing Date or any Straddle Period.&#160; Immucor will have the right to control any
Tax audit or administrative or other proceeding relating to taxable periods
ending on or before the Closing Date.&#160;
The Shareholders Agent Committee will be entitled to participate at
their expense in any Tax audit or administrative or other proceeding relating
to Taxes attributable to the period ending on or before the Closing Date or to
the portion of a Straddle Period ending on the day before the Closing
Date.&#160; If a proposed settlement of any
audit or other proceeding relating to the period ending on or before the
Closing Date or to a Straddle Period would have a material adverse effect on
the Matrix Shareholders or Matrix for any period ending on or before the
Closing Date, such settlement may not be entered into without the consent of
the Shareholders Agent Committee (which will not be unreasonably withheld or
delayed).</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Cooperation on Tax Matters.</i></b>&#160; Immucor, Merger Sub, and the Shareholders
Agent Committee will cooperate fully, as and to the extent reasonably requested
by the other party, in connection with any Tax matters relating to Matrix
(including the provision of reasonably relevant records or information).</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.11</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>New
Subsidiary License and Operating Agreement.</b>&#160;
Prior to the Closing, (a)&nbsp;Matrix shall, and shall cause New
Subsidiary to, enter into the New Subsidiary License and (b)&nbsp;the operating
agreement of the New Subsidiary shall be amended, if necessary, to reflect the
terms of the rights and obligations of Matrix with respect to its ownership of
membership interests in New Subsidiary as set forth in <u>Exhibit&nbsp;C</u>.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.12</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Trade
Secrets Protocol.</b>&#160; Prior to Closing,
Matrix shall disclose to Immucor in reasonable detail the Trade Secrets
included in Matrix Intellectual Property related to those steps for producing
encoded micro-particle bead libraries and assembling them in chips, as follows:
(a)&nbsp;making the beads, (b)&nbsp;staining the beads, (c)&nbsp;attaching BSA
to the beads, (d)&nbsp;attaching oligonucliotides to the BSA, (e)&nbsp;assembling
functionalized beads on wafers in random arrays, (f)&nbsp;segmenting the wafers
along etch lines into chips, and (g)&nbsp;quality control; and the Trade
Secrets included in Matrix Intellectual Property related to the manufacture and
process of the raw wafers used in the aforementioned chips. The disclosure
process contemplated by this <u>Section&nbsp;5.12</u> for the manufacture of
polystyrene beads will take place over a period of at least three days. At
least one day (currently intended to be the first day) will be dedicated to the
set up of the process; at least one day (currently intended to be the second
day) will be dedicated to the actual manufacture of beads; and at least one day
(currently intended to be the third day) will be dedicated to measurement
of&#160; the beads for proper size and consistency
and quality control. Disclosure sessions will be scheduled by mutual consent of
Matrix and Immucor, but not prior to the termination of the HSR Waiting Period
unless Matrix agrees otherwise.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;5.13</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Actions
to Avoid and Notices of Breaches of Representations and Warranties.</b> Through
the Closing, (a)&nbsp;each party will inform the other promptly in writing of</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='40',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">any facts or circumstances that
could be reasonably expected to constitute or result in a breach of any of its
representations, warranties or covenants; and (b)&nbsp;without limiting the
foregoing, consistent with applicable Law (including antitrust laws), Matrix
will inform Immucor promptly of any issues or events that arise after the date
of this Agreement and that are material to Matrix&#146;s Business or prospects.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE VI.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONDITIONS PRECEDENT TO THE CLOSING</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.1</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Conditions
of the Parties&#146; Obligations to Effect the Closing.</b>&#160; The respective obligations of the Parties to
consummate the Merger and the other transactions contemplated hereby shall be
subject to the satisfaction or waiver (if permitted by applicable Law or
Governmental Order) by each Party prior to the Closing of the following
conditions:</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">No Injunctions</i></b>.&#160; No Governmental Entity shall have enacted,
issued, promulgated, enforced or entered any Governmental Order or Law that is
in effect and that has the effect of making the Closing illegal or otherwise
prohibiting consummation of the transactions contemplated by this Agreement,
including the Merger; <u>provided</u>, <u>however</u>, that, to the extent
otherwise required by this Agreement, each of the Parties shall have used its
reasonable best efforts to prevent the entry of such Governmental Order and to
appeal as promptly as possible any such Governmental Order that is entered, and
diligently prosecute such appeal; <u>provided</u>, <u>further</u>, that this Section&nbsp;6.1(a)&nbsp;will
not be a condition to Closing for Matrix if the Governmental Order is issued in
any suit brought by or otherwise sought by a Matrix Shareholder, a holder of
Matrix Options or an Affiliate of Matrix.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Authorizations.</i></b>&#160; All Authorizations of Governmental Entities
required to consummate the transactions contemplated by this Agreement,
including the Merger, shall have been obtained, all such Authorizations shall
remain in full force and effect, no appeal shall have been filed challenging
any such Authorizations, all statutory waiting periods in respect thereof,
including the HSR Waiting Period, shall have expired or been terminated or
waived and, in the case of Immucor and Merger Sub, no such Authorizations or
expiration of a statutory waiting period shall contain a materially adverse
condition.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.2</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Conditions
to Obligations of Immucor and Merger Sub.</b>&#160;
The obligation of Immucor and Merger Sub to consummate the Merger and
the other transactions contemplated hereby shall be subject to the fulfillment,
prior to or at the Closing, of each of the following conditions (any or all of
which may be waived by Immucor):</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Injunction, etc.</i></b>&#160; No Claim by the FTC, the Antitrust Division,
or any other Governmental Entity shall have been instituted or threatened at
any time based, in whole or in part, on information provided under the HSR Act
and seeking to enjoin all or a part of the transactions contemplated
hereunder.&#160; In addition, no legal action,
lawsuit or other legal proceeding shall have been instituted by any Person, or,
to the Knowledge of Immucor, shall have been threatened by any Governmental
Entity, which has not been withdrawn, dismissed or otherwise eliminated, and
which seeks (i)&nbsp;to prohibit, restrict or delay consummation of the
transactions contemplated hereby or to limit in any respect the right of
Immucor to control the Business of Matrix after the Closing Date, or (ii)&nbsp;to
subject Immucor, Merger Sub or their</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='41',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">directors or officers to
liability on the ground that it or they have violated any Law in relation to
the transactions contemplated by this Agreement or based on the conduct of the
Business and affairs of Matrix prior to the Effective Time, provided that in
the case of either clause (i)&nbsp;or clause (ii)&nbsp;of this sentence,
Immucor has made a good faith determination that such instituted or threatened
legal action, lawsuit or other legal proceeding has or could reasonably be
expected to have, individually or in the aggregate with all such legal actions,
lawsuits or other legal proceedings and other events and circumstances, a
Matrix Material Adverse Effect.</font></h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Representations and Warranties;
Covenants and Agreements</i></b>&#160;
The representations and warranties of Matrix contained in this Agreement
(x)&nbsp;shall have been true and correct at the date hereof; and (y)&nbsp;except
for changes contemplated in this Agreement, shall also be true and correct in
all respects at and as of the Closing Date, with the same force and effect as
if made at and as of the Closing Date, except to the extent that the failure of
such representations and warranties to be true and correct as of the Closing Date
has not and could not reasonably be expected to have, individually or
considered in the aggregate with all such breaches and failures and other
events and circumstances, a Matrix Material Adverse Effect; <u>provided</u>, <u>however</u>,
that representations and warranties that are confined to a specified date shall
speak only as of such date and all &#147;material,&#148; &#147;in all material respects,&#148; &#147;material
adverse effect,&#148; &#147;immaterial,&#148; &#147;materially&#148; and similar materiality qualifiers
in <u>Article&nbsp;III</u> shall be ignored for purposes of clause (y)&nbsp;of
this sentence and for purposes of the following sentence.&#160; Matrix shall have performed or complied (or
cured any noncompliance) in all material respects with all agreements and
covenants required by this Agreement to be performed or complied with by it at
or prior to the Closing Date.&#160;
Notwithstanding the foregoing to the contrary, Matrix shall be permitted
to remedy at or prior to Closing any breaches of its warranties and
representations which were neither intentional nor as a result of Matrix&#146;s
recklessness, subject to the following:</h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Matrix
shall have complied with its obligations under <u>Section&nbsp;5.13(a)</u>&nbsp;regarding
the breach and shall also inform Immucor in writing in advance of the details
of any proposed remedy for the breach.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
full cost of such remedy will reduce the Aggregate Merger Consideration.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If
such remedy or any prospective remedy results in the imposition on Matrix of
any material obligations or restrictions other than a cash payment, such remedy
or prospective remedy will be subject to Immucor&#146;s prior written approval,
which approval may not be unreasonably withheld.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>At
the Closing, Matrix will deliver to Immucor a certificate, dated as of the
Closing Date, executed on its behalf by an authorized officer to the effect
that (A)&nbsp;all the representations and warranties contained in this
Agreement either (1)&nbsp;are true and correct as of the Closing (and for
purposes of this certificate there will be no Material Adverse Effect or other
materiality qualifiers), or (2)&nbsp;are being remedied as provided above, and (B)&nbsp;describing
any that previously have been remedied and the total cost, including related
expenses, of their remedy.</h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">42</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='42',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If
the certificate identified in subsection (iv)&nbsp;above discloses any
representations and warranties that are not true and correct at Closing,
Immucor and Matrix will negotiate in good faith to reach agreement on an amount
to be deducted from the Aggregate Merger Consideration pursuant to <u>Section&nbsp;1.9(a)(viii)</u>&nbsp;for
those items in addition to amounts for already-cured items.&#160; If the parties fail to reach an agreement,
then the amount reasonably estimated by Immucor will be withheld and added to
the Escrow Fund.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Nothing
in this <u>Section&nbsp;6.2(b)</u>&nbsp;shall limit Immucor&#146;s right to refuse
to close based on (A)&nbsp;uncured breaches of Matrix&#146;s representations and
warranties that in the aggregate together with all other events and
circumstances rise to the level of a Material Adverse Effect, (B)&nbsp;<u>Section&nbsp;6.2(d)</u>&nbsp;or
(C)&nbsp;material violations of Matrix&#146;s agreements or covenants.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Certificate</i></b>.&#160; Matrix shall have delivered to Immucor a
certificate, dated as of the Closing Date, executed on its behalf by an
authorized officer, to the effect that the conditions specified in <u>Sections
6.2(b)</u>&nbsp;(only as to covenants and agreements), <u>6.2(d)</u>&nbsp;and <u>6.2(e)</u>&nbsp;have
been satisfied.</h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">No Material Adverse Effect</i></b>.&#160; After the date of this Agreement there shall
not have occurred any events or circumstances which individually or in the
aggregate with other events and circumstances have resulted or reasonably could
be expected to result in a Matrix Material Adverse Effect.</h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Appraisal Rights</i></b>.&#160; Holders of no more than five percent (5%) of
the outstanding shares of Matrix Capital Stock shall have properly made a
demand in writing to Matrix for an appraisal with respect to such holder&#146;s
shares of Matrix Capital Stock in accordance with the DGCL.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Matrix Shareholder Approval</i>.&#160; </b>Within two hours after the execution and
delivery of this Agreement: (i)&nbsp;the consummation of the transactions
contemplated by this Agreement shall have been approved by the Matrix
Shareholders in accordance with Matrix&#146;s certificate of incorporation, bylaws
and all applicable Laws through the Required Merger Stockholder Votes and (ii)&nbsp;Immucor
shall have received a copy of the Majority Stockholders Consent&#160; certified by the Secretary of Matrix or other
officer responsible for the books and records of Matrix as being a true and
correct copy of the original.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Completed Disclosure</i></b><b><font style="font-weight:bold;">.</font>&#160; </b>Trade Secrets required to be disclosed to
Immucor pursuant to <u>Section&nbsp;5.12</u> shall have been disclosed so that
technical experts of Immucor with a reasonable amount of training will be able
to replicate the processes covered by the Trade Secrets.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Certain Confirmations Regarding Stock Ownership and
Options</i></b>.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Contemporaneously
with the delivery of the Final Payment Schedule, Immucor shall have received
from Reinhart Boerner Van Deuren s.c., counsel to Matrix, a report detailing
the steps taken in developing the Final Payment Schedule, any discrepancies or
omissions noted in the minute books and stock records of Matrix</h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">43</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='43',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and, if
applicable, the reasons it has determined it cannot issue a standard
capitalization opinion as to Matrix in form, scope and substance reasonably
satisfactory to Immucor.</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Matrix
shall have delivered to Immucor waivers and releases as contemplated by the
last sentence of <u>Section&nbsp;1.7</u> duly executed by each holder of a
Matrix Option.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Immucor
shall be reasonably satisfied that the Final Payment Schedule fully and
accurately reflects all outstanding shares of Matrix Capital Stock and all
outstanding Matrix Options, the legal and beneficial owners thereof and that
all shares of Matrix Capital Stock have been duly authorized and validly issued
in compliance with all applicable Laws and all applicable contractual
restrictions.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding
the foregoing, (x)&nbsp;so long as it has received the report referred to in
clause (i)&nbsp;above, Immucor will not be able to refuse to close if the
conditions set forth in this <u>Section&nbsp;6.2(h)</u>&nbsp;are not satisfied
unless such failure (together with all Breaches and other events and
circumstances) rises to the level of or results in a Matrix Material Adverse
Effect; (y)&nbsp;Immucor will be entitled to withhold from the Aggregate Merger
Consideration and include in the Escrow Fund an amount reasonably estimated by
it to provide it adequate security for the failure of the conditions set forth
in this <u>Section&nbsp;6.2(h)</u>, and identified possible concerns relating
to the Final Payment Schedule; and (z)&nbsp;the time period for claims under <u>Section&nbsp;11.3(a)</u>&nbsp;arising
out of or relating to (1)&nbsp;the failure of clause (ii)&nbsp;this <u>Section&nbsp;6.2(h)</u>,
(2)&nbsp;any Breach of <u>Section&nbsp;3.2</u> or (3)&nbsp;any Covered Loss
resulting in reduction to the Aggregate Merger Consideration pursuant to <u>Section&nbsp;11.2(a)(v)</u>,
shall be three years instead of one year. For purposes of the conditions set
forth in this <u>Section&nbsp;6.2(h)</u>&nbsp;only, if any failure or breach
clearly can be remedied or cured by payment of a known amount of money, the
failure or breach will not be considered in determining whether or not a Matrix
Material Adverse Effect has occurred and Immucor will be entitled to withhold that
amount from the Aggregate Merger Consideration and include it in the Escrow
Fund.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Employee Bonus Plan and Closing Bonus Plan</i></b><b><font style="font-weight:bold;">.</font>&#160;
</b>Matrix shall have duly implemented a employee bonus plan (the &#147;<b><u style="font-weight:bold;">Employee Bonus Plan</u></b>&#148;) and a closing
bonus plan (the &#147;<b><u style="font-weight:bold;">Closing Bonus Plan</u></b>&#148;)
containing the terms described on <u>Exhibit&nbsp;D</u> to this Agreement and
otherwise on terms reasonably satisfactory to Immucor.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;6.3</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Conditions
to Obligations of Matrix.</b>&#160; The
obligation of Matrix to consummate the Merger and the other transactions
contemplated hereby shall be subject to the fulfillment, prior to or at the
Closing, of each of the following conditions (any or all of which may be waived
by Matrix):</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Representations and Warranties;
Covenants and Agreements</i></b>.&#160;
The representations and warranties of Immucor and Merger Sub contained
in this Agreement (x)&nbsp;shall have been true and correct at the date hereof,
and (y)&nbsp;except for changes contemplated in this Agreement, shall also be
true and correct in all respects at and as of the Closing Date, with the same
force and effect as if made at and as of the Closing Date, except to the extent
that the failure of such representations and warranties to be true and correct
as of the Closing Date has</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='44',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">not and could not
reasonably be expected to have, individually or considered in the aggregate
with all such breaches and failures, an Immucor Material Adverse Effect; <u>provided</u>,
<u>however</u>, that representations and warranties that are confined to a specified
date shall speak only as of such date and all &#147;material,&#148; &#147;in all material
respects,&#148; &#147;material adverse effect,&#148; &#147;immaterial,&#148; &#147;materially&#148; and similar
materiality qualifiers in <u>Article&nbsp;IV</u>, shall be ignored for purposes
of clause (y)&nbsp;of this sentence and for purposes of the following
sentence.&#160; Immucor and Merger Sub shall
have performed or complied (or cured any noncompliance) in all material
respects with all agreements and covenants required by this Agreement to be
performed or complied with by them at or prior to the Closing Date.</font></h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Certificate</i></b>.&#160; Each of Immucor and Merger Sub shall have
delivered to Matrix a certificate, dated as of the Closing Date, executed on
its behalf by an authorized officer, to the effect that the conditions specified
in <u>Sections 6.3(a)</u>&nbsp;and <u>6.3(c)</u>&nbsp;have been satisfied.</h3>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">No Material Adverse Effect</i></b><b>.</b>&#160; After the date of
this Agreement there shall not have occurred any events or circumstances which
individually or in the aggregate with other events and circumstances have
resulted or reasonably could be expected to result in a breach of <u>Section&nbsp;4.7</u>.</h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Matrix Shareholder Approval</i></b>.&#160; The consummation of the transactions
contemplated by this Agreement shall have been approved by the Matrix
Shareholders in accordance with Matrix&#146;s certificate of incorporation, bylaws
and all applicable Laws.</h3>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE VII.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEMS TO BE DELIVERED AT THE CLOSING</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;7.1</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To
be Delivered by Matrix.</b>&#160; At the
Closing, Matrix shall deliver, or cause to be delivered, to Immucor the
following:</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
certificates referred to in <u>Section&nbsp;6.2(b)</u>&nbsp;and <u>6.2(c)</u>.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
Certificate of Merger duly executed by Matrix in the form required by
applicable Law.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Matrix&#146;s
corporate minute books, corporate seal and stock records.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Letters
of resignation and release in forms reasonably satisfactory to Immucor,
effective as of the Closing Date, from each of the officers and directors of
Matrix.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An
opinion from Reinhart Boerner Van Deuren s.c., counsel to Matrix, substantially
in the form attached hereto as <u>Exhibit&nbsp;A</u>, dated as of the Closing
Date.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Copies
of the resolutions of the Board of Directors of Matrix, and its stockholders,
authorizing the execution, delivery and performance of the Matrix Delivered
Agreements, certified by the Secretary of Matrix or other officer responsible
for the books and records of Matrix as being true and correct copies of the
originals which have not been modified or amended and which are in effect at
the Closing.</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">45</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='45',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A
certificate of the Secretary of Matrix or other officer responsible for the
books and records of Matrix certifying as of the Closing as to the incumbency
of the officers of Matrix and as to the signatures of such officers who have
executed documents delivered at the Closing on behalf of Matrix.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Certificates,
dated within twenty (20) days of the Closing, of the applicable Governmental
Entity establishing that Matrix and New Subsidiary are each in existence and
otherwise in good standing to transact business.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A
certificate meeting the requirements of Treasury Regulation
&#167;&nbsp;1.1445-2(c)(3).</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
New Subsidiary License, the amendments to the operating agreement of New
Subsidiary contemplated by <u>Section&nbsp;5.11</u> (if any), and other
agreements relating to the New Subsidiary, duly executed by Matrix, the New
Subsidiary and the Matrix Shareholders, if applicable.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A
written statement by Lazard of all amounts due to Lazard as described in <u>Section&nbsp;1.9(a)(ii)</u>,
together with a written confirmation that no other amounts will be due and
payable to Lazard after the Closing, in connection with the transactions
contemplated by this Agreement or otherwise.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(l)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Such
other documents as Immucor may reasonably request.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;7.2</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To
be Delivered by Immucor and Merger Sub<i>.</i></b>&#160; At the Closing, Immucor and Merger Sub shall
deliver to Matrix, the Exchange Agent, the Escrow Agent or the Shareholder
Agent Committee, as applicable, the following:</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
Aggregate Merger Consideration, which includes the Exchange Fund, the Escrow
Fund and the Expenses Fund.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
certificate referred to in Section&nbsp;6.3(b).</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Copies
of the resolutions of the Boards of Directors of Immucor and Merger Sub,
authorizing the execution, delivery and performance of the Transaction
Documents to which Immucor or Merger Sub is party, certified by the Secretary
or Assistant Secretary of Immucor and Merger Sub, respectively, as being true
and correct copies of the originals which have not been modified or amended and
which are in effect at the Closing.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A
certificate of the Secretary or Assistant Secretary of Immucor and Merger Sub
certifying as of the Closing as to the incumbency of the officers of Immucor
and Merger Sub and as to the signatures of such officers who have executed
documents delivered at the Closing on behalf of Immucor and Merger Sub.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Certificates,
dated within twenty (20) days of the Closing, of the applicable Governmental
Entity establishing that each of Immucor and Merger Sub is in existence and
otherwise is in good standing to transact business.</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">46</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='46',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Such
other documents as Matrix may reasonably request.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE VIII.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TERMINATION AND ABANDONMENT</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;8.1</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Termination
and Abandonment.</b>&#160; This Agreement may
be terminated and abandoned at any time prior to the Closing Date:</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By
mutual written consent of the Parties;</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By
Immucor if any event shall have occurred as a result of which any condition set
forth in <u>Section&nbsp;6.1</u> or <u>6.2</u> is no longer capable of being
satisfied; <u>provided</u>, <u>however</u>, that the right to terminate this
Agreement pursuant to this <u>Section&nbsp;8.1(b)</u>&nbsp;shall not be
available to Immucor if the condition to its obligation to perform became
incapable of fulfillment due to its failure, or the failure of Merger Sub or
any of Immucor&#146;s other Affiliates, to fulfill any obligation under this
Agreement in any material respect;</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By
Matrix, if any event shall have occurred as a result of which any condition set
forth in <u>Section&nbsp;6.1</u> or <u>6.3</u> is no longer capable of being satisfied;
<u>provided</u>, <u>however</u>, that the right to terminate this Agreement
pursuant to this <u>Section&nbsp;8.1(c)</u>&nbsp;shall not be available to
Matrix if the condition to its obligation to perform became incapable of
fulfillment due to its failure, or the failure of any of its Affiliates, to
fulfill any obligation under this Agreement in any material respect;</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By
Immucor or Matrix, if the Closing shall not have occurred on or before the date
six months after the date the HSR Waiting Period commences; <u>provided</u>, <u>however</u>,
that a Party whose breach of this Agreement has resulted in the Closing not
having occurred on or before said date shall not have the right to terminate
this Agreement pursuant to this <u>Section&nbsp;8.1(d)</u>; <u>provided further</u>,
that if the HSR Waiting Period has expired during such six-month period of time
but one or more other conditions have not yet been satisfied, either Immucor or
Matrix may extend such period for up to ten (10)&nbsp;additional Business Days
by notice to the other party given prior to the expiration of the six-month
period.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By
Immucor, if the condition set forth in the first sentence of <u>Section&nbsp;6.2(a)</u>&nbsp;shall
have failed at any time after the date of this Agreement; or</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By
Immucor, for any or no reason, at any time prior to the satisfaction of its
conditions to Closing as set forth in <u>Sections 6.1</u> or <u>6.2</u>.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;8.2</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Specific
Performance; Remedies Cumulative.</b> The Parties acknowledge that the rights
of each Party to consummate the transactions contemplated hereby are special,
unique, and of extraordinary character, and that, in the event that any Party
violates or fails and refuses to perform any covenant made by it herein, the
other Party or Parties will be without adequate remedy at Law.&#160; In the event that any party violates, fails
or refuses to perform any covenant made by it herein, the other Party or
Parties may, in addition to any remedies at Law, institute and prosecute an
action in a court of competent jurisdiction to enforce specific performance of
such covenant or seek any other equitable relief, including without limitation,
the right to require the other party to consummate the transactions consummated
herein.&#160; No exercise</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">47</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='47',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">of a remedy available to a Party shall be deemed an election excluding
any other remedy available to such Party.&#160;
Notwithstanding the foregoing or anything to the contrary in this
Agreement, Matrix shall be entitled to specific performance, including the
right to require Immucor to consummate the transactions consummated herein,
only if all conditions to closing set forth in <u>Sections 6.1</u> and <u>6.2</u>
have been satisfied (other than <u>Section&nbsp;6.2(c)</u>&nbsp;which
nonetheless must be satisfied in connection with Closing).</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;8.3</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Rights
and Obligations upon Termination.</b>&#160; If
this Agreement is not consummated for any reason, each Party will destroy or
redeliver all documents, work papers, and other materials of any Party relating
to the transactions contemplated hereby, whether obtained before or after the
execution hereof, to the Party furnishing the same, except to the extent
previously delivered to third parties in connection with the transactions
contemplated hereby, and all information received by any Party hereto with
respect to the business of any other Party shall not at any time be used for
the advantage of, or disclosed to third parties by, such Party to the detriment
of the Party furnishing such information; <u>provided</u>, <u>however</u>, that
this <u>Section&nbsp;8.3</u> shall not apply to any documents, work papers,
material or information which is a matter of public knowledge or which
heretofore has been or hereafter is published in any publication for public
distribution or filed as public information with any Governmental Entity.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;8.4</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Effect
of Termination.</b>&#160; Except for the
provisions of <u>Sections 5.4</u>, <u>5.6</u>, <u>8.3</u>, this <u>8.4</u>, and
<u>8.5</u>, and <u>Article&nbsp;IX</u>, which shall survive any termination of
this Agreement, in the event of the termination and abandonment of this
Agreement pursuant to this <u>Article&nbsp;VIII</u>, this Agreement shall
forthwith become void and have no further effect, without any liability on the
part of any Party hereto or its respective officers, directors or stockholders;
<u>provided</u>, <u>however</u>, that in the event that this Agreement is
terminated by Immucor pursuant to <u>Section&nbsp;8.1(b)</u>, then Matrix shall
promptly, but in no event later than two (2)&nbsp;Business Days after being
notified of such by Immucor, pay Immucor all of the reasonable and documented
out-of-pocket expenses incurred by Immucor or Merger Sub, or any of their
respective Affiliates in connection with this Agreement and the transactions
contemplated by this Agreement.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;8.5</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investment
upon Termination under Certain Circumstances.</b>&#160; If any of the following occur (a)&nbsp;Immucor
or Matrix terminates this Agreement pursuant to <u>Section&nbsp;8.1(d)</u>&nbsp;as
a result of a failure of the condition set forth in <u>Section&nbsp;6.1(b)</u>&nbsp;and
the HSR Waiting Period has not expired when this Agreement is so terminated, (b)&nbsp;Immucor
terminates this Agreement pursuant to <u>Section&nbsp;8.1(e)</u>, (c)&nbsp;Matrix
terminates this Agreement pursuant to Section&nbsp;8.1(c)&nbsp;as a result of
the failure of Immucor or any of its Affiliates to fulfill any warranty,
representation, covenant or other obligation under this Agreement in any
material respect, or (d)&nbsp;Immucor terminates this Agreement pursuant to <u>Section&nbsp;8.1(f)</u>,
Matrix shall, as its sole and exclusive remedy, have the option to issue to
Immucor, and upon the exercise of such option Immucor shall have the obligation
to purchase, Matrix Capital Stock as provided in this <u>Section&nbsp;8.5</u>; <u>provided</u>
that to exercise such option Matrix shall so notify Immucor in writing within
thirty (30) Business Days after such termination and Immucor shall have thirty
(30) Business Days after its receipt of such notice to purchase Matrix Capital
Stock as provided in this <u>Section&nbsp;8.5</u>.&#160; The value of the Matrix Capital Stock, and
the purchase price therefor, shall be payable in cash or immediately available
funds and shall be in the amounts as follows (the &#147;<b><u style="font-weight:bold;">Investment
Amount</u></b>&#148;): (x)&nbsp;in the case of the termination referenced in
Clauses <u>8.5(a)</u>&nbsp;or <u>(b)</u>, the Investment Amount</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='48',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">shall be $10.0 million, or (y)&nbsp;in
the case of the termination referenced in Clauses <u>8.5(c)</u>&nbsp;or <u>(d)</u>,
the Investment Amount shall be determined based on the date of termination as
follows:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="55%" style="border-collapse:collapse;margin-left:1.5in;width:55.0%;">
 <tr>
  <td width="64%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:64.32%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Termination&nbsp;Date</font></b></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="30%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:30.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Investment&nbsp;Amount</font></b></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:64.32%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="30%" colspan="2" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:30.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.32%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On or prior to March&nbsp;31, 2008</font></p>
  </td>
  <td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.02%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="27%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:27.98%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.0 Million</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.32%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="30%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:30.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.32%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">After March&nbsp;31, 2008 but on or prior
  to April&nbsp;30, 2008</font></p>
  </td>
  <td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.02%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="27%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:27.98%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.0 Million</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.32%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="30%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:30.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.32%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">After April&nbsp;30, 2008</font></p>
  </td>
  <td width="4%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:4.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.02%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="27%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:27.98%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.0 million</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Matrix Capital Stock to be issued will be Series&nbsp;E Stock or if
a later series of Matrix preferred stock is then being offered to potential
investors, such later series of stock.&#160;
The number of shares to be issued in exchange for such Investment Amount
shall be equal to the Investment Amount divided by a value per share determined
by dividing (x)&nbsp;the equity value of Matrix as determined below by (y)&nbsp;the
fully diluted number of shares of Matrix Capital Stock outstanding as of the
date of termination, taking into account any anti dilution rights that may be
triggered by the issuance of Matrix Capital Stock to Immucor pursuant to this <u>Section&nbsp;8.5</u>.&#160; The equity value of Matrix for purposes of
this <u>Section&nbsp;8.5</u> shall be an amount equal to the amount that would
have been the Aggregate Merger Consideration if the Merger had been consummated
on the date of termination.&#160; In
consideration of the Investment Amount, Matrix shall issue and deliver the
determined number of shares of Matrix Capital Stock free and clear of all preemption
rights, claims, contractual restrictions and other Liens.&#160; Such shares shall when delivered be duly
authorized, validly issued, fully paid and non-assessable.&#160; Notwithstanding anything to the contrary in
this Agreement and except as otherwise expressly provided in the last sentence
of Section&nbsp;8.2, Matrix&#146;s right to require the investment and receive
payment of the Investment Amount from Immucor pursuant to this <u>Section&nbsp;8.5</u>,
whether or not Matrix elects to exercise that right, shall be the sole and
exclusive, direct or indirect, remedy of Matrix and its Subsidiaries against
Immucor, Merger Sub, and any of their respective former, current or future
stockholders, managers, members, directors, officers, employees, agents,
general or limited partners, managers, members, stockholders, Affiliates or
assignee of any of the foregoing (each, a &#147;<b><u style="font-weight:bold;">Immucor Affiliate</u></b>&#148;)
for the loss suffered as a result of the failure of the Merger to be
consummated, including in the event Immucor or Merger Sub breaches its representations,
warranties, covenants, agreements or obligations under this Agreement, and upon
payment of the Investment Amount, none of Immucor, Merger Sub, or any Immucor
Affiliate shall have any further liability or obligation relating to or arising
out of this Agreement or the transactions contemplated hereby, including the
Merger</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE IX.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">GENERAL PROVISIONS</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.1</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notices.</b>&#160; All notices and other communications under
this Agreement shall be in writing and may be given by any of the following
methods:&#160; (a)&nbsp;personal delivery;</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='49',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&nbsp;facsimile
transmission; (c)&nbsp;registered or certified mail (airmail if to an address
in a country other than the country in which the sender is located), postage
prepaid, return receipt requested; or (d)&nbsp; delivery service requiring
acknowledgment of receipt.&#160; Any such
notice or communication shall be sent to the appropriate Party at its address
or facsimile number given below (or at such other address or facsimile number
for such Party as shall be specified by notice given hereunder):</font></p>

<p style="margin:0in 0in .0001pt 1.5in;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to Immucor or Merger Sub, to:</font></p>

<p style="margin:0in 0in .0001pt 1.5in;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immucor,&nbsp;Inc.<br>
3130 Gateway Drive<br>
Norcross, Georgia 30071<br>
Fax: (770) 242-8930<br>
Attn:&#160; Chief Executive Officer</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy (which shall not constitute notice) to each of:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immucor,&nbsp;Inc.<br>
3130 Gateway Drive<br>
Norcross, Georgia 30071<br>
Fax: (770) 242-8930<br>
Attn:&#160; General Counsel</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">and</font></u></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sutherland Asbill&nbsp;&amp; Brennan LLP</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">999 Peachtree Street, N.E.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Atlanta, Georgia&#160; 30309-3996</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax: (404) 853-8806</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn: Edward W. Kallal,&nbsp;Jr.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 108.3pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to Matrix:</font></p>

<p style="margin:0in 0in .0001pt 108.3pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BioArray Solutions, Ltd. <br>
35 Technology Drive</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Warren, New Jersey 07059</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax:&#160; (908) 226-0800<br>
Attn:&#160; President&nbsp;&amp; CEO</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 145.35pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy (which shall not constitute
notice) to:</font></p>

<p style="margin:0in 0in .0001pt 145.35pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Reinhart Boerner Van Deuren s.c.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1000 North Water Street, Suite&nbsp;2100</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Milwaukee, Wisconsin 53202</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax:&#160; (414) 298-8097</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn:&#160; Thomas A. Myers</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='50',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 108.3pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to the Shareholders Agent Committee:</font></p>

<p style="margin:0in 0in .0001pt 108.3pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NGN Capital</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">369 Lexington Avenue<br>
New York, New York 10017<br>
Fax:&#160; (212) 972-0080<br>
Attn:&#160; William Gedale</font></p>

<p style="margin:0in 0in .0001pt 142.5pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 145.35pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy (which shall not constitute
notice) to:</font></p>

<p style="margin:0in 0in .0001pt 145.35pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Reinhart Boerner Van Deuren s.c.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1000 North Water Street, Suite&nbsp;2100</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Milwaukee, Wisconsin 53202</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax:&#160; (414) 298-8097</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn:&#160; Thomas A. Myers</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All such notices and communications shall be deemed received upon (a)&nbsp;actual
receipt thereof by the addressee, (b)&nbsp;actual delivery thereof to the
appropriate address as evidenced by an acknowledged receipt, or (c)&nbsp;in the
case of a facsimile transmission, upon transmission thereof by the sender and
confirmation of receipt.&#160; In the case of
notices or communications sent by facsimile transmission, the sender shall
contemporaneously mail a copy of the notice or communication to the addressee
at the address provided for above.&#160;
However, such mailing shall in no way alter the time at which the
facsimile notice or communication is deemed received.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.2</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Table
of Contents; Headings; Rules&nbsp;of Construction.</b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
Table of Contents and headings contained herein are for convenience of
reference only, do not constitute a part of this Agreement, and shall not be
deemed to limit or affect any of the provisions hereof.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b><u style="font-weight:bold;">Include</u></b>&#148; and &#147;<b><u style="font-weight:bold;">including</u></b>&#148; and similar expressions are
not expressions of limitation and shall be construed as if followed by the
words &#147;without limitation.&#148;</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
words &#147;<b><u style="font-weight:bold;">herein</u></b>,&#148; &#147;<b><u style="font-weight:bold;">hereto</u></b>,&#148; &#147;<b><u style="font-weight:bold;">hereof</u></b>&#148; and words of similar import refer to this
Agreement as a whole and not to any particular Section&nbsp;or paragraph
hereof.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Words
importing the singular will also include the plural, and vice versa.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
symbol &#147;<b>$</b>&#148; means United States
Dollars.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.3</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amendment.</b> &#160;At any time prior to the Effective Time,
whether before or after approval of the Merger by the Matrix Shareholders, any
provision of this Agreement may be amended if such amendment is in writing and
signed by Matrix, Immucor and Merger Sub; provided, however, that, after
receipt of approval of the Merger by the Matrix Shareholders, if any such
amendment shall, in the reasonable judgment of either Immucor or Matrix, by
applicable Law or in accordance with the rules&nbsp;and regulation of a stock
exchange require further</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='51',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">approval of the Matrix
Shareholders, the effectiveness of such amendment shall be subject to the
approval of the Matrix Shareholders in accordance with applicable Law.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.4</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Severability.</b>&#160; If any provision of this Agreement is
invalid, illegal or incapable of being enforced by any Law or public policy,
all other provisions of this Agreement will nevertheless remain in full force
and effect so long as the economic or legal substance of the transactions
contemplated hereby is not affected in any manner adverse to any Party
hereto.&#160; Upon any such determination that
any provision is invalid, illegal or incapable of being enforced, the Parties
hereto will negotiate in good faith to modify this Agreement so as to effect
the original intent of the Parties as closely as possible in an acceptable
manner to the end that the transactions contemplated by this Agreement are
consummated to the extent possible.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.5</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Waiver.</b>&#160; The failure of any Party hereto at any time
or times to require performance of any provision hereof shall in no manner
affect the right to enforce the same.&#160; No
waiver by any Party of any condition, or the breach of any provision contained
in the Matrix or Purchaser Delivered Agreements, or whether by conduct or
otherwise, in any one or more instances shall be deemed or construed as a
further or continuing waiver of any such condition or breach or a waiver of any
other condition or of the breach of any other provision herein or therein.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.6</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No
Third Party Beneficiaries; Assignment.</b>&#160;
This Agreement shall be binding on the Parties and their respective
successors and assigns and shall inure to the benefit of the Parties and their
respective successors and permitted assigns.&#160;
Nothing in this Agreement shall create or be deemed to create any third
party beneficiary rights in any Person.&#160;
Except for any assignment to a wholly-owned subsidiary of Merger Sub or
Immucor, in which event Merger Sub and Immucor shall remain liable for the
performance of this Agreement, no transfer or assignment of this Agreement or
of any rights or obligations under this Agreement prior to the Closing may be
made by any Party without the prior written consent of the other Parties (which
consent shall not be withheld unreasonably) and any attempted transfer or
assignment without that required consent shall be void.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.7</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Time
of the Essence; Computation of Time.</b>&#160;
Time is of the essence of each and every provision of this
Agreement.&#160; Whenever the last day for the
exercise of any right or the discharge of any duty under this Agreement shall
fall upon Saturday, Sunday or a public or legal holiday, the Party having such
right or duty shall have until 6:00&nbsp;p.m. New York time on the next
succeeding regular Business Day to exercise such right or to discharge such
duty.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.8</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Counterparts.</b>&#160; This Agreement may be executed by each Party
upon a separate copy, and in such case one counterpart of this Agreement shall
consist of enough of such copies to reflect the signatures of all of the
Parties.&#160; This Agreement may be executed
in two (2)&nbsp;or more counterparts, each of which shall be an original, and
each of which shall constitute one and the same agreement.&#160; Any Party may deliver an executed copy of
this Agreement and of any documents contemplated hereby by facsimile
transmission to another Party and such delivery shall have the same force and
effect as any other delivery of a manually signed copy of this Agreement or of
such other documents.</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='52',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-09.htm',USER='c900127',CD='Mar 15 04:00 2008' -->



<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.9</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Governing
Law; Consent to Jurisdiction; Waiver of Jury Trial.</b>&#160; This Agreement shall be governed by and
construed in accordance with the Laws of the State of New York (except as it
relates to corporate law involving Immucor, Merger Sub or Matrix, in which case
it shall be governed by the Laws of the State of Georgia or Delaware, as the
case may be, and except as it relates to the procedures for the Merger, in
which case it shall be governed by the DGCL), without giving effect to any Laws
of such State that would make such choice of Laws ineffective.&#160; Each Party hereto hereby submits to the
non-exclusive jurisdiction of the United States District Court for the Southern
District of New York and of any New York State Court sitting in Manhattan for purposes
of all legal proceedings arising out of or relating to this Agreement or the
transactions contemplated hereby.&#160; Each
Party hereto irrevocably waives, to the fullest extent permitted by Law, any
objection which it may now or hereafter have to the laying of the venue of any
such proceeding brought in such a court and any claim that any such proceeding
brought in such a court has been brought in an inconvenient forum.&#160; Each Party hereto hereby irrevocably waives
any and all right to trial by jury in any legal proceeding arising out of or
relating to this Agreement or the transactions contemplated hereby.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.10</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Entire
Agreement.</b>&#160; This Agreement (with its
Exhibits and the Disclosure Letter) contains, and is intended as, a complete
statement of all the terms of the arrangements among the Parties with respect
to the matters provided for herein and therein, and supersedes any previous
agreements and understandings among the Parties with respect to those matters,
except for the Confidentiality Agreement dated as of September&nbsp;20, 2007 by
and between Immucor and Matrix.</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;9.11</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indemnification
by Immucor.</b>&#160; If the Closing occurs,
Immucor shall indemnify and hold the Matrix Shareholders harmless from and
against any and all liabilities, damages, claims, costs and expenses (including
attorneys and other professional reasonable fees and costs) suffered or
incurred by the Matrix Shareholders which result from or arise out of (i)&nbsp;the
Breach of any representation or warranty made by Immucor or Merger Sub in this
Agreement or (ii)&nbsp;any breach, violation or failure to perform of any
covenant or agreement made by Immucor or Merger Sub in this Agreement.&#160; Immucor shall not be required to indemnify
the Matrix Shareholders unless the Shareholders Agent Committee gives notice to
Immucor of the facts that the Shareholders Agent Committee determines are a
basis for indemnification on or before the first anniversary of the Effective
Time.&#160; Further, Immucor shall not be
required to indemnify the Matrix Shareholders until the aggregate amount of the
losses described in the first sentence of this <u>Section&nbsp;9.11</u>
incurred or suffered by the Matrix Shareholders exceeds $200,000 and then
Immucor shall indemnify the Matrix Shareholders only up to an aggregate amount
of such losses not in excess of $5,000,000.&#160;
Subject to the foregoing provisions set forth in this <u>Section&nbsp;9.11</u>,
any indemnification obligation of Immucor or Merger Sub to the Matrix
Shareholders under this <u>Section&nbsp;9.11</u> shall be satisfied by payment
of the amount of such obligation to the Shareholders Agent Committee; <u>provided</u>,
<u>however</u> that the amount of any such payment due to the Shareholders
Agent Committee may be offset against the amounts of any Covered Damages
payable to Immucor or Merger Sub as contemplated by <u>Article&nbsp;XI</u>.&#160; If the Closing occurs, except with respect to
Immucor&#146;s obligations under <u>Article&nbsp;I</u> regarding payment of the
Aggregate Merger Consideration, its obligations under <u>Article&nbsp;XI</u>
and its obligations with respect to the Escrow Fund, the remedies provided in
this <u>Section&nbsp;9.11</u> constitute the sole and exclusive remedies for
recoveries against Immucor or Merger Sub for breaches of the</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='53',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">representations, warranties,
covenants and agreements of Immucor or Merger Sub in this Agreement and for any
other acts or omission relating to the acquisition by Immucor of Matrix.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE X.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SHAREHOLDERS AGENT COMMITTEE</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.1</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Appointment
and Acceptance.</b>&#160; As an integral
component of the conversion of Matrix Capital Stock pursuant to <u>Article&nbsp;I</u>
and in order to facilitate the consummation of the transactions contemplated by
this Agreement and resolution of matters after the Closing between Immucor,
Merger Sub and the Matrix Shareholders, each of William Gedale, Daniel Vapnek
and Michael Seul, Ph.D. and the successors of each of them, acting as provided
in this Agreement, are hereby irrevocably constituted and appointed as the
attorney-in-fact and agent for each Matrix Shareholder and Participating Option
Holder in his, her or its name, place and stead in connection with the
transactions contemplated by this Agreement (collectively, the &#147;<b><u style="font-weight:bold;">Shareholders Agent Committee</u></b>&#148;), and
each acknowledges that such appointment, being an integral part of the manner
and basis of the conversion of the Matrix Capital Stock and being relied upon
by Immucor and the Escrow Agent, is coupled with an interest.&#160; By executing and delivering this Agreement
under the heading &#147;Shareholders Agent Committee,&#148; each of such individuals
hereby (a)&nbsp;accepts this appointment and authorization to act as a member
of the Shareholders Agent Committee as attorney-in-fact and agent on behalf of
the Matrix Shareholders in accordance with the terms of this Agreement, and (b)&nbsp;agrees
to perform his obligations under, and otherwise comply with, this Agreement.</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.2</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Authorization.</b>&#160; The Shareholders Agent Committee:</p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Execution and Delivery of Agreements</i></b>.<i>&nbsp; </i>Is authorized and directed (i)&nbsp;to
deliver to Immucor, on behalf of the delivering Matrix Shareholder as provided
in this Agreement, share certificates representing such Matrix Shareholder&#146;s
Matrix Capital Stock, a letter of transmittal relating to such Matrix Capital
Stock, and all other materials to be delivered in connection with this
Agreement; (ii)&nbsp;to execute, deliver, and to accept delivery of, on behalf
of the Matrix Shareholders, the Escrow Agreement and the other agreements,
instruments and documents to be, or as, delivered by or on behalf of the Matrix
Shareholders pursuant to this Agreement; (iii)&nbsp;to execute, deliver, and to
accept delivery of, on such Matrix Shareholder&#146;s behalf such amendments as may
be deemed by the Shareholders Agent Committee in its sole discretion to be
appropriate under this Agreement, the Escrow Agreement or any agreement, document
or instrument delivered pursuant to this Agreement (each, a &#147;<b><u style="font-weight:bold;">Transaction Document</u></b>&#148;); and (iv)&nbsp;to
execute and deliver, and to accept delivery of, on his behalf such agreements,
instruments and other documents as may be deemed by the Shareholders Agent
Committee in its sole discretion to be appropriate under any Transaction
Document;</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Notices and Determinations</i></b>.<i>&nbsp; </i>Is authorized to bind the Matrix
Shareholders by all notices received, by all agreements and determinations
made, and by all agreements, instruments and other documents executed and
delivered by the Shareholders Agent Committee under any Transaction Document;</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='54',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Disputes and Consents</i></b>.<i>&nbsp; </i>Is authorized and directed (i)&nbsp;to
dispute or to refrain from disputing any claim made by Immucor under any
Transaction Document; (ii)&nbsp;to negotiate and compromise any dispute which
may arise under, and to exercise or refrain from exercising remedies available
under any Transaction Document and to sign any releases or other documents with
respect to such dispute or remedy; (iii)&nbsp;to waive any condition contained
in any Transaction Document; (iv)&nbsp;to give any and all consents under any
Transaction Document; and (v)&nbsp;to give such instructions and to do such other
things and refrain from doing such other things as the Shareholders Agent
Committee in its sole discretion deems necessary or appropriate to carry out
the provisions of any Transaction Document; and</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Payments &#150; Receipt and Disbursements</i></b>.<i>&nbsp; </i>Is authorized and directed (i)&nbsp;to
receive any payments made to the Matrix Shareholders or to the Shareholders
Agent Committee on the Matrix Shareholders&#146; behalf pursuant to any Transaction
Document, (ii)&nbsp;to invest such funds pending their disbursement in such
manner as the Shareholders Agent Committee in its sole discretion deems
appropriate, and (iii)&nbsp;to disburse to the Matrix Shareholders payments
made to the Shareholders Agent Committee under any Transaction Document
(specifically including the Escrow Agreement) in accordance with <u>Article&nbsp;I</u>,
but only after (A)&nbsp;payment of any accountants&#146;, attorneys&#146; and others&#146;
fees and expenses incurred by or on behalf of the Matrix Shareholders in
connection with any Transaction Document and (B)&nbsp;withholding such amount
from any distribution as the Shareholders Agent Committee, in its sole and
absolute discretion, deems reasonable to pay such costs and expenses that it
determines may be incurred after the Closing relating to potential disputes
arising with respect to indemnification or other obligations of the Matrix
Shareholders under any Transaction Document or this Agreement (such amounts to
be held in, and disbursed from, the Expenses Fund as described in <u>Section&nbsp;2.2(d)</u>).</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.3</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Procedural
Matters.</b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Meetings and Written Consents</i></b>.<i>&nbsp; </i>Actions by the Shareholders Agent
Committee will by made either (i)&nbsp;at a meeting (and participation by means
of a conference telephone call in which all participants can hear each other
will constitute attendance) or (ii)&nbsp;by written consent. &#160;Any member of the Shareholders Agent Committee
may give notice of a meeting, which notice will be given in a manner and for a
time and place that is reasonably determined by the person giving the notice to
be most convenient to the majority of the persons who would participate in the
meeting and provides information as to how those who cannot attend the meeting
in person can participate by telephone in a manner in which all the other
attendees, including others participating by telephone, can hear each other.&#160; Any such written consent may be circulated by
any member of the Shareholders Agent Committee (and it will be sent at the same
time to all the other members of the Shareholders Agent Committee), but if any
member of the Shareholders Agent Committee thereafter gives reasonable notice
of a meeting, then such matter will be considered at a meeting even if the
consent has been signed by a majority of the members of the Shareholders Agent
Committee.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Required Vote or Signatures</i></b>.<i>&nbsp; </i>Decisions of the Shareholders Agent
Committee at a meeting may be made only if at least a majority of the members
are participating, and decisions need not be unanimous but will require the
affirmative vote of at</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">55</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='55',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">least a majority of the
members.&#160; Written consents need not be
unanimous but will be effective when signed by at least a majority of the
members.&#160; If a member does not
participate in a decision (whether by attendance at a meeting or by signing a
written consent), then such member will be given prompt notice of the action
taken.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Minutes and Other Records</i></b>.<i>&nbsp; </i>The Shareholders Agent Committee
will keep minutes of (i)&nbsp;its meetings, (ii)&nbsp;copies of written
consents and notices and other instruments under this Agreement, (iii)&nbsp;reasonable
documentation of receipts and disbursements involving the Expenses Fund and
otherwise under this Agreement, and (iv)&nbsp;reasonable documentation of
material decisions under this Agreement.&#160;
Such minutes, copies and documentation will be maintained by the
Shareholders Agent Committee and will be available for inspection by any Matrix
Shareholder, upon reasonable prior notice to the Shareholders Agent Committee,
at a reasonable location and time specified by the Shareholders Agent
Committee.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.4</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Third
Party Beneficiaries and Reliance.</b>&#160;
The Shareholders Agent Committee is authorized to act on behalf of the
Matrix Shareholders notwithstanding any dispute or disagreement among the
Matrix Shareholders and Immucor, the Escrow Agent and any other person will be
entitled to rely on any and all actions taken (or not taken) by the
Shareholders Agent Committee under any Transaction Document that appear to have
been taken in accordance with this Agreement without any duty of inquiry as to
the genuineness of the writing or other communication and without any
obligation of inquiry of any of the Matrix Shareholders.</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.5</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Successors.</b>&#160; If a member of the Shareholders Agent
Committee resigns or ceases to function in his capacity as such for any reason
whatsoever, then the other members will promptly appoint a successor and give
notice to Immucor and the Escrow Agent; <u>provided</u>, <u>however</u>, that
if for any reason no successor has been appointed within 30 days, then the
Matrix Shareholders who own (or owned) at least 51% of the Matrix Capital Stock
may appoint a successor; and <u>provided</u>, <u>further</u>, that if for any
reason no successor has been appointed pursuant to the foregoing provision
within 45 days, then any member of the Shareholders Agent Committee may petition
a court of competent jurisdiction for appointment of a successor.&#160; The Matrix Shareholders may at any time and
for any reason remove any one or more members of the Shareholders Agent
Committee by written consent of the Matrix Shareholders who own (or owned
immediately before the Effective Time) at least 51% of the Matrix Capital Stock
and may contemporaneously therewith appoint a successor or successors by such
written consent.&#160; The appointment of a
successor pursuant to the foregoing will be by a written instrument (i)&nbsp;that
is signed by the requisite number of persons or by a judge or clerk of a court
competent jurisdiction and (ii)&nbsp;that sets forth the explanation of how
such persons satisfy the foregoing voting requirements, and promptly thereafter
a copy of such instrument will be given to Immucor and the other members of the
Shareholders Agent Committee.</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.6</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Survival
of Authorization.&#160; </b>THE AUTHORIZATIONS AND AGREEMENTS
IN THIS AGREEMENT WILL REMAIN IN FORCE IF ANY MATRIX SHAREHOLDER SUBSEQUENTLY
BECOMES MENTALLY OR PHYSICALLY DISABLED OR INCOMPETENT.&#160; SUCH RECORDINGS AND FILINGS OF THIS AGREEMENT
MAY&nbsp;BE MADE AS ANY PERSON DEEMS APPROPRIATE.&#160; NO FILING</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">56</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='56',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">OF ANY INVENTORY OR POSTING OF
A SURETY BOND WILL BE REQUIRED OF ANY PERSON, IN CONNECTION WITH THIS ARTICLE.</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.7</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Standards
and Liability.</b>&#160; The Shareholders
Agent Committee will take actions under this Agreement that treats each of the
Matrix Shareholders in the same manner.&#160;
Notwithstanding anything to the contrary in this Agreement, no member of
the Shareholders Agent Committee will have any liability for any act or
omission in connection with this Agreement except such that arises from gross
negligence or willful misconduct or fraud.</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.8</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indemnification.</b>&#160; The Shareholders Agent Committee shall be
indemnified and held harmless for any and all liability, loss, cost, damage or
expense (including reasonable and actual attorneys&#146; fees and expenses)
reasonably incurred or suffered as a result of the performance of such member&#146;s
duties under any Transaction Document or this Agreement, except such that
arises from gross negligence or willful misconduct.&#160; Such indemnity shall be funded from the
Expenses Fund and any residual amounts in the Escrow Fund otherwise available
for distribution to the Matrix Shareholders.</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.9</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No
Implied Agency or Partnership.</b>&#160; No
party other than the Shareholders Agent Committee is the agent or
representative of any other party.&#160;
Except as provided with respect to the Shareholders Agent Committee,
nothing in this Agreement will be construed to make a party liable to any other
person for or on account of any claim or act or omission of any other
party.&#160; Nothing in this Agreement will be
construed to create a partnership or joint venture among the parties.</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;10.10</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Expenses.</b>&#160; No member of the Shareholders Agent Committee
is entitled to any fee for such member&#146;s activities pursuant to this Agreement,
but each will be reimbursed from the Expenses Fund (to the extent it has
sufficient funds) and from any residual amounts in the Escrow Fund otherwise
available for distribution to the Matrix Shareholders for such member&#146;s
reasonable expenses (including reasonable and actual attorneys&#146; fees and expenses)
actually incurred in connection with his performance of such member&#146;s duties in
accordance with this Agreement.</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE XI.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CERTAIN POST-CLOSING CONSIDERATION ADJUSTMENTS</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;11.1</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Survival;
Agreed Disclaimer of Effect of Knowledge.</b>&#160;
The covenants and agreements contained in this Agreement or in any
instrument pursuant to this Agreement shall survive the Closing until fully
performed.&#160; Each representation and
warranty of Matrix in this Agreement, including the Final Payment Schedule, or
in any certificate delivered pursuant to <u>Sections 6.2(b)</u>,&#160; <u>6.2(c)</u>&nbsp;or <u>6.2(f)</u>&nbsp;shall
survive until the expiration of the period during which a claim for adjustment
to the Aggregate Merger Consideration may be made, and thereafter for Pending
Claims until the Pending Claims have been resolved.&#160; Each representation and warrant of Immucor
and Merger Sub in this Agreement or in any certificate delivered pursuant to <u>Section&nbsp;6.3(b)</u>&nbsp;shall
survive until the expiration of the period during which a claim for
indemnification against Immucor or Merger Sub may be made pursuant to <u>Section&nbsp;9.11</u>.&#160; Notice must be given of any claim in respect
of a breach or alleged breach of a representation or warranty under <u>Section&nbsp;11.2</u>
prior to the termination of the relevant survival period.&#160; Each party, acknowledging that the</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">57</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='57',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">other is entitled to rely on
its representations and warranties in this Agreement (with each of the
representations and warranties in each Section&nbsp;hereof qualified only by the
disclosures in the section of the Disclosure Letter specified by such Section),
in order to preserve the benefit of the bargain otherwise represented by this
Agreement, agrees that neither the survival of such representations, warranties,
covenants and agreements, nor their enforceability, nor any remedies for
breaches of them will be affected by any knowledge of a party regardless of
when or how such party acquired such knowledge, specifically including
knowledge of a breach obtained after the signing of this Agreement and before
the Closing occurs.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;11.2</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Covered
Damages.</b>&#160; The Aggregate Merger
Consideration is subject to reduction as provided in this <u>Section&nbsp;11.2</u>
for Covered Damages, subject to the limitations set forth in this <u>Article&nbsp;XI</u>,
including <u>Section&nbsp;11.5(e)</u>, which limits the reduction of the
Aggregate Merger Consideration for Covered Damages to the Escrow Fund.</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Covered General Damages</i></b>.&#160; If the Closing occurs, notwithstanding any
investigation conducted or notice of knowledge obtained by or on behalf of any
party hereto, the Aggregate Merger Consideration shall be reduced in accordance
with <u>Section&nbsp;1.10</u> by any of the following amounts (&#147;<b><u style="font-weight:bold;">Covered General Damages</u></b>&#148;) suffered or
incurred by Immucor or Merger Sub or any of their respective Affiliates,
directors, officers, agents, employees, successors or assigns (each such
protected party, an &#147;<b><u style="font-weight:bold;">Immucor Protected
Party</u></b>&#148;):</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Covered Loss involving, arising out of or related to any Breach (and, in the
case of a Third Party Claim, any alleged Breach) of any representation or
warranty made by Matrix in this Agreement (other than <u>Section&nbsp;3.13</u>)
either as of the date<b>  </b>of this
Agreement or as re-made as of the Closing; <u>provided</u>, <u>however</u>,
that the determination of whether such a Breach has occurred will disregard:</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>materiality
qualifiers;</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>knowledge
qualifiers, other than those involving knowledge of contemplated or threatened
acts or omissions of third parties;&#160; and</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(C)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as
to the representations and warranties as deemed re-made as of the Closing, the
failure of the Disclosure Letter to list contracts or other similar obligations
entered into or incurred by Matrix in the ordinary course of business (other
than with respect to the Matrix Intellectual Property) after the date of this
Agreement and not in violation of <u>Section&nbsp;5.2</u>;</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">provided</font></u>, <u>further</u>, that
contracts and other obligations entered into after the date of this Agreement
as described in clause (C)&nbsp;above are deemed Leases, Indebtedness and
Matrix Contracts, as applicable, to the extent they would otherwise be included
in such defined terms had they been entered into on or before the date of this
Agreement and, thus, the representations and warranties in this Agreement as to
the characteristics and status of Leases, Indebtedness and Matrix Contracts, as
applicable, are deemed made as to such additional contracts and obligations as
of the Closing Date;</h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">58</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='58',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Covered Loss involving, arising out of or related to any breach, violation or failure
to perform of any covenant or agreement made by Matrix in this Agreement;</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Covered Loss involving, arising out of or related to any obligation or
liability (whether absolute, contingent, known or unknown, determinable or
indeterminable, or otherwise) of Matrix relating to any of the following:</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Taxes relating to periods ending on or before the Closing Date, or to the
portion of any Straddle Period for which Matrix Shareholders are responsible
under this Agreement, in excess of the amount of such Taxes paid before the
Closing;</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
act or omission occurring, or any fact or circumstance existing, before the
Closing Date or relating to the execution, delivery and performance of any
Matrix Delivered Agreement that entitles any officer, director, agent or other
person to indemnification pursuant to the certificate of incorporation, bylaws
or other corporate authorization of Matrix in effect on or before the Closing
Date with respect to any act or omission before the Closing Date and any
disputes between or among any of the Matrix Shareholders (or former equity
owners of Matrix) with respect to the execution, delivery and performance of
this Agreement or the purchase, issuance or sale of Matrix Capital Stock or
other equity interests in Matrix or its predecessors in interest;</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(C)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Indebtedness of Matrix that was neither paid off prior to the Closing Date nor
reflected in the calculation of the Price Adjustments (and any related Liens);
or</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(D)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except
to the extent taken into account in determining the Aggregate Merger
Consideration pursuant to <u>Section&nbsp;1.9</u>, any liability or claim
involving Matrix&#146;s current or former officers, directors, shareholders,
partners, agents, independent contractors, employees, leased employees, or the
beneficiaries of any of them (excluding those relating to compensation accrued
in the ordinary course but unpaid as of he Closing Date, related withholdings,
payroll taxes, medical expenses, and workers&#146; compensation costs or under
Matrix&#146;s bonus, incentive compensation, employee benefit, welfare, fringe
benefit or other plan or arrangement to the extent permitted by or disclosed
pursuant to this Agreement) including any claims arising as a result of the
actions contemplated by <u>Section&nbsp;5.8</u>;</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Covered Loss involving, arising out of or related to any of the matters, if
any, described in <u>Section&nbsp;11.2(a)(iv)&nbsp;to the Disclosure Letter</u>;
or</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Covered Loss involving, arising out of or related to any failure of (x)&nbsp;the
Final Payment Schedule to fully and accurately reflect all outstanding shares
of Matrix Capital Stock and all outstanding Matrix Options and the legal and
beneficial owners thereof, or (y)&nbsp;any shares of Matrix Capital Stock to
have been duly authorized and validly issued in compliance with all applicable
Laws and all applicable contractual restrictions.</h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='59',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Covered IP Damages</i></b>.&#160; If the Closing occurs, notwithstanding any
investigation conducted or notice of knowledge obtained by or on behalf of any
party hereto, the Aggregate Merger Consideration shall be reduced in accordance
with <u>Section&nbsp;1.10</u> by (x)&nbsp;80% of each of the Covered Losses
described in subsections <u>11.2(b)(i)-(iv)</u>&nbsp;which are suffered or
incurred by any Immucor Protected Party (including any Covered Losses with
respect to the OGT Patents, even if such Covered Losses are suffered or
incurred by Matrix during the period beginning on the date of this Agreement
and ending on the Closing Date), and (y)&nbsp;except as otherwise provided in
the foregoing clause (x)&nbsp;with respect to the OGT Patents, 100% of each of
the Covered Losses described in subsections <u>11.2(b)(i)-(iv)</u>&nbsp;which
are suffered or incurred by Matrix during the period beginning on the date of
this Agreement and ending on the Closing Date, without duplication of amounts
otherwise reflected in the Price Adjustments pursuant to <u>Section&nbsp;1.9(a)(viii)</u>&nbsp;(all
the Covered Losses described in this Section&nbsp;11.2(b)&nbsp;being referred
to as the &#147;<b><u style="font-weight:bold;">Covered IP Damages</u></b>&#148;).</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Covered Loss involving, arising out of or related to any Breach (and, in the
case of a Third Party Claim, any alleged Breach) of any representation or
warranty made by Matrix in <u>Section&nbsp;3.13</u> either as of the date of
this Agreement or as re-made as of the Closing; <u>provided</u>, <u>however</u>,
that the determination of whether such a Breach has occurred will disregard:</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>materiality
qualifiers;</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>knowledge
qualifiers, other than those involving knowledge of contemplated or threatened
acts or omissions of third parties;&#160; and</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(C)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as
to the representations and warranties as deemed re-made as of the Closing, the
failure of the Disclosure Letter to list contracts or other similar obligations
entered into or incurred by Matrix in the ordinary course of business with
respect to the Matrix Intellectual Property after the date of this Agreement
and not in violation of <u>Sections 5.2(b)(v)</u>, <u>(vii)</u>&nbsp;or <u>(xiv)</u>;</h5>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">provided</font></u>, <u>further</u>, that
contracts and other obligations entered into after the date of this Agreement
as described in clause (C)&nbsp;above are deemed Third Party Intellectual
Property Licenses to the extent they would otherwise be included in such
defined term had they been entered into on or before the date of this Agreement
and, thus, the representations and warranties in this Agreement as to the
characteristics and status of Matrix Intellectual Property are deemed made as
to such additional contracts and obligations as of the Closing Date.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Covered Loss involving, arising out of or related to any breach, violation, or
failure to perform, of any covenant or agreement made by Matrix in <u>Sections
5.2(b)(v)</u>, <u>(vii)</u>&nbsp;or <u>(xiv)</u>, <u>5.11</u> or <u>5.12</u> as
they relate to Matrix Intellectual Property.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
Covered Loss involving, arising out of or related to any Claim that any of the
following infringes upon, misappropriates, violates or conflicts in any way
with any Intellectual Property or other right held by any Person: (A)&nbsp;the
operation of the Business of Matrix as presently operated or as operated prior
to the Closing Date, (B)&nbsp;the</h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">60</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='60',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">use of any of the
Matrix Intellectual Property in the manner currently used in the Business or as
currently contemplated by Matrix to be used in the Business, or (C)&nbsp;any
immunohematology products either currently or as of the Effective Time sold or
distributed by Matrix or planned by Matrix to be sold or distributed in the
future (which current and planned immunohematology products include HEA 1128,
HPA, Rh CE variants, RhD variants, and HLA A and B) to the extent the Claim is
directed against the BeadChip Platform (as defined below) or a product-specific
component (e.g. probe, primer, enzyme), or (D)&nbsp;any other immunohematology
products sold or distributed by Matrix in the future to the extent that the
Claim is directed against the BeadChip Platform.&#160; For purposes hereof, (x)&nbsp;the &#147;Beadchip
Platform&#148; means Matrix&#146;s BeadChip technology platform comprising a format for
producing a deploying on a semiconductor wafer assembled random arrays of
encoded microparticles, as well as related imaging analysis hardware and
software, and (y)&nbsp;&#147;planned&#148; means under formal product development guided
by &#147;design control.&#148;</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
license fees or royalties (&#147;<b><u style="font-weight:bold;">Covered License Fees</u></b>&#148;)
which are paid or payable during the period ending on the fifth anniversary of
the Closing Date pursuant to (x)&nbsp;any Reasonable License, and other Covered
Losses arising out of or relating to any Reasonable License, or (y)&nbsp;any
license or royalty agreement entered into by Matrix after the date hereof with
respect to Intellectual Property, and other Covered Losses arising out of or
relating to any such license or royalty agreement.&#160; For purposes of this Agreement, a &#147;<b><u style="font-weight:bold;">Reasonable License</u></b>&#148; is any license or
royalty agreement, entered into prior to the third anniversary of the Effective
Time with respect to which Immucor gives notice to the Shareholders Agent
Committee prior to the third anniversary of the Effective Time, authorizing
Immucor or any of its Affiliates to use the Intellectual Property of any Person
not an Affiliate of Immucor which is entered into based on the determination by
Immucor that in its judgment, exercised in a commercially reasonable way, the
license or royalty agreement is necessary or appropriate to settle or resolve
any claim or potential claim that is or upon assertion would be or otherwise
involve a Covered Loss under <u>Section&nbsp;11.2(b)(i)</u>, <u>(ii)</u>&nbsp;or
<u>(iii)</u>.&#160; Without limitation,
Immucor&#146;s judgment will have been exercised in a commercially reasonable way if
it reasonably determines that the license or royalty agreement is necessary or
appropriate taking into account the strengths and weaknesses of the positions
on the Intellectual Property, the potential costs of any litigation,
arbitration, claim or other controversy, the potential for disruption in the
marketplace and the potential costs of the license or royalty agreement, but
disregarding the adjustments to the Aggregate Merger Consideration provided for
in this<br>
<u>Section&nbsp;11.2(b)</u>.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;11.3</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Certain
Limitations.</b>&#160; Notwithstanding the
foregoing:</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Time Limitations</i></b>.&#160; The Aggregate Merger Consideration shall not
be reduced by any Covered Damages unless Immucor or Merger Sub gives notice to
the Shareholders Agent Committee of the facts that Immucor or Merger Sub
determines are a basis for claiming such reduction:</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">61</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='61',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in
the case of Covered General Damages, except as otherwise provided in <u>Section&nbsp;6.2(h)(iv)</u>&nbsp;or
<u>11.3(a)(ii)(B)</u>, on or before the first anniversary of the Effective
Time; and</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in
the case of (A)&nbsp;Covered IP Damages (including with respect to Covered
License Fees) or (B)&nbsp;Covered General Damages arising out of or related to
any Breach (and, in the case of a Third Party Claim, any alleged Breach) of any
representation or warranty made by Matrix in <u>Section&nbsp;3.15(f)</u>, on or
before the third anniversary of the Effective Time.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt .5in;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Basket for Covered General Damages</i></b>.&#160; There shall be no reduction of the Aggregate
Merger Consideration by the amount of any Covered General Damages until the
total amount of Covered General Damages exceeds, in the aggregate, $200,000, at
which point the Aggregate Merger Consideration shall be reduced by the total
amount of Covered General Damages.&#160; The
foregoing limitation does not apply to: (i)&nbsp;any Covered Loss with respect
to, as a result of, or involving a Breach of, a representation or warranty in <u>Sections
3.1</u>, <u>3.2</u>, <u>3.3</u>, <u>3.14</u>, <u>3.15</u> or <u>3.26</u>; or (ii)&nbsp;any
Covered Loss resulting in reduction to the Aggregate Merger Consideration
pursuant to <u>Sections 11.2(a)(ii)</u>&nbsp;through <u>(v)</u>; <u>provided</u>,
<u>however</u>, that the matters described in the foregoing clauses (i)&nbsp;and
(ii)&nbsp;will not be taken into account in determining whether Covered General
Damages exceed $200,000.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;11.4</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Distributions
from the Escrow Fund.</b>&#160; Distributions
from the Escrow Fund shall be made to the Shareholders Agent Committee, for the
benefit of the Matrix Shareholders, as follows:</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>$5,000,000
million, less the amount of (i)&nbsp;any Covered General Damages that have been
deducted from the Escrow Fund before the first anniversary of the Effective
Time, (ii)&nbsp;any Covered General Damages subject to a Pending Claim (in the
amount reasonably estimated by an Immucor Protected Party with respect to such
Pending Claim), (iii)&nbsp;any Covered IP Damages that have been deducted from
the Escrow Fund before the first anniversary of the Effective Time, (iv)&nbsp;any
Covered IP Damages subject to a Pending Claim (in the amount reasonably
estimated by an Immucor Protected Party with respect to such Pending Claim), as
of the first anniversary of the Effective Time, and (v)&nbsp;any Covered IP
Damages with respect to Covered License Fees not yet due and payable, shall be
paid out on the fifth Business Day after the first anniversary of the Effective
Time:</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>$5,000,000
less the amount of (A)&nbsp;any Covered General Damages that have been deducted
from the Escrow Fund after the first anniversary and before the second
anniversary of the Effective Time, (B)&nbsp;any Covered General Damages subject
to a Pending Claim (in the amount reasonably estimated by an Immucor Protected
Party with respect to such Pending Claim) as of the second anniversary of the
Effective Time, without duplication of amounts otherwise then being withheld
from distribution, (C)&nbsp;any Covered IP Damages that have been deducted from
the Escrow Fund after the first anniversary and before the second anniversary
of the Effective Time, (D)&nbsp;any Covered IP Damages subject to a Pending
Claim (in the amount reasonably estimated by an Immucor Protected Party with
respect to such Pending Claim) as of the second anniversary of the Effective
Time, without duplication of amounts otherwise then being withheld from
distribution, and (E)&nbsp;any Covered IP</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">62</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='62',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Damages with respect to
Covered License Fees not yet due and payable, as reasonably estimated by
Immucor, without duplication of amounts otherwise then being withheld from
distribution, shall be paid out on the fifth Business Day following the second
anniversary of the Effective Time; and</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
balance of the Escrow Fund less the amount of (A)&nbsp;any Covered General
Damages that have been deducted from the Escrow Fund after the second
anniversary and before the third anniversary of the Effective Time, (B)&nbsp;any
Covered General Damages subject to a Pending Claim (in the amount reasonably
estimated by an Immucor Protected Party with respect to such Pending Claim) as
of the third anniversary of the Effective Time, without duplication of amounts
otherwise then being withheld from distribution, (C)&nbsp;any Covered IP
Damages that have been deducted from the IP Portion after the second
anniversary and before the third anniversary of the Effective Time, (C)&nbsp;any
Covered IP Damages subject to a Pending Claim (in the amount reasonably
estimated by an Immucor Protected Party with respect to such Pending Claim) as
of the third anniversary of the Effective Time, without duplication of amounts
otherwise then being withheld from distribution, and (D)&nbsp;any Covered IP
Damages with respect to Covered License Fees not yet due and payable, as
reasonably estimated by Immucor, without duplication of amounts otherwise then
being withheld from distribution, shall be paid out on the fifth Business Day
following the third anniversary of the Effective Time.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Following
payment in full of all Pending Claims and any Covered IP Damages with respect
to Covered License Fees, the balance of the Escrow Fund, if any, shall be
distributed to the Shareholders Agent Committee for the benefit of the Matrix
Shareholders.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;11.5</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Procedures.</b>&#160; All claims for adjustment of the Aggregate
Merger Consideration under this <u>Article&nbsp;XI</u> will be asserted and
resolved in accordance with the following procedures:</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Notice of Facts Forming Basis for
Claim</i></b>.&#160; Notice must be
given of facts that are the basis of a claim for adjustment of the Aggregate
Merger Consideration under this <u>Article&nbsp;XI</u> by the Immucor Protected
Party claiming such adjustment (&#147;<b><u style="font-weight:bold;">Claimant</u></b>&#148;)
to the Shareholders Agent Committee before the expiration of the applicable
time period specified in <u>Section&nbsp;11.3(a)</u>.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Defense of Third Party Claims</i></b>.</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Generally</u>.&#160; If a claim or demand for adjustment of the
Aggregate Merger Consideration is based upon an asserted liability or
obligation to a person not a party nor a successor or assign of a party (a &#147;<b><u style="font-weight:bold;">Third Party Claim</u></b>&#148;), then (and without
limiting the obligations under <u>Section&nbsp;11.5(a)</u>), the Claimant will
undertake in good faith to give prompt notice of any such Third Party Claim to
the Shareholders Agent Committee; <u>provided</u>, <u>however</u>, that a
failure to provide such prompt notice of a Third Party Claim shall not
prejudice any right to adjustment of the Aggregate Merger Consideration under
this Agreement except to the extent that the Shareholders Agent Committee is
prejudiced by such failure.&#160; The
Shareholders Agent Committee will</h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">63</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='63',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt 36.7pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">defend such claims
or actions at its expense with counsel chosen and paid by it and will give
written notice (the &#147;<b><u style="font-weight:bold;">Notice of Defense</u></b>&#148;)
to the Claimant within 30 days after the date such notice of a Third Party
Claim is deemed received that acknowledges that it is defending the claim and
that identifies the lawyer retained for the defense.&#160; If the Shareholders Agent Committee defends a
matter that involves a person with whom Immucor has a business relationship,
the Shareholders Agent Committee will undertake such defense in a manner that
has due regard for Immucor&#146;s relationship with such person.&#160; The Claimant will be entitled to participate
in the defense of such claim or action and to employ lawyers of its choice for
such purpose at its own expense.</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Control
of Defense; Exceptions, etc</u>.&#160;
Notwithstanding anything to the contrary in this <u>Section&nbsp;11.5</u>:
(A)&nbsp;the Claimant will be entitled to participate in the defense of such
claim or action and to employ lawyers of its choice for such purpose at its own
expense; and (B)&nbsp;the Claimant will be entitled to assume control of the
defense of such claim and the Shareholders Agent Committee will pay the
reasonable fees and expenses of lawyers retained by the Claimant (excluding the
fees and expenses of the Claimant&#146;s lawyers before the date of such assumption
of the defense), if: (1)&nbsp;the claim is subject to <u>Section&nbsp;11.2(b)</u>;
(2)&nbsp;the claim or action involves any product manufactured or sold or other
work performed before the Closing; (3)&nbsp;the Claimant reasonably believes
that such claim or action could be reasonably expected to have a material
adverse effect on the Claimant&#146;s assets, business or reputation; (4)&nbsp;the
Claimant reasonably believes that there exists or could arise a conflict of
interest that, under applicable principles of legal ethics, could prohibit a
single legal counsel from representing both the Claimant and the Shareholders
Agent Committee in such claim or action, and such conflict has not been timely
waived; (5)&nbsp;the Shareholders Agent Committee either failed to give a
Notice of Defense or has failed or is failing to prosecute or defend vigorously
such claim or action; (6)&nbsp;criminal penalties or injunctive relief could be
imposed on the Claimant in connection with such claim or action; or (7) the
Shareholders Agent Committee fails or refuses to acknowledge that the Third
Party Claim is a Covered Loss subject to the Aggregate Merger Consideration
adjustment provisions contained in this <u>Article&nbsp;XI</u>.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Settlement</u>.&#160; The Shareholders Agent Committee may not
settle any such claims or actions without the consent of the Claimant (which
consent will not be unreasonably withheld or delayed).</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Other</u>.&#160; If the Shareholders Agent Committee does not
duly give the Notice of Defense as provided above or is not defending a Third
Party Claim by reason of this <u>Section&nbsp;11.5(b)</u>&nbsp;or otherwise,
then it will be deemed to have irrevocably waived its right to defend or settle
such claims, but it will have the right, at its expense, to attend, but not
otherwise participate in, proceedings with such third parties.&#160; The parties will not be entitled to dispute
the amount of any Covered Loss related to such Third Party Claim resolved as
provided in the foregoing sentence, and such resolved Covered Loss will be
satisfied within three Business Days as provided in <u>Section&nbsp;11.5(e)</u>.</h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h4 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Covered
Loss for Covered License Fees</u>.&#160;
Notwithstanding the foregoing, if a Covered Loss involves Covered
License Fees and the Shareholders Agent Committee did not consent or agree to
the material terms of the Reasonable License, then</h4>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">64</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='64',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt 36.7pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">in responding to
the initial claim for reduction of the Aggregate Merger Consideration pursuant
to <u>Section&nbsp;11.2(b)(iv)</u>&nbsp;with respect to such Reasonable
License, the Shareholders Agent Committee will be entitled to contest through
arbitration as provided in <u>Section&nbsp;11.5(d)</u>, whether Immucor&#146;s
judgment was reasonably exercised as provided in <u>Section&nbsp;11.2(b)(iv)</u>.</font></h4>

<h4 align="left" style="font-weight:normal;margin:0in 0in .0001pt 37.05pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h4>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Notice of Base or Determined Covered
Loss</i></b>.&#160; When a Covered Loss
as to which a notice has been timely given in accordance with <u>Section&nbsp;11.5(a)</u>&nbsp;is
paid or is otherwise fixed or determined, then the Claimant will give the
Shareholders Agent Committee notice of such Covered Loss, in reasonable detail
and specifying the amount of such Covered Loss, and the provision upon which
the claim for adjustment of the Aggregate Merger Consideration for such Covered
Loss is based (which notice will be in addition to the notice required under <u>Section&nbsp;11.5(a)</u>,
but the notices under this Section&nbsp;and under <u>Section&nbsp;11.5(a)</u>&nbsp;hereof
may be given simultaneously and in a single instrument when appropriate and in
compliance with both provisions).&#160; If the
Shareholders Agent Committee is permitted to dispute such claim, it will,
within 30 days after receipt of notice of the claim of Covered Loss against it
pursuant to this Section, give counter notice, setting forth the basis for
disputing such claim, to the Claimant.&#160;
If no such counter notice is given within such thirty-day period or if
the Shareholders Agent Committee acknowledges such adjustment of the Aggregate
Merger Consideration, then such Covered Loss will be satisfied within three
Business Days as provided in <u>Section&nbsp;11.5(e)</u>.&#160; If, within 30 days after the receipt of
counter notice by the Claimant, the parties will not have reached agreement as
to the claim in question (during which time the parties will negotiate in good
faith to resolve the dispute), then the claim for adjustment of the Aggregate
Merger Consideration will be submitted to and settled by arbitration as
provided below (it being expressly understood and agreed that if such counter
notice is duly given, it is the intention of the parties that any such claim
will be resolved by arbitration as provided in this <u>Section&nbsp;11.5</u>).</h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Arbitration</i></b>.&#160; Arbitration will be by a panel of three
arbitrators experienced in the matters at issue, one of which shall be selected
by Immucor, one of which shall be selected by the Shareholders Agent Committee,
and the third of which shall be selected by Immucor and the Shareholders Agent
Committee in accordance with the Commercial Arbitration Rules&nbsp;of the
American Arbitration Association (the &#147;<b><u style="font-weight:bold;">Rules</u></b>&#148;).&#160; The arbitration will be held in such place in
the New York, New York, metropolitan area as may be specified by the
arbitrators (or any place upon which the Shareholders Agent Committee, Immucor
and the arbitrators may agree), and will be conducted in accordance with the Rules&nbsp;except
as modified in this <u>Section&nbsp;11.5(d)</u>&nbsp;and (regardless of any
other choice of law provision in this Agreement) the Federal Arbitration Act (9
U.S.C. &#167;&#167; 1 et seq.).&#160; The claimant will
request that the American Arbitration Association (&#147;<b><u style="font-weight:bold;">AAA</u></b>&#148;) appoint a neutral and impartial
arbitrator as the third arbitrator in accordance with the Commercial
Arbitration Rules&nbsp;and the procedures set forth in this <u>Section&nbsp;11.5(d)</u>,
subject to the following: (i)&nbsp;the AAA will send simultaneously to each
party an identical list of at least nine arbitrator candidates (each of whom
will be either a retired judge with experience in commercial cases or a
practicing attorney with at least 15 years experience with large commercial
cases and some previous experience as an arbitrator); (ii)&nbsp;each party will
be permitted to strike two names from the list, will rank the remaining
candidates on the list, and will return the list to the AAA within 15 days of
the date of receipt; (iii)&nbsp;if a party does not return the list within the
time specified, all</h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">65</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='65',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.55pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">persons named in
the list will be considered acceptable; and (iv)&nbsp;from among the persons
who remain on both lists the AAA will invite the acceptance of the arbitrator
with the highest combined ranking to serve as the third arbitrator.&#160; The dispute resolution process will be held
at the offices of one of the arbitrators (or as the parties and the arbitrators
otherwise agree), and will be conducted according to the following provisions
of this <u>Section&nbsp;11.5(d)</u>.&#160; The
parties will submit such factual information and materials as they may desire
to place before the arbitrators and shall respond to questions as requested by
the arbitrators, the arbitrators may hold a one-day hearing, and the
arbitrators will undertake in good faith to issue a report (which will set
forth the determined relief, but need not set forth findings or explanations of
their determination) within 30 days after the dispute is referred to them.&#160; The arbitrators&#146; report will be based (to the
extent they consider it appropriate) on such information and on Matrix&#146;s
accounting and other records.&#160; The
arbitrators will not vary the terms of this Agreement, but rather will strictly
apply them to the dispute.&#160; The
arbitrators will not award costs or fees to any party.&#160; The decision and award of the arbitrators
will be final and binding on the parties as to any matters submitted under this
Section&nbsp;and may be entered in any court having jurisdiction.&#160; Each party will pay 50% of the arbitrators&#146;
fees and expenses, but otherwise each party will pay its own expenses in the
arbitration.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160; <b><i style="font-weight:bold;">Satisfaction of Obligation for
Covered Losses</i></b>.&#160; Subject
to the procedures set forth above and in accordance with the deadlines
specified in the preceding subsections, the Matrix Shareholders&#146; liability for
any Covered Losses will be satisfied by the Escrow Agent&#146;s satisfying such
Covered Loss as provided in the Escrow Agreement up to the full amount of the
Escrow Fund.&#160; Payments pursuant to the
foregoing will be by wire transfer or by check, as the Claimant may direct; <u>provided</u>,
<u>however</u>, that in the absence of directions within a reasonable period of
time, payment may be made by check.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;11.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Certain
Rules.</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160; <b><i style="font-weight:bold;">General</i></b>.&#160; The obligations in this <u>Article&nbsp;XI</u>
are for the benefit of the stated persons, their permitted successors and
assigns and their officers, directors, employees, agents and Affiliates, and
thus, among other things, includes any Covered Loss incurred or suffered by a
successor owner of an operation or asset of Matrix or replacements of them; and
consistent with the foregoing, Immucor or a successor owner (but not both) will
be entitled to the extent provided in this <u>Article&nbsp;XI</u> to claim an
adjustment to the Aggregate Merger Consideration for any Covered Loss incurred
or suffered by a successor owner of any operation or asset of Matrix.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160; <b><i style="font-weight:bold;">Mitigation</i></b>.&#160; Each party will use reasonable commercial
efforts to mitigate any Covered Loss that is potentially the basis for an
adjustment to the Aggregate Merger Consideration pursuant to this <u>Article&nbsp;XI</u>.</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt 16.35pt;text-align:left;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160; <b><i style="font-weight:bold;">Other</i></b>.&#160; No limitation in this <u>Article&nbsp;XI</u>
(including <u>Sections 11.3</u>, <u>11.5</u> and <u>11.7</u>) applies to any
Covered Loss with respect to, as a result of or involving (i)&nbsp;any breach
of a representation, warranty, covenant or agreement in this Agreement, whether
by act or omission, intended to mislead the party relying on it or (ii)&nbsp;fraud.</font></h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='66',FILE='C:\JMS\c900127\08-8252-1\task2782111\8252-1-kc-11.htm',USER='c900127',CD='Mar 15 04:05 2008' -->



<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Section&nbsp;11.7 Exclusive Remedies.</font></b> &#160;If the Closing occurs, the remedies provided
in this <u>Article&nbsp;XI</u> constitute the sole and exclusive remedies for
recoveries against the Matrix Shareholders for breaches of the representations,
warranties, covenants and agreements in this Agreement and for the matters
specifically listed in this <u>Article&nbsp;XI</u> as being the basis for
adjustment to the Aggregate Merger Consideration; provided, however, that
neither the foregoing nor anything else in this Agreement will limit the right
of any Immucor Protected Party (a)&nbsp;to enforce the performance of this
Agreement by any remedy available to it in equity, including specific
performance or (b)&nbsp;to any remedy whatsoever with respect to the Employment
Agreements, the Non-Competition Agreements and the New Subsidiary License.&#160; The Shareholders Agent Committee, on behalf
of the Matrix Shareholders, hereby waives any requirement that the party
seeking such equitable relief post a bond or other security.</p>

<h3 align="left" style="font-weight:normal;margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h3>

<h1 style="font-size:10.0pt;font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;text-indent:0in;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:none;">ARTICLE XII.</font></b><font face="Times New Roman" style="font-weight:normal;text-transform:none;"><br>
</font><font face="Times New Roman" style="text-transform:none;">DEFINITIONS</font></h1>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For purposes of this Agreement (and whether
or not underlined or used in the singular or plural):</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">2006
Balance Sheet</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.6</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">409A
Plan</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.14(k)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Acquisition
Proposal</u></b>&#148; has the meaning given such term in <u>Section&nbsp;5.5</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Agreement</u></b>&#148;
has the meaning given such term in the Preamble to the Agreement.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Affiliate</u></b>&#148;
means, with respect to any Person, any other Person who directly or indirectly,
through one or more intermediaries, controls, is controlled by, or is under
common control with, such Person, and the term &#147;control&#148; means the possession,
directly or indirectly, of the power to direct or cause the direction of the
management and policies of a Person, whether through the ownership of voting
securities, by contract or otherwise, and the terms &#147;controlled&#148; and &#147;controlling&#148;
have meanings correlative thereto.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Aggregate
Merger Consideration</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.6(c)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Assumed Option Aggregate
Transaction Consideration</u></b>&#148; means the sum of (i)&nbsp;the
Aggregate Merger Consideration (determined for this purpose without regard to <u>Section&nbsp;1.9(a)(vii)</u>)
plus (ii)&nbsp;the aggregate amount payable to Matrix if all Matrix Options
outstanding immediately prior to the Effective Time were exercised in full at
that time.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&#147;<u>Assumed Option Per Share Consideration</u>&#148;</font></b>
means the amount determined by dividing (i)&nbsp;the Assumed Option Aggregate
Transaction Consideration by (ii)&nbsp;the sum of (A)&nbsp;the total number of
shares of Matrix Common Stock, Series&nbsp;A Stock and Series&nbsp;B Stock
issued and outstanding immediately prior to the Effective Time, other than
Excluded Shares, plus (B)&nbsp;the total number of shares of Matrix Common
Stock issuable under all Matrix Options outstanding immediately prior to the
Effective Time.</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='67',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Authorization</u></b>&#148;
means any consent, authorization, clearance, order or approval, or filing or
registration.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Breach</u></b>&#148;
with respect to a representation or warranty means a misrepresentation, a
representation or warranty&#146;s being inaccurate or the omission of a fact
necessary to make any representation or warranty not misleading.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Business</u></b>&#148;
with respect to Matrix, means the business of Matrix as conducted as of the
date of this Agreement or as described in that certain Confidential Offering
Memorandum issued on March&nbsp;23, 2007 (the &#147;<b><u style="font-weight:bold;">Memorandum</u></b>&#148;) in connection with the offering and sale of Series&nbsp;E
Stock by Matrix.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Business
Day</u></b>&#148; means any day other than Saturday, Sunday, any day which is
a legal holiday under the Laws of the State of New York and any day on which
banking institutions in the State or City of New York are authorized or
required by Law to close.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Certificate
of Designation</u></b>&#148; means each of the Series&nbsp;C Certificate of
Designation, the</font> Series&nbsp;D Certificate of Designation, or the
Series&nbsp;E Certificate of Designation, as applicable.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Certificate
of Merger</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.2</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Claim</u></b>&#148;
means any claim, action, suit or proceeding.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Claimant</u></b>&#148;
has the meaning given such term in <u>Section&nbsp;11.5(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Closing</u></b>&#148;
has the meaning given such term in <u>Section&nbsp;1.2</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Closing
Date</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.2</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Code</u></b>&#148;
means </font>the Internal
Revenue Code of 1986, as amended.</p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Commercially
Available Software</u></b>&#148; means any Computer Software used by Matrix
pursuant to a Third Party Intellectual Property License, which License provides
that such Software may be used only for Matrix&#146;s internal business processing
and which Software was licensed for a license fee of less than $10,000 and is
generally commercially available.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Common
Stock Share Evaluation</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.6(c)(vii)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Computer
Software</u></b>&#148; means all computer software, including programs and
applications, object and source code, databases, algorithms, and documentation
therefor, in each case including all copyrights therefor.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Convertible
Preferred Stock</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.6(c)(viii)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Copyrights</u></b>&#148;
means all works of authorship, whether copyrightable or not, copyrights,
and&nbsp;mask works.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='68',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Covered
Damages</u></b>&#148; means and includes Covered General Damages and Covered
IP Damages.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Covered
General Damages</u></b>&#148; has the meaning given such term in <u>Section&nbsp;11.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Covered
IP Damages</u></b>&#148; has the meaning given such term in <u>Section&nbsp;11.2(b)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Covered
Loss</u></b>&#148; means any loss (whether in the nature of a cost, damage,
expense, payment, license fee, royalty payment, diminution in value, liability
or obligation or otherwise) incurred or suffered with respect to the acts or
omissions or facts or circumstances with respect to which such term is used and
includes (i)&nbsp;lost profits, lost revenues, special, incidental,
consequential, punitive or any other damages; (ii)&nbsp;any investigation,
cleanup, remediation or other response costs associated with obligations under
Environmental Laws; (iii)&nbsp;related attorneys&#146;, accountants&#146; and other
professional advisors&#146; fees and expenses (including those as to investigation,
prosecution or defense of any claim or threatened claim, rendering of opinions
concerning Intellectual Property matters, negotiations of settlements,
potential settlements, licenses and USPTO related third party disputes) and any
attorneys&#146; fees and expenses in connection with one or more appellate or
bankruptcy proceedings arising out of any such claim; (iv)&nbsp;amounts paid in
settlement of a dispute with a person not a party that if resolved in favor of
such third party would constitute a matter as to which a party is indemnified
or otherwise compensated (including as contemplated by <u>Article&nbsp;XI</u>)
pursuant to this Agreement, even though such settlement does not acknowledge
that the underlying facts or circumstances constitute a breach of a
representation and warranty or other indemnified or otherwise compensable
matter; (v)&nbsp;reasonable costs and expenses necessary to mitigate or avoid
an indemnification claim against another party pursuant to this Agreement or
that would have been reasonably expected to have been incurred by Matrix under
prior management because of customer relationships, expenses of litigation or
similar business reasons; (vi)&nbsp;to the extent that Matrix or Immucor takes
corrective action as to products manufactured or work performed before the
Closing Date by Matrix, Matrix or Immucor&#146;s cost, and (vii)&nbsp;interest on
the amount of each of the foregoing at the Prime Rate from the date such Covered
Loss was incurred until paid.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Designated
Matrix Employees</u></b>&#148; has the meaning given such term in <u>Section&nbsp;5.8</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">DGCL</u></b>&#148;
has the meaning given such term in <u>Section&nbsp;1.1</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Disclosure
Letter</u></b>&#148; means the letter delivered by Matrix to Immucor on the
date hereof, which contains certain exceptions to the representations and
warranties of Matrix in this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Dispute
Notice</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.9(d)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Dissenting
Shares</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.8</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Dissenting
Stockholder</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.8</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Distributor</u></b>&#148;
means any natural person or entity appointed by Matrix to distribute its
products.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='69',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Effective
Time</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.2</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Employee
Plans</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.14(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">End-User
Customer</u></b>&#148; means any customer other than a Distributor.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Environmental
Law</u></b>&#148; means any and all federal, state and local laws and
regulations pertaining to the protection of the environment, natural resources,
and health and safety as it relates to environmental protection currently in
effect in any and all jurisdictions in which the party in question owns
property or conducts business, including the Clean Air Act, as amended, the
Comprehensive Environmental, Response, Compensation, and Liability Act of 1980,
as amended (&#147;<b><u style="font-weight:bold;">CERCLA</u></b>&#148;), the
Federal Water Pollution Control Act, as amended, the Occupational Safety and
Health Act of 1970, as amended, the Resource Conservation and Recovery Act of
1976, as amended (&#147;<b><u style="font-weight:bold;">RCRA</u></b>&#148;),
the Safe Drinking Water Act, as amended, the Toxic Substances Control Act, as
amended, the Hazardous&nbsp;&amp; Solid Waste Amendments Act of 1984, as
amended, the Superfund Amendments and Reauthorization Act of 1986, as amended,
the Hazardous Materials Transpiration Act, as amended, and the Oil Pollution
Act of 1990.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">ERISA
Affiliate</u></b>&#148; means each trade or business (whether or not
incorporated) that together with Matrix is treated as a single employer
pursuant to Code Section&nbsp;414(b), (c), (m)&nbsp;or (o)&nbsp;or under the
comparable provisions of ERISA.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Escrow
Agent</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.2(b)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Escrow
Agreement</u></b>&#148; means that certain Escrow Agreement to be entered
into, as of the Effective Date, by and among Matrix, Immucor, the Shareholders
Agent Committee and the Escrow Agent.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Escrow
Amount Per Share</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Escrow
Fund</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Estimated
Price Adjustments</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.9(b)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&#147;<u>Exchange Act</u>&#148; </font></b>means<b>  </b>the Securities Exchange Act of 1934, as
amended, and the rules&nbsp;and regulations thereunder.</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Exchange
Agent</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.1(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Exchange
Fund</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.1(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Excluded
Shares</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.6(b)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Expenses
Fund</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.2(d)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">FIRPTA
Certificate</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.1(b)(i)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Governmental
Entity</u></b>&#148; means any executive, judicial or other public authority,
agency, department, bureau, division, unit or court or other public Person.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='70',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Governmental
Order</u></b>&#148; means any material order, writ, judgment, injunction,
decree, stipulation, determination, agreement, arrangement or award entered by
or with any Governmental Entity.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Hazardous
Materials</u></b>&#148; means any element, compound, substance or other
material (including any pollutant, contaminant, hazardous waste, hazardous
substance, chemical substance or product that is listed, classified or
regulated pursuant to any Environmental Law, including any petroleum product,
by-product or additive, asbestos, presumed asbestos-containing material,
asbestos-containing material, medical waste, biological waste,
chloroflourocarbon, hydrochloroflourocarbon, lead-containing paint or plumbing,
polychlorinated biphenyls (PCBs), radioactive material, infectious materials,
potentially infectious or toxic materials or disinfecting agents.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">HSR
Waiting Period</u></b>&#148; means the waiting period applicable to the
Merger under the HSR Act.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Immucor</u></b>&#148;
has the meaning given such term in the Preamble to the Agreement.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Immucor
Material Adverse Effect</u></b>&#148; means a material adverse effect on the
business, properties, assets, liabilities, results of operations, prospects or
financial condition of Immucor and its subsidiaries, taken as a whole, but
excluding any effect resulting from (a)&nbsp;general economic conditions or
general effects on the industry in which Immucor and Merger Sub are primarily
engaged, (b)&nbsp;the public announcement of the transactions contemplated by
this Agreement or (c)&nbsp;from action taken by Matrix or any of its Affiliates
or representatives.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Immucor
Protected Property</u></b>&#148; has the meaning given such term in <u>Section&nbsp;11.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Indebtedness</u></b>&#148;
means, as to any Person, without duplication (a)&nbsp;all obligations of such
Person for borrowed money (including reimbursement and all other obligations
with respect to surety bonds, letters of credit and bankers&#146; acceptances,
whether or not matured), (b)&nbsp;all obligations of such Person to pay the
deferred purchase price of property or services, except trade accounts payable
and accrued commercial or trade liabilities arising in the ordinary course of
business, (c)&nbsp;all interest rate and currency swaps, caps, collars and
similar agreements or hedging devices under which payments are obligated to be
made by such Person, whether periodically or upon the happening of a
contingency, (d)&nbsp;all indebtedness created or arising under any conditional
sale or other title retention agreement with respect to property acquired by
such Person (even though the rights and remedies of the seller or lender under
such agreement in the event of default are limited to repossession or sale of
such property), (e)&nbsp;all obligations of such Person under leases which have
been or should be, in accordance with GAAP consistently applied, recorded as
capital leases, (f)&nbsp;all indebtedness secured by any Lien (other than Liens
in favor of lessors)&nbsp;on any property or asset owned by that Person
regardless of whether the indebtedness secured thereby shall have been assumed
by that Person or is non-recourse to the credit of that Person, together with
any accrued and unpaid interest thereon, and (g)&nbsp;any guarantees made by
such Person of any of the Indebtedness of any other Person described in clauses
(a)&nbsp;through (f).</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Independent
Accountants</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.9(e)</u>.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">71</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='71',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Individual
Escrow Amount</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Information Statement</u></b>&#148;
has the meaning given such term in <u>Section&nbsp;5.1(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Intellectual
Property</u></b>&#148; means all intellectual property and other similar
proprietary rights in any jurisdiction, whether owned or held for use under
license, whether registered or unregistered, including such rights in and to: (i)&nbsp;Trademarks;
(ii)&nbsp;Patents; inventions, invention disclosures, discoveries and
improvements, whether or not patentable; (iii)&nbsp;Copyrights; (iv)&nbsp;Trade
Secrets; (v)&nbsp;Computer Software; (vi)&nbsp;domain names and uniform
resource locators; (vii)&nbsp;moral rights; and (viii)&nbsp;claims, causes of
action and defenses relating to the enforcement of any of the foregoing; in
each case, as applicable, including any registrations of, applications to
register, and renewals, modifications and extensions of, any of the foregoing
with or by any governmental authority in any jurisdiction.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Knowledge</u></b>&#148;
means, with (i)&nbsp;respect to Matrix, the present actual knowledge of Dr.&nbsp;Michael
Seul and Messrs.&nbsp;Chiu Chau, R. James Danehy and Eric Mirabel, and (ii)&nbsp;with
respect to Immucor and Merger Sub, the present actual knowledge of Immucor&#146;s
CEO, President, CFO or General Counsel.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Law</u></b>&#148;
means any law, ordinance, regulation, policy, order and rule&nbsp;in effect as
of the Closing Date.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Lazard</u></b>&#148;
has the meaning given such term in <u>Section&nbsp;1.9(a)(ii)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Leases</u></b>&#148;
has the meaning given such term in <u>Section&nbsp;3.16(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Liabilities</u></b>&#148;
means and includes Matrix&#146;s Indebtedness and its other liabilities or
obligations of any kind whatsoever, whether accrued, absolute, contingent,
changing, known, unknown, determinable, indeterminable, liquidated,
unliquidated or otherwise and whether due or to become due in the future.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Licensed
Matrix Intellectual Property</u></b>&#148; has the meaning given such term in
<u>Section&nbsp;3.13(c)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Liens</u></b>&#148;
means liens, mortgages, security interests, pledges, charges, other rights of
third parties or other encumbrances.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Mailing
Date</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.7</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Majority Stockholders
Consent</u></b>&#148; has the meaning given such term in <u>Section&nbsp;5.1(c)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix</u></b>&#148;
has the meaning given such term in the Preamble to the Agreement.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Capital Stock</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Certificates</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.6(c)(ix)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Common Stock</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.2(a)</u>.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='72',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Contracts</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.17</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Delivered Agreements</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.3</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Financial Statements</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.6</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Intellectual Property</u></b>&#148; means all Intellectual Property that is
used or held for use in connection with the Business of Matrix.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Licenses</u></b>&#148; means any licenses, permits, certificates, franchises,
registrations, consents, Authorizations or other rights filed with, granted,
issued by, or entered by any Governmental Entity that are required for the
conduct of Matrix&#146; Business as now and then being conducted.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix</u></b><u>
<b>Material Adverse Effect</b></u>&#148; means
(i)&nbsp;a material adverse effect on the Business, properties, assets,
liabilities, results of operations, financial condition or prospects of Matrix,
taken as a whole, but excluding any effect resulting from (a)&nbsp;general
economic conditions or general effects on the industry in which Matrix is
primarily engaged, (b)&nbsp;the public announcement of the transactions
contemplated by this Agreement, or (c)&nbsp;action taken by Immucor or any of
its Affiliates or representatives; or (ii)&nbsp;the assertion of one or more
Claims or the occurrence of other events or circumstances regarding
Intellectual Property which lead Immucor to determine in good faith that, if
the Closing occurs, the amounts Immucor Protected Parties are reasonably likely
to recover in respect of Covered IP Damages under <u>Article&nbsp;XI</u> of
this Agreement will be materially less than the sum of (x)&nbsp;80% of the
amounts Immucor Protected Parties are reasonably likely to suffer or incur
after the Closing&#160; Date that would be
Covered IP Damages, plus (y)&nbsp;100% of the amounts Matrix has incurred after
the date of this Agreement and is reasonably likely to incur on or prior to the
Closing Date that would be Covered IP Damages.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Option</u></b>&#148; means each option or warrant or other right to acquire
shares of Matrix Capital Stock.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Shareholders</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Matrix
Shareholders Agreements</u></b>&#148; has the meaning given such term in <u>Section&nbsp;5.9</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Merger</u></b>&#148;
has the meaning given such term in <u>Section&nbsp;1.1</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Merger
Sub</u></b>&#148; has the meaning given such term in the Preamble to the Agreement.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Multi-Employer
Plan</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.14(a)(iii)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">New
Subsidiary</u></b>&#148; means BCT Holdings, LLC, a Delaware limited
liability company.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">New
Subsidiary License</u></b>&#148; means that certain license agreement to be
entered into prior to the Closing by Matrix and the New Subsidiary with respect
to certain of Matrix&#146;s Intellectual Property Rights substantially in the form
attached hereto as <u>Exhibit&nbsp;B</u>.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='73',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Notice
of Defense</u></b>&#148; has the meaning given such term in <u>Section&nbsp;11.5(b)(i)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman"><font style="font-size:10.0pt;font-weight:bold;">&#147;</font><u>OGT Patents</u>&#148; </font></b>means those patent and patent rights
listed in <u>Section&nbsp;3.10 of the Disclosure Schedule</u>.</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Option
Cash Payment</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.7</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Owned
Matrix Intellectual Property</u></b>&#148; has the meaning given such term in
<u>Section&nbsp;3.13(c)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Participants</u></b>&#148;
means current or former employees, officers, directors, independent
contractors, leased employees, consultants or agents of Matrix or any ERISA
Affiliate or their beneficiaries or dependents.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Participating
Option Holders</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Party</u></b>&#148;
or &#147;<b><u style="font-weight:bold;">Parties</u></b>&#148; has the
meaning given such terms in the Preamble to the Agreement.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Patents</u></b>&#148;
means all issued patents, including design patents and utility patents, pending
patent applications, and any and all reissues, divisions, continuations,
continuations-in-part, continuing patent applications, reexaminations, and
extensions thereof, any counterparts claiming priority therefrom, utility
models, patents of importation/confirmation, certificates of invention,
certificates of registration and like rights.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Pending
Claim</u></b>&#148; means any claim for the payment of Covered Damages to an
Immucor Protected Party that is pending, including one as to which notice of
facts giving rise to the claim has been given pursuant to <u>Section&nbsp;11.5(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Pension/Profit-Sharing
Plan</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.14(a)(i)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Per
Share Merger Consideration</u></b>&#148; means and includes the Series&nbsp;E
Per Share Merger Consideration, Series&nbsp;D Per Share Merger Consideration, Series&nbsp;C
Per Share Merger Consideration, Series&nbsp;B Per Share Merger Consideration, Series&nbsp;A
Per Share Merger Consideration and Common Stock Per Share Merger Consideration,
as applicable.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Person</u></b>&#148;
means any individual, sole proprietorship, partnership, joint venture,
corporation, estate, trust, unincorporated organization, association, limited
liability company, institution or other entity.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Preferred Class&nbsp;Merger
Votes</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.3(b)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&#147;<u>Preferred Stock Waivers</u>&#148; </font></b>has
the meaning given such term in <u>Section&nbsp;3.3(b)</u>.</p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Price
Adjustments</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.9(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Prime
Rate</u></b>&#148; means the prime rate as published in the &#147;Money Rates&#148;
table of <u>The Wall Street Journal</u> on the first publication date of the
calendar quarter in which a Covered Loss was</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='74',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">incurred and on the first such
day of each subsequent calendar quarter in which such Covered Loss is unpaid.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Prior
Transactions</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.30</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Properties</u></b>&#148;
has the meaning given such term in <u>Section&nbsp;3.16(b)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Purchaser
Delivered Agreements</u></b>&#148; has the meaning given such term in <u>Section&nbsp;4.2</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Reasonable License</u></b>&#148;
has the meaning given such term in Section&nbsp;11.2(b)(iv).</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&#147;<u>Required Merger Stockholder Votes</u>&#148; </font></b>has
the meaning given such term in <u>Section&nbsp;3.3(b)</u>.</p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">SEC </u></b>&#147;
means the U.S. Securities and Exchange Commission.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;A
Per Share Merger Consideration</u></b>&#148; has the meaning given such term
in <u>Section&nbsp;1.6(c)(vi)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;A
Stock</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;B
Per Share Merger Consideration</u></b>&#148; has the meaning given such term
in <u>Section&nbsp;1.6(c)(v)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;B
Stock</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&#147;<u>Series&nbsp;C Certificate of Designation</u>&#148;
</font></b>means the Certificate of Designation of Series&nbsp;C
Convertible Preferred Stock of Matrix dated November&nbsp;30, 2004, as amended.</p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;C
Per Share Merger Consideration</u></b>&#148; has the meaning given such term
in <u>Section&nbsp;1.6(c)(iv)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;C
Share Evaluation</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.6(c)(iv)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;C
Stock</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&#147;<u>Series&nbsp;D Certificate of Designation</u>&#148;
</font></b>means the Certificate of Designation of Series&nbsp;D
Convertible Preferred Stock of Matrix dated May&nbsp;26, 2005, as amended.</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;D
Per Share Merger Consideration</u></b>&#148; has the meaning given such term
in <u>Section&nbsp;1.6(c)(iii)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;D
Share Evaluation</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.6(c)(iii)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;D
Stock</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&#147;<u>Series&nbsp;E Certificate of Designation</u>&#148;
</font></b>means the Certificate of Designation of Series&nbsp;E
Convertible Preferred Stock of Matrix dated June&nbsp;21, 2007, as amended.</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='75',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;E
Per Share Merger Consideration</u></b>&#148; has the meaning given such term
in <u>Section&nbsp;1.6(c)(ii)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;E
Share Evaluation</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.6(c)(ii)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Series&nbsp;E
Stock</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Shareholders
Agent Committee</u></b>&#148; has the meaning given such term in <u>Section&nbsp;10.1</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Share
Valuation</u></b>&#148; means and includes the Series&nbsp;E Share Valuation,
Series&nbsp;D Share Valuation, Series&nbsp;C Share Valuation, Series&nbsp;A
Share Valuation and Common Stock Share Valuation, as applicable.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Specified
Taxes</u></b>&#148; has the meaning given such term in <u>Section&nbsp;5.10(c)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Straddle
Period</u></b>&#148; has the meaning given such term in <u>Section&nbsp;5.10(b)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Subsidiary</u></b>&#148;
means, with respect to Matrix, any corporation or other organization, whether
incorporated or unincorporated, of which at least fifty percent (50%) of the
securities or interests having by the terms thereof voting power to elect at
least fifty percent (50%) of the board of directors or others performing
similar functions with respect to such corporation or other organization is
directly or indirectly owned or controlled by Matrix.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Surviving
Corporation</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.1</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Tax</u></b>&#148;
or &#147;<b><u style="font-weight:bold;">Taxes</u></b>&#148; means and
includes any and all taxes, fees, levies, assessments, duties, tariffs,
imposts, and other charges of any kind (together with any and all interest,
penalties, additions to tax and additional amounts imposed with respect
thereto) imposed by any Governmental Entity, including: domestic, central,
local, state or other jurisdictional taxes or other charges on or with respect
to income, estimated income, franchises, business, occupation, windfall or
other profits, gross receipts, property, sales, use, capital stock, payroll,
employment, social security, workers&#146; compensation, unemployment compensation,
or net worth; taxes or other charges in the nature of excise, withholding, ad
valorem, stamp, transfer, value added, or gains taxes; license, registration
and documentation fees; and customs duties, tariffs, and similar charges.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Tax
Authority</u></b>&#148; has the meaning given such term in <u>Section&nbsp;3.15(b)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Tax
Return</u></b>&#148; means any return, report, or similar statement required
to be filed with respect to any Tax (including any schedules or attachments
thereto), including any information return, claim for refund, amended return or
declaration of estimated Tax and any amendments to any of the foregoing.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Third
Party Claim</u></b>&#148; has the meaning given such term in <u>Section&nbsp;11.5(b)(i)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Third
Party Intellectual Property Licenses</u></b>&#148; has the meaning given such
term in <u>Section&nbsp;3.13(b)</u>.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='76',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Total
Fund Shares</u></b>&#148; has the meaning given such term in <u>Section&nbsp;2.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Total
Option Cash Payments</u></b>&#148; has the meaning given such term in <u>Section&nbsp;1.7</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Trade
Secrets</u></b>&#148; means all trade secrets (including those trade secrets
defined in the Uniform Trade Secrets Act and under corresponding foreign
statutory and common law), and other material confidential or non-public
business information, including ideas, formulas, compositions, technical
documentation, operating manuals and guides, plans, designs, sketches,
inventions, production molds, product specifications, equipment lists,
engineering reports and drawings, architectural and engineering plans,
manufacturing and production processes and techniques; computer software and/or
hardware design, development, testing, support and maintenance techniques,
methodologies, processes and/or procedures, drawings, specifications, plans,
proposals, research records, inspection processes, invention records and
technical data, financial, marketing and business data, pricing and cost
information, business and marketing plans and customer and supplier lists and
information, licensing records, service and parts records, warranty records, maintenance
records and similar records and all other know-how, whether or not protected by
patent, copyright or trade secret law and rights to limit the use or disclosure
of the foregoing.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Trademarks</u></b>&#148;
means all trademarks, service marks, logos, brand names, certification marks,
trade dress, assumed names, trade names and other indications of origin and the
goodwill associated with the foregoing.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">Transaction
Document</u></b>&#148; has the meaning given such term in <u>Section&nbsp;10.2(a)</u>.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">USCIS</u></b>&#148;
means U.S. Citizenship and Immigration Services.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><u style="font-weight:bold;">USPTO</u></b>&#148;
means U.S. Patent and Trademark Office.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[<i>signatures
on next page</i>]</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">77</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='77',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be
duly executed as of the date first above written.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">IMMUCOR:</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IMMUCOR, INC.</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.08%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.92%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">/s/&nbsp;</font>Gioacchino
  DeChirico</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt 40.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gioacchino DeChirico</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt 40.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President and CEO</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">MERGER SUB</font></b>:</p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">MATRIX ACQUISITION COMPANY,
  INC.</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.08%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.92%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/&nbsp;Gioacchino DeChirico</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt 40.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gioacchino DeChirico</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt 40.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">MATRIX:</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIOARRAY SOLUTIONS, LTD.</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.08%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.92%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">/s/&nbsp;</font>Michael
  Seul</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt 40.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael Seul, Ph.D.</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt 40.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CEO</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SHAREHOLDERS AGENT COMMITTEE:</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/&nbsp;William Gedale</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="border:none;padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">William Gedale</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/&nbsp;Daniel Vapnek</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="border:none;padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel Vapnek</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/&nbsp;Michael Seul</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="border:none;padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael Seul, Ph.D.</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">78</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='78',FILE='C:\JMS\brosent\08-8252-1\task2786109\8252-1-kc-13.htm',USER='brosent',CD='Mar 17 15:55 2008' -->


</body>

</html>
</TEXT>
</DOCUMENT>
